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Around 1% of all pregnancies are twin gestations. Approximately 70% of twin pregnancies 
are non-identical twins (dizygotic); the other 30% are identical (monozygotic) twins. 
Dizygotic twins result from the fertilization of two eggs, and apart from a few exceptions, 
have separate placentas and separate inner (amnion) and outer (chorion) membranes. 
Each fetus is supplied by its own placenta. Therefore, by definition, dizygotic twins are 
dichorionic (DC) (e.g. have two placentas).
In monozygotic twinning, one zygote (fertilized egg) splits into two separate embryos, 
ultimately forming two (identical) individuals. Placentation in monozygotic twins 
depends on the timing of separation. If  cleavage occurs before day 3 post-conception, 
both twins have separate placentas and each twin has its own chorionic and amniotic 
membranes.1 Such twins are often indistinguishable from dizygotic twins, at least on 
ultrasound and by placental examination. 
In the majority of monozygotic twins (70-75%), cleavage occurs within 3-8 days 
and twins share one single placenta, one single chorionic membrane but they have 
separate amniotic sacs. These twins are called monochorionic (MC) diamniotic twins. 
Division after 8 days results in monochorionic monoamniotic (MA) twins (sharing one 
placenta and one amniotic sac). MA pregnancies are rare and account for 1-5% of all 
monozygotic twin pregnancies.2-4 Except for some sporadic cases5,6 all MC pregnancies 
are monozygotic. (Figure 1)
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Figure 1. Dizygotic twins versus monozygotic twins resulting in dichorionic (DC) and monochorionic 
(MC) twins
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IChorionicity (whether or not twins share a placenta), rather than zygosity, determines the outcome of twin pregnancies. MC twins have a two times higher risk on adverse 
perinatal outcome compared to DC twins and four times higher compared to singletons.7,8 
Some complications can only occur in twins that share a placenta, therefore ultrasound 
examination, preferably in the first trimester, to determine the number of placentas and 
amniotic sacs is crucial.
Problems that occur exclusively in MC pregnancies arise from the blood vessels that 
connect the circulations of both twins, called vascular anastomoses. These vascular 
anastomoses are present in virtually all MC twin placentas, and almost never occur 
in DC placentas. Three different types of vascular anastomoses can be identified: 
unidirectional artery to vein anastomoses (AV) and the superficial bidirectional artery-
to-artery (AA) and vein to vein (VV) anastomoses. (Figure 2) Intertwin transfusion 
through these vascular anastomoses can lead to various complications including twin-
twin transfusion syndrome (TTTS), twin anemia polycythemia sequence (TAPS) and 
twin reversed arterial perfusion (TRAP).
Figure 2. Placenta injected with colored dye illustrating the different types of vascular anastomoses 
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2. TWIN-TWIN TRANSFUSION SYNDROME
TTTS is a condition that complicates 10% of MC pregnancies.8,9 This syndrome is 
the result of an unbalanced exchange of blood through the vascular anastomoses at 
the placental surface. This imbalance occurs when blood flow from one twin through 
unidirectional AV anastomoses is insufficiently compensated by blood flow through AV 
anastomoses in the opposite direction or through bidirectional superficial AA or VV 
anastomoses. This imbalance creates a transfusion from one twin (the donor) to the 
other twin (the recipient). The number, size and type of anastomoses play an important 
role in the development of TTTS.10,11 
The transfusion causes the donor twin to have decreased blood volume resulting in 
decreased urinary output, leading to a low level of amniotic fluid (oligohydramnios). 
The blood volume of the recipient twin is increased, which causes a higher than normal 
urinary output, which leads to excess amniotic fluid (polyhydramnios) and can strain the 
fetal heart and eventually can lead to heart failure. (Figure 3) 
Figure 3. Twin-twin transfusion syndrome. (TTTS) D is donor, R is recipient
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ITTTS carries a high risk of adverse perinatal outcome due to miscarriage, intrauterine death or premature birth. The polyhydramnios in turn may cause the rupture of 
membranes, contractions, cervical shortening and immature or premature birth. If  not 
treated, mortality rates in TTTS may be as high as 80 to 100%.12-14 Treatment options for 
TTTS include symptomatic treatment with amniodrainage (draining of excess amniotic 
fluid through a needle that is passed into the sac of the recipient to reduce the symptoms 
caused by polyhydramnios) or causal treatment with fetoscopic laser coagulation of the 
vascular anastomoses. First choice treatment is laser coagulation.12,15-17 (Figure 4)




Fetoscopic laser coagulation is a technique used to separate the fetal circulations by 
coagulating the connecting vessels with a laser beam. (Figure 4) The surgeon introduces 
a small fetoscope into the amniotic cavity of the recipient twin, identifies the vascular 
equator (place where the vascular anastomoses meet) and attempts to laser them one by 
one. By coagulation of all vascular anastomoses the underlying cause of the disease is 
addressed through a single intervention.
With this treatment, perinatal outcome improved compared to serial amniodrainage, 
(drainage of the excess amniotic fluid without adressing the cause of the problem; the 
vascular anastomoses) however, results are still far from optimal. After laser therapy 
survival rates of both fetuses reach 35-67%.12,18-22 Among the surviving children, 4–16% 
have signs of cerebral injury and 6–18% have neurodevelopmental complications.23-26 
 
The goal of fetoscopic laser surgery is to coagulate all anastomoses. However, in up to 
4-33% of treated pregnancies, some intertwin vascular connections remain patent.27-31 
These remaining connections, called residual anastomoses, are associated with severe 
complications such as TAPS (13%) or recurrent TTTS (14%).32,33 A modified laser 
technique; the Solomon technique, was developed to minimize the occurrence of residual 
anastomoses. (Figure 5)
The rationale of the Solomon technique is coagulation of the whole vascular equator 
from one placenta margin to the other (drawing a line). Recently, a large randomized 
controlled trial showed that the Solomon technique significantly reduced the risk on 
TAPS and recurrent TTTS.33,34 
15
I
Figure 5. Fetal therapy team during operation and vascular anastomoses before and after laser 
coagulation using Solomon technique
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4. LEARNING CURVE
It has only been 25 years since fetoscopic surgery was performed for the first time and 
nowadays it is still offered in a limited number of highly specialized Maternal Fetal 
Medicine (MFM) centers around the world. Recently published series from even the 
most experienced groups still show a high percentage of single or double fetal loss, and a 
mean gestational age at birth of around 32 weeks.21,22 In this thesis we evaluate outcomes 
of the pioneers in fetal therapy in the beginning years compared to current performance.
Since 2000, over 600 MC twin pregnancies complicated by TTTS have been treated with 
fetoscopic laser surgery in the Leiden University Medical Center (LUMC). The LUMC 
is one of the eight tertiary care centers in the Netherlands, and serves as the national 
referral center for fetal therapy. Per year 60-70 patients are treated with laser surgery.
With the acceptance of laser surgery as the best treatment, an increasing number of 
centers offering this procedure are expected. There is concern that a more widespread 
use of this technique, at least temporarily, will lead to less favourable outcomes due to 
learning curve impacts and small numbers. Since TTTS is rare, and both the surgical 
procedure as well as careful selection of cases and optimal timing of treatment is 
complex, concentration of care in specialized MFM centers has been advocated. 
The concept of a “learning curve” is being used increasingly in surgical training and 
education to denote the process of gaining knowledge and improving skills.35,36 An 
often-arising question in all types of surgery is the actual number of procedures an 
individual operator has to perform to achieve satisfactory outcomes and results. In 
principle, novice surgeons are assumed to perform surgery less safely and efficiently than 
more experienced colleagues at the peak of their career.37 
In addition, there are hardly any studies that address monitoring of performance 
among experienced operators in fetoscopic surgery. In other (surgical) areas this topic 
is extensively studied since assessment of performance can improve quality of care.38 
Without the use of quality monitoring systems, substandard care and errors may easily 
be underestimated. 
Therefore in this thesis we aim to investigate the learning curves and evaluate performance 
of individual operators in fetoscopic surgery.
 
Several authors initially documented treatment criteria and laser techniques39,40 and 
(minor) modifications have been introduced through the years.31,41-43 Today, quite 
substantial differences appear to exist between centers in their specific approaches, 
instrumentation and guidelines for accepting patients for laser surgery, making it difficult 
to compare results between centers. 
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IAs in many fields of medicine and in particular in surgery, concentration of care for highly specialized procedures has been recommended,44,45 and the relationship between 
surgical volume and operative outcome was investigated.46,47 Performance by high-
volume surgeons and at high-volume hospitals is associated with reduction in morbidity 
and lower costs.48,49 In this thesis we aim to identify the differences in practice of fetal 
therapy centers and relate this to center volume. 
5. CHALLENGING MONOCHORIONIC PREGNANCIES
Fetoscopic laser therapy, although quite effective, is associated with high risk of 
complications.43,50,51 Complications that occur in the first week after fetoscopic laser 
surgery include miscarriage, premature rupture of membranes immediately after 
intervention, placental abruption and intrauterine fetal death. Late complications 
include preterm premature rupture of membranes before 32 weeks gestations, fetal 
demise, recurrence of TTTS and TAPS and neonatal death.
Some surgeries are more challenging than others. In this thesis we concentrate on the 
following subgroups with TTTS; monoamniotic (MA) pregnancies, pregnancies with 
unintentional perforation of the intertwin dividing membranes and triplets.
Spontaneous MA pregnancies are rare and account for 1% of all monozygotic 
conceptions.2,3,52 The perinatal loss rate in MA twins varies from 8 to as high as 42%.53,54,55 
High perinatal loss rates have been attributed mainly to umbilical cord entanglement, 
intertwin transfusion syndromes, discordant fetal abnormalities or growth and preterm 
birth.2,56,57 
Due to close proximity of the umbilical cord insertions and absence of amniotic 
membrane separating the two cords, entanglement (with the cords forming a knot) 
occurs in almost all MA pregnancies. During labor and birth compression on either 
of the cords by pulling the knot may lead to discontinuation of the blood flow, and 
is suspected to be the cause of double intrauterine fetal demise. Fetal sonographic 
surveillance and preterm caesarean section as mode of delivery is advised. In some of 
these cases antenatal surgical interventions become necessary. In this thesis we aim to 
review relevant aspects of fetal surgical interventions in complicated MA pregnancies.
 
As with all invasive procedures, perioperative complications of laser surgery itself  
increase the risk of adverse outcome.58 One of these complications is unintentional 
perforation of the intertwin dividing membranes (e.g. the plane of separation between 
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the two twins by the amniotic membranes), thereby creating an iatrogenic MA twin 
pregnancy. 
Some of the complications of spontaneous MA may also occur in iatrogenic MA 
pregnancies. Clinical implications of iatrogenic MA twins, and optimal management 
strategies in these pregnancies, have not yet been established. Since perforation is not 
always detected during or directly after surgery, this diagnosis can be missed easily, 
unless specific attention is given to its features during follow up examinations. If  rupture 
of the intertwin membranes is suspected, pregnancies are often monitored more closely, 
hospitalization after viability is considered and a preterm cesarean section is scheduled 
between 32 and 34 weeks’ gestation to prevent cord accidents. (Figure 6) Uncomplicated 
MC twin pregnancies after laser surgery are often allowed to continue to around 36 
weeks. Therefore, in this thesis we study if  this group of MC pregnancies treated with 
laser therapy was associated with lower gestational age at birth, with concomitant 
adverse effects on neonatal morbidity.
Figure 6. Iatrogenic monoamniotic (MA) placenta with knot in the umbilical cords
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ITTTS is not only seen in MC twins, it can also occur in higher order multiple pregnancies such as triplet gestations. Management options depend on the type of placentation; 
triplet pregnancies can be trichorionic (i.e. 3 fetuses with separate placentas and amniotic 
cavities), dichorionic (DC) (i.e. monochorionic twins and a singleton with a separate 
placenta) or monochorionic (MC). (i.e. 3 fetuses with one shared placenta and three 
amniotic cavities) The prognosis of TTTS in MC triplets is considered to be different 
from DC triplets and has been reported to be severe, with higher rates of mortality 
and preterm birth, despite intervention.59,60 Although technically more challenging, 
fetoscopic surgery is feasible in triplets. In this thesis we compare perinatal outcome of 
MC and DC triplets with TTTS.
6. STANDARDIZED TREATMENT AND TRAINING
It is clear that fetoscopic surgery is restricted to a few highly specialized surgeons. 
However, coming years more fetal surgery will be performed. It is expected that new 
centers that start to perform fetal therapy will exhibit a learning curve and require 
guidance in learning the procedure. To ensure that the level of expertise is maintained, an 
evidence based training curriculum and continuous process of reporting and monitoring 
of outcomes is required. 
Standardized surgical training programs for fetoscopic surgery are nonexistent. Since 
definitions of errors and inadequate technique are lacking, educators often base their 
teaching on personal experience and individual preferences. In this thesis we focus on 
the development of evidence-based guidelines for fetoscopic laser treatment of TTTS.
Learning skills from an experienced mentor will always continue to play a significant 
role in training. However, there is an increasing need for a standardized evidence-based 
tool to train and evaluate trainees. In this thesis we develop and a procedure-specific 
evaluation tool for fetoscopic laser surgery. 
As for any other procedure it seems logical to offer appropriate training and supervise 
early practice. Since fetoscopic procedures are performed on an infrequent basis, the 
surgeon in training is forced into a lengthy and expensive stay in a (often distant) 
fetal therapy center to accumulate at least some hands-on experience. Even large 
fetal treatment centers have limited numbers of cases, and animal models are lacking, 
therefore teaching and training this procedure is challenging. 
In addition, ethical concerns are raised about teaching basic skills on a patient, when 
alternatives are available. Skills acquired on box trainers 61,62 and virtual reality trainers63,64 
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are transferable to surgery on real patients. Simulator training may bypass the early 
learning curve, which is known to be associated with an higher rate of complications.65 
Therefore we investigate if  a standardized training curriculum using a high fidelity 
simulator can contribute to retaining high standards and quality of care in fetal therapy. 
(Figure 7)
Figure 7. Simulator model for fetal therapy
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I7. OUTLINE OF THIS THESIS
Teaching and quality control in fetoscopic surgery
Fetoscopic surgery is a surgical technique that is used to treat fetus(es) that are still inside 
the pregnant uterus. Coming years, more fetoscopic surgery will be performed. The most 
commonly performed procedure is laser surgery for twin-twin transfusion syndrome. 
This thesis shows learning curves for this procedure and current practice in relation 
to technical aspects and pregnancy outcomes. We show how to monitor performance 
and address specific subgroups in which laser surgery can be more complicated. Since 
teaching and training in fetoscopic surgery is challenging, we create and validate an 
evidence-based evaluation tool for the laser procedure. To conclude, we develop a 
standardized training curriculum with a high fidelity simulator model.
Part I. General introduction
Part II. Learning curve and current practice 
Chapter 1 – Learning curve and ongoing quality control for fetoscopic laser 
coagulation in TTTS. Using the cumulative sum analysis this study assesses 
the learning curves and monitored ongoing performance of four operators 
performing fetoscopic laser therapy. 
Chapter 2 – Global survey on laser surgery for TTTS. In this study we evaluate 
the differences between international fetal centers in their treatment of TTTS 
by fetoscopic laser therapy.
Chapter 3 – Review of literature on survival after fetoscopic laser surgery in 
TTTS comparing the outcomes of early years of practice with current practice.
 
Part III. Challenging monochorionic pregnancies
Chapter 4 – Case series and review of the literature on antenatal surgical 
interventions in MA pregnancies complicated by TTTS, TRAP, discordant 
anomalies, or request for elective reduction.
Chapter 5 – In this study we evaluate management and outcome of pregnancies 
treated with laser surgery for TTTS complicated by iatrogenic rupture of 
the intertwin dividing membranes compared to those with intact intertwin 
membranes. 
Chapter 6 – In this study we evaluate outcome of monochorionic triplets 
complicated by feto-fetal transfusion syndrome. We compare monochorionic 
triplets with dichorionic triplet and perform a review of the literature.
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Part IV. Model for training laser therapy
Chapter 7 – Study on the essential steps of the laser procedure for TTTS. Using 
the Delphi methodology we create an evidence based evaluation instrument to 
assess fetal surgeons.
Chapter 8 – In this study we assess reliability and construct validity of an 
evaluation instrument that can be used for technical skills assessment and 
feedback in training fetal surgeons. 
Chapter 9 – We conducted a randomized controlled trial to evaluate the effect of 
a standardized simulator training for fetoscopic laser surgery. 
Part V. Summary 
Part VI. General discussion
In the summary and general discussion the most important findings of this 
thesis are outlined and future perspectives are given.
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ABSTRACT
Objective. To identify a learning curve and monitor operator performance for fetoscopic 
laser surgery for twin-to-twin transfusion syndrome using cumulative sum analysis. 
Design. Retrospective cohort study. 
Setting. National tertiary referral center for invasive fetal therapy. 
Population. A total of 340 consecutive monochorionic pregnancies with twin-to-twin 
transfusion syndrome treated with fetoscopic laser coagulation between August 2000 
and December 2010. 
Methods. A learning curve was generated using learning curve cumulative sum analysis 
and cumulative sum methodology to assess changes in double survival across the case 
sequence. Laser surgery was initially performed by two operators, joined by a third and 
fourth operator after 1 and 2 years, respectively. 
Main outcome measures. Individual operator performance, double perinatal survival at 
4 weeks.
Results. Overall survival of both twins occurred in 59% (201/340), median gestational 
age at birth was 32.0 weeks. Cumulative sum graphs showed that level of competence 
for double survival for the operators was reached after 26, 25, 26, and 35 procedures, 
respectively. Two operators kept their competence level and continued to improve after 
completing the initial learning process; two others went out of control at one point in 
time, according to the cumulative sum boundaries. A difference in learning effect was 
associated with number of procedures performed annually and previous experience with 
other ultrasound-guided invasive procedures. 
Conclusions. This study shows that all operators reached a level of competence after at 
least 25 fetoscopic laser procedures and confirms the value of using the cumulative sum 




Mastering the skills necessary to perform surgical procedures with success, ease, and 
safety represents a learning curve for each surgeon. The learning curve itself  ultimately 
represents the acquisition of competency, which affords an understanding of a new 
technique, technical modifications to the technique and improvements in support staff  
and perioperative care. 
Learning curve patterns may vary depending on the type of surgical procedure, choice of 
outcome measurements1, and from one surgeon to another.2 Surgical training programs 
commonly prescribe a certain length of time or number of procedures performed to 
certify operators as proficient. A common question is: what is the actual number of 
procedures an individual operator has to perform to achieve satisfactory outcome 
results? The course of performance of an individual or group of surgeons can be plotted 
over time. In principle, novice surgeons are assumed to perform surgery less safely and 
efficiently than more experienced colleagues at the peak of their career.3 
Although there is growing interest in tracking individual surgical outcome, traditional 
monitoring tools generally fail to consider the gradual learning process of starting 
surgeons. Cumulative sum (CUSUM) analysis is a graphical method for quality control 
to show changes in individual surgical performance. This technique is increasingly used 
as a management tool in medicine for competence monitoring.4 The learning curve 
CUSUM (LC-CUSUM) test has been proposed to determine when a surgeon reaches a 
predefined level of performance while learning a new procedure.5 
Twin-to-twin transfusion syndrome (TTTS) is one of the most common major 
complications of monochorionic twin pregnancies and carries a high risk of perinatal 
mortality and morbidity.6 Fetoscopic laser coagulation is the treatment of choice 8,9 and 
with an increasing number of centers offering this procedure there is concern that, at 
least temporarily, less favorable outcomes will be seen because of learning curve effects. 
Identifying a learning curve for laser surgery is a logical step in the progression of 
incorporating this technique into the surgeons’ armamentarium of procedures available 
in highly specialized Maternal–Fetal Medicine centers.10
We aim to use the CUSUM methodology to define the learning curve and monitor 
operator performance for fetoscopic laser coagulation.
MATERIAL AND METHODS
At the Leiden University Medical Center, the national referral center for invasive fetal 
therapy, a retrospective study was performed on prospectively collected data on all 
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monochorionic twin pregnancies with TTTS treated by fetoscopic laser coagulation of 
vascular anastomoses between August 2000 and December 2010. Inclusion criteria for 
laser surgery were: monochorionic pregnancy, gestational age between 13 and 28 weeks, 
TTTS Quintero stage 1 with severe clinical symptoms of polyhydramnios, or TTTS 
Quintero stage ≥2. For this analysis, cases were not included if  mothers were clinically in 
labor at time of diagnosis (n = 17). None of the other pregnancies were excluded once 
the fetoscope had been introduced into the amniotic cavity, even if  laser coagulation was 
not possible. Details on the procedure were previously reported (11). 
All surgeons eligible for training and performing fetoscopic laser surgery were experienced 
maternal–fetal medicine specialists with an academic career focusing on fetal medicine. 
Preconditions for training included extensive knowledge and experience in fetal medicine, 
expertise in diagnostic procedures including highest level of ultrasound, amniocentesis, 
chorionic villus sampling, and fetal blood sampling. All fetal surgeons were well-trained 
gynecologic laparoscopists. 
Laser surgery was initially performed by two operators, joined by a third and fourth 
operator after 1 and 2 years, respectively. In the initial stage each procedure was 
attended by at least two operators; however, only one was performing the fetoscopy and 
laser surgery, others could observe and help to determine vascular anastomoses. Two 
procedures were performed by a foreign operator in the first year of laser therapy and 
excluded for learning curve analyses. 
The technique that was used for the laser procedure underwent minor adjustments through 
the years, similar for all operators. Some of the women (n = 84) included in this study 
also participated in the randomized Solomon trial (www.trialregister.nl; NTR1245). The 
data on obstetric and neonatal outcomes were derived from medical charts. Demographic 
characteristics, details on the fetoscopic surgery, further interventions, and outcomes 
were prospectively collected in our fetal database. Pregnancy outcomes included survival 
up to 4 weeks after birth, intrauterine fetal demise and preterm delivery. 
All surgeries were classified as failed or successful. Criteria for classifying a procedure 
as failed were: fetal loss of one or both twins and the occurrence of perinatal death 
within 28 days after the procedure. For this analysis, double perinatal survival, defined 
as survival up to 4 weeks of age, was chosen as a primary outcome. Individual prior 
experience with other ultrasound guided invasive procedures, such as intrauterine blood 
transfusion, chorionic villus sampling, and amniocentesis per operator was assessed. 
Individual performance with fetoscopic laser coagulation was analyzed by describing 





For each surgeon, two types of CUSUM charts were constructed, to assess the learning 
curve and to monitor performance according to the number of successful procedures;5,12 
these are described in more detail in Appendix S1. A CUSUM score was computed 
from the successive outcomes, with successes yielding an increase in the score and 
failures yielding a decrease in score. In graphs, CUSUM scores are plotted on the y-axis 
against the consecutive number of procedures on the x-axis. The horizontal limit lines 
in CUSUM-graphs determine the spacing between unacceptable (H0) and acceptable 
(H1) boundaries, i.e. the null and alternative hypotheses. Once the score has reached 
a predefined level (L), the test rejects the null hypothesis in favor of the alternative 
and performance is deemed acceptable. In LC-CUSUM graphs the learning phase is 
completed when limit “L1” is crossed with accumulation of successive scores. CUSUM 
scores are then reset at 0 before starting the monitoring phase. 
Control limits decide whether performance is unacceptable. In this study an “expert 
level” was calculated, to define acceptable and unacceptable boundaries as input for 
the CUSUM analysis, based on three of the largest recently published studies6,13,14 and 
the only randomized controlled trial on fetoscopic laser therapy in TTTS.9 Combining 
outcomes of these recent studies with survival rates of 67%,13 54%,14 and 57%,6 
respectively, we calculated the “expert level” to be a mean survival of both twins at 4 
weeks after delivery of 59% (H1: p = 0.59). The unacceptable boundary was set as 36% 
(H0: p = 0.36).9 
The CUSUM score emits a signal in case of persistent deviation towards a deterioration 
or improvement in performance; by reaching either lower (H0) or upper (H1) limits. 
Conversely, the performance is assumed to be acceptable as long as the CUSUM 
score remained within the limits. The thresholds L1 (for competence) and L2 (for 
incompetence) are set differently. As it is likely that performance will be less successful 
during the learning phase, and to minimize the probability that performance of an 
operator who is not yet competent is noted as acceptable; L1 = 3.4. To quickly identify 
suboptimal performance of an operator who already completed the learning phase; L2 
= 2.5. 
Factors that may influence the outcome of the procedure such as gestational age, 
Quintero stage, placenta localization, and introduction technique were compared for all 
procedures performed by each operator by using chi-squared test and one-way analysis 
of variance. Taking these patients’ risk factors into consideration, all CUSUM scores 
were calculated based on risk-adjusted case failure. Therefore operative failures in high-
risk patients are not as visually significant on the CUSUM chart as they would be in 
low-risk patients. A p-value ≤0.05 was considered to indicate statistical significance. 
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Statistical analysis was performed with IBM SPSS Statistics for Windows version 21.0 
(IBM Corp., Armonk, NY, USA). No ethics approval was required for this study.
RESULTS
In total, 340 monochorionic pregnancies treated with fetoscopic laser coagulation were 
included in this study. Characteristics and outcomes of all treated pregnancies sorted by 
procedures per operator are described in Table 1. Operator 1 performed significantly more 
combined open laparoscopy for anterior placenta in the starting years of fetoscopy.15 
Other possible confounding factors, such as Quintero stage and placenta localization, 
were not significantly different between all operators, nonetheless high-risk patients (i.e. 
advanced Quintero stage, anterior placenta) were identified to calculate adjusted-risk 
CUSUM scores. Secondary analysis of preoperative characteristics over the consecutive 
years showed no significant differences. Overall perinatal survival rates of at least one 
twin and double survival were 86% (294/340) and 59% (201/340), respectively.
Survival rate at birth, including triplet pregnancies, was 76% (528/690), equally divided 
among recipient twins in 72% (244/340) and donor twins in 75% (256/340). Neonatal 
death occurred in 21 neonates [from 19 pregnancies, 6% (19/340)]. Delivery occurred 
before 24 weeks in 11% (36/340), before 28 weeks in 18% (61/340), before 32 weeks in 41% 
(139/340), and before 34 weeks in 57% (194/340) of pregnancies. Ten triplet pregnancies 
were treated, all were dichorionic triamniotic triplets. In five triplets, all children survived 
at birth, in the five other cases single intrauterine fetal demise occurred. One former 
recipient died within 4 weeks after birth. Figure 1 shows the number of procedures 
performed per individual operator and fetal outcome using LC-CUSUM and CUSUM 
plots. The graphical data demonstrate a range of time over which competence was 
attained and kept. Operators 1 and 2, starting at almost the same time in 2000, had 
similar learning curves. The learning phase of operators 1 and 2 ended after procedure 
26 and 25, respectively, demonstrated by crossing the L1 threshold. For operator 1 an 
alarm was set at the 95th procedure (red circle), indicating inadequate performance. The 
performance of operator 2 remained in between alarms and therefore performance was 
deemed adequate. Operator 3 finished the learning curve after 26 procedures; however, 
after setting stricter boundaries, performance became unacceptable after the 38th 
procedure because of accumulated failures. Performance improved directly hereafter, as 
shown by the dotted line in the plot. Operator 4, starting 2 years after the first operator 
was declared competent after 35 procedures and remained competent. In Table 2, 
number of procedures performed, individual success rates and previous experience with 























































































































































































































































































































































































































































































































































































































































































The individual learning curve cumulative sum (LC-CUSUM) and cumulative sum (CUSUM) plots for 
fetoscopic laser coagulation in twin-twin transfusion syndrome in four operators representing double 
survival at 4 weeks. 
Legend: The consecutive number of performed procedures on the x-axis is plotted against the actual 
CUSUM value on the y-axis. LC-CUSUM and CUSUM scores are plotted in terms of the successive procedures, 
evaluating performance by double survival. LC-CUSUM is applied until acceptable performance has been 
reached and CUSUM is used thereafter to ensure that adequate level is maintained. For the LC-CUSUM 
(black line), as long as the score remains below the limit “L1” (dotted line), the operator is not considered 
proficient; when the LC-CUSUM score crosses this limit, the operator has completed the learning phase. For 
the CUSUM (blue line), as long as the score remains under the limit, the operator is considered to maintain 
an acceptable performance. The dotted blue lines represent the CUSUM score from operators that showed 























































































































































































































































































































Our study shows an increase in survival rates with growing operator experience, using 
an LC-CUSUM method to assess individual learning curves. In addition, the CUSUM 
analysis for continuous monitoring of individual performance proved both feasible 
and highly insightful. The number of procedures required to reach an adequate level of 
performance ranged between 26 and 35 in our four operators. The minimal individual 
variation in learning profiles may be explained by the “group” learning effect, by 
influence of general expertise and exchange of experience. 
Two operators showed a peak in failure rate during their CUSUM monitoring phase. Such 
an event may have multiple explanations, which cannot be inferred from the CUSUM 
analysis but requires in depth analysis of the procedures itself, such as difference in 
technical details with other operators, and particular case mix during this period. This 
is an illustrative example of the use of CUSUM plots for monitoring of performance 
among experienced operators, a practice which these operators continued beyond the 
study period. In particular, CUSUM enables almost real-time evaluation, in contrast 
to other less sophisticated methods, such as annual or 3-monthly reports. The use of 
CUSUM prevents potentially hazardous delay in taking action to improve outcome. 
In the case of real-time assessment one should consider monitoring and coaching these 
operators according to the LC-CUSUM standards, until they again reach acceptable 
levels of performance. However, awareness of underperformance alone may already 
improve outcomes. 
Due to the retrospective design of this study, ongoing CUSUM scores were plotted and 
rapid recovery was demonstrated within a short time. The difference in learning curves 
between all operators was probably the result of operator 4. Operator 4 reached a level 
of competence after 35 procedures. The slow initial accrual of cases by operator 4 could 
certainly have contributed to the upward trend of the CUSUM curve for these first 35 
procedures. Operators 1 and 2 performed approximately 12 procedures per year, whereas 
operator 4 started off  performing only four cases annually, although often supervised by 
an experienced colleague. Compared with the other operators, also previous experience 
with other ultrasound-guided invasive procedures was considerably different for 
operator 4. During analysis of preliminary results of this study in 2010 we already noted 
this effect and assured that surgeries were more equally divided among operators by 
making logistical changes in our clinic. Equal division of the number of procedures 
performed by each operator annually should be taken into account in case of learning 
curve assessment of rare procedures such as laser surgery in TTTS. 
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To optimize the learning curve in our center, in the initial phase each procedure was 
attended by at least two operators. In addition, all treated cases were discussed monthly 
in a multidisciplinary setting, with exchanging of ideas and suggestions for improvement 
of technique and prevention of complications. Another most helpful tool, in our view, 
was the systematic evaluation of each treated placenta through careful placental injection 
of colored dye.16
The learning curve in our series represents the improvement of both the operators, from 
experience and practice, and the performance of the entire team at managing pregnancies 
involving TTTS. Teamwork, discussion (including international audits),17 stimulation, 
controllability, and continuity may be beneficial factors. Previous authors have shared 
their opinion on a learning curve for fetoscopic laser coagulation in TTTS. Julian De 
Lia, the pioneer of laser surgery in TTTS, describes that the end of his learning curve 
was reached after 33 procedures, although without further explanation.18 Hecher et al. 
reported a learning curve of 75 procedures and found a significant increase in perinatal 
survival over time.19 Defining a learning curve with a predefined number of cases fails 
to take into account that individual operators may not achieve proficiency with a fixed 
sample size. Papanna et al. used similar LC-CUSUM and CUSUM analysis to determine 
the learning curve for three operators, reaching a level of competence after 60, 21, and 21 
procedures, respectively.20 However, this study did not include risk adjustment for high-
risk patients, which may highly influence the slope of the CUSUM plots. Results of our 
center with four operators showed similar pregnancy outcomes as published series with 
one operator19 and the presumed disadvantage of dilution of procedures does not seem 
to exist in our unit, likely due to the team approach.
Case selection, by either treating predominantly high risk or low-risk cases during the 
learning phase, may bias learning curve results. This effect should be taken into account 
during assessment of competence. Setting appropriate thresholds for acceptable and 
unacceptable performance is difficult. In this study we used literature-based expert levels, 
but an alternative may include historical data from the own unit with advantage of 
having comparable case-mix. Likewise, the choice of design parameters for CUSUM is 
critical to its performance, other surgical parameters such as operating time or presence 
of residual anastomoses may be useful endpoints to classify the operation as successful 
or failed. One of the limitations in this study is that the effect on an individual learning 
curve by assisting another operator was not measured. This however may have a positive 
influence on individual expertise levels. This effect was described by Kolkman et al., 
who showed that mentor traineeship can accelerate the learning curve of advanced 
laparoscopic procedures.21 The other attributable effect that was not measured included 
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the extent of the operators’ experience with obstetric ultrasound, invasive fetal diagnostic 
and therapeutic procedures, and endoscopy prior to starting laser therapy. These skills 
probably contributed to a steeper individual learning curve.
In summary, this study evaluated the learning curve for fetoscopic laser coagulation as 
an example of minimal invasive intrauterine treatment. CUSUM analysis is well suited 
to the assessment of procedures with a binary outcome, but accurate and appropriate 
standards of practice must be determined before assessment to ensure the correct 
identification of underperformance. A prospective study would be able to evaluate the 
value of the CUSUM technique as a continuous audit system, allowing urgent real-
time feedback to improve the quality of surgery. Determination of an accurate learning 
curve, as well as evaluation of individual surgeons, will be of great value with relevance 
to other procedures to decrease medical error and substandard performance, and to 
improve quality.
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The cumulative sum (CUSUM) methodology is a graphical method  to assess changes in 
individual surgical performance (1). CUSUM sequentially tests the null hypothesis that the 
process is in control, i.e. its mean is equal to a given target. Thus, it detects when the process 
changes to an out of control state. The learning curve CUSUM (LC-CUSUM) was developed 
based on two one-sided test procedures where the null hypothesis is that the process is out 
of control (2).
We introduced a null- and alternative hypothesis, but it should be stressed that a CUSUM 
analysis itself is not a hypothesis test. Irrespective of the level of expertise of the trainee, 
his or her CUSUM will eventually cross the threshold. Hence, the null hypothesis is always 
rejected and the probability of a type I error (α) is 1. Consequently, the probability of a type II 
error (β) is 0 (3). For this reason, the performance of a CUSUM procedure must be quantified 
differently. 
Biau et al. recommended using simulation of average run lengths (ARL) (4). A simulated 
cohort of surgeons is used in which each surgeon was assumed to have a probability of making 
an error in a single case. The cumulated score for each case in the series was calculated until 
it crossed the terminating barrier L1, or until the maximum number of cases was reached. The 
run length is therefore defined as the number of cases until threshold L1 is crossed. This is a 
random variable, whose distribution depends on the skill of the surgeon. The ARL under H0 
and H1 is sometimes used to quantify the performance of the CUSUM procedure. However, 
since the distribution of the run length is highly skewed, we prefer the Median Run Length 
(MRL).
Ideally, we would like the MRL to be very short under H1 (if operator is underachieving 
this will easily be detected), and very long under H0 (since it is likely that performance will 
be less successful while in the learning phase, if MRL under H0 is long, the probability of 
declaring a surgeon competent who in fact is not becomes small). By raising or lowering 
the threshold L1 we can change the MRL, but increasing the MRL under H0 means also 
increasing it under H1.
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We used a Monte Carlo simulation (10,000 runs) to determine the MRL for our set of 
parameters. We found:
MRL for competence under H0: (p=0.36) 263
MRL for competence under H1: (p=0.59) 23 
When a surgeon has been declared “competent” everything is turned around and (starting 
from zero) a CUSUM is constructed for:
H0: p=0.59 and H1: p=0.36
Now we continue on-going monitoring of performance until the CUSUM crosses a pre-
defined limit L2=2.5 When that happens, the performance is discussed with the surgeon and 
possibly remedial actions are taken. Again, we computed the MRL:
MRL for incompetence under H0: (p=0.36) 89
MRL for incompetence under H1: (p=0.59) 15 
We can turn a CUSUM into a hypothesis test, by choosing a fixed number ‘n’ and rejecting the 
null hypothesis if the threshold is crossed before the n-th case. In our case, we choose n=30, 
since this is a generally accepted number of procedures after which the learning curve should 
be completed (5;6). For the learning phase we found the probability of a type I error (α) is 
0.05 and the power (1- β) 0.72. Therefore according to this analysis the probability to reject 
the hypothesis that performance is unacceptable, when performance is indeed unacceptable 
is low and the probability to reject the hypothesis that performance is unacceptable when in 
fact it is acceptable is high.
For the second phase, we found that the probability of a type I error is 0.17 and the power 
0.87.
LC-CUSUM holds the feature that a barrier at 0 cannot be crossed and the score remains at 
0 if the operator accumulates successive failures. In this way a starting surgeon will not have 
to compensate unnecessarily for the accumulated failures when starting a procedure. Since 
the performance of the surgeon is out of control at the beginning, an upper limit indicating 
this inadequate procedure is unnecessary.  After an operator crossed boundary ‘h’ he or she 
has reached a level of competency and further performance is monitored with a CUSUM test.
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ABSTRACT
Objective. To evaluate differences between international fetal centers in their treatment 
of twin–twin transfusion syndrome (TTTS) by fetoscopic placental laser coagulation.
Methods. Fetal therapy centers worldwide were sent a web-based questionnaire. 
Participants were identified through networks and through scientific presentations 
and papers. Questions included physician and center demographics, treatment criteria, 
operative technique and instrumentation. Laser treatment was compared between low-
volume (< 20 procedures/year) and high-volume (≥ 20 procedures/year) centers. Data 
were analyzed using descriptive statistics.
Results. Of 106 fetal therapy specialists approached, 76 (72%) from 64 centers in 25 
countries responded. Of these, 48% (31/64) of centers and 63% (48/76) of operators 
performed fewer than 20 laser procedures annually. Comparison of low- and high-
volume centers showed differences in technique, gestational age limits for treatment and 
geography. High-volume centers more often used the Solomon technique and applied 
wider gestational age limits for treatment. Europe and Asia had more high-volume 
centers, whereas South America, the Middle East and Australia had mainly low-volume 
centers.
Conclusion. This survey revealed significant differences between fetal centers in several 
aspects of fetoscopic placental laser therapy for TTTS. Increasing awareness of TTTS, 
and of laser coagulation as its preferred treatment, will lead to an increase in centers 
offering this modality, especially in Asia, Africa, South America and the Middle East. 
Considering the rarity of TTTS and the relative complexity of the procedure, developing 
international guidelines for techniques, instrumentation and suggested minimum 




Since the acceptance of laser coagulation of placental vascular anastomoses as the 
best treatment for twin–twin transfusion syndrome (TTTS), perinatal morbidity and 
mortality associated with this condition have substantially reduced.1 However, results 
are still far from ideal, with overall mortality rates varying from 26% to 48% and 
significant attendant complications, such as iatrogenic preterm prelabor rupture of 
membranes, extremely premature delivery, twin anemia–polycythemia sequence (TAPS) 
and recurrence of TTTS.2,3
Fetoscopic surgery is now routinely offered in fetal medicine centers across the world. 
Since TTTS is relatively rare and the surgical procedure is quite complex, concentration 
of care in these specialized centers has been advocated.4 Several authors have documented 
the treatment criteria and techniques5,6 and (minor) modifications to the technique have 
been made over the years,3,7,8 but as yet no literature that systematically documents the 
specific implementation of fetal therapy worldwide exists. 
With the economic growth in developing countries, an increasing number of centers 
wishing to offer this procedure is expected. This raises some concern that a more 
widespread use of laser treatment may, at least temporarily, lead to less favorable 
outcomes owing to ‘learning-curve’ effects.9,10 Because of the absence of uniform 
guidelines, centers base their practice on personal and mentor experience and individual 
preferences. Without the use of quality-monitoring systems, substandard care and errors 
may easily be underestimated. Therefore, we advocate the development of evidence-
based guidelines for fetoscopic laser treatment of TTTS. 
Today, differences appear to exist between centers in their specific approaches, 
instrumentation and guidelines for accepting patients for laser surgery, making it difficult 
to compare results between centers. With this international survey, we hope to take an 
important first step in the process of developing evidence-based international guidelines 
by evaluating differences between international fetal centers in their treatment of TTTS 
by fetoscopic placental laser coagulation.
METHODS
A participant database of e-mail addresses was created from the International Fetal 
Medicine and Surgery Society (IFMSS), the North American Fetal Therapy Network 
and the Eurofetus group. Furthermore, in 2013 fetal therapists were approached at the 
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IFMSS annual meeting in Jerusalem and at the International Conference of Prenatal 
Diagnosis and Therapy in Lisbon. Finally, fetal therapists who published on intrauterine 
therapeutic procedures indexed in PubMed were contacted. From this database, a list of 
106 fetal medicine specialists was generated.
The specialists identified were asked to participate in an anonymous survey if  they were 
actively involved in the evaluation and treatment of pregnancies complicated by TTTS. A 
web-based questionnaire was sent by e-mail between May and August 2013. Reminders 
were sent out to non-responders or responders with incomplete survey responses every 
2 weeks up to 3 months after the initial invitation. E-mail addresses of all potential 
participants were linked to a unique key to track automatically responses and match 
blindly respondents from the same center.
The survey was designed de novo and consisted of three domains: specialist and center-
specific demographics, laser technique for TTTS and instrumentation. Questions were 
generated through a discussion of fetal therapy specialists of the Leiden University 
Medical Center, Leiden, The Netherlands and the Fetal Medicine Unit of the Mount Sinai 
Hospital, University of Toronto, Toronto, Canada. The demographics included type of 
practice, geographical location, experience, number of TTTS cases evaluated and treated 
per year and number of fetal surgeons per center (Appendix S1). The technique domain 
of the survey consisted of questions on inclusion and exclusion criteria for laser therapy, 
anesthesia, entry technique, laser technique, cerclage and amnioreduction policy and 
postpartum placenta color-dye injection (Appendix S2). The instrumentation section of 
the survey consisted of questions regarding the fetoscopes and operating sheaths used in 
different clinical situations and the types of laser used (Appendix S3). The questionnaire 
gathered both quantitative and qualitative data from categorical, multiple choice and 
open-ended questions. A free-text field accompanied all questions to gather additional 
information and comments from the participants. The survey was pretested for face 
validity before distribution by an expert panel of five experienced colleagues. Survey 
entries were not eligible if  the respondent did not perform laser treatment for TTTS.The 
total response rate was based on the number of fully completed eligible surveys.
The data were exported into an Excel spreadsheet (MS Office 2010; Microsoft 
Corp.,Mountain View, CA, USA) and descriptive statistics were undertaken using SPSS 
20 v. 20.0 (IBM Corp., Armonk, NY, USA).
Data were analyzed per respondent and per center. For the center analysis, responses 
from operators from the same center were grouped. When discrepancies existed, the 
mean was used in numerical variables and in the case of categorical data; the centers’ 
predominant answer was used.
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For additional analysis, all centers were categorized into two groups depending on the 
number of laser procedures performed annually. Centers that performed ≥20 procedures 
annually were considered ‘high-volume’ centers and compared with ‘low-volume’ centers 
performing<20 procedures per year. Continuous variables are reported as mean (SD) 
or median (range); group differences were compared using the Mann–Whitney U-test 
or independent Student’s t-test. Proportions were compared using the chi-square test 
or Fisher’s exact test, as appropriate, and P≤0.05 was considered to indicate statistical 
significance.
RESULTS
Of 106 fetal therapy specialists approached, 76 (72%) responded. In total, 64 centers 
from 25 countries participated. Most centers were located in North America (n=22 
(34%)) and Europe (n=19 (30%)) (Figure 1).
Figure 1 
Geographical location of respondents and corresponding distribution of low-volume (n = 31, 48%) ( ) 
vs high-volume (n = 33, 52%) ( ) fetal therapy centers offering laser treatment for twin–twin transfusion 
syndrome.
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The majority (80%) were based in university medical centers. Figure 2 shows the annual 
mean number of laser procedures carried out per center and the total number of laser 
procedures per geographical area. Thirty-one (48%) centers performed <20 procedures 
per year and were classified as low volume, compared with 33 (52%) that were classified 
as high volume. Forty-eight (63%) fetal therapists who responded performed <20 
procedures per annum and 59 (78%) were older than 45 years of age and had a median 
of 20 (range, 4–37) years’ experience in their field of practice. They had a median of 9 
(range, 0.5–25) years’ experience with laser procedures in TTTS. Almost all performed 
other twin-pregnancy related invasive procedures. Table 1 describes the demographics 
of the respondents. No significant differences in geographic distribution existed between 
responders and non-responders. 
North America South America           Europe                Asia           Middle East               Australia
Mean no. lasers per center


























Total number of reported annual laser procedures ( ) according to geographical area and corresponding 









< 36 years —
36–45 years 17 (22)
46–55 years 38 (50)
≥ 56 years 21 (28)
Medical specialty 
Maternal–fetal medicine 72 (95)
Pediatric surgery 4 (5)
Years of experience with invasive obstetric procedures 18 (13–23)
Years of experience with laser therapy  9 ± 4.6






≥ 50 5 (7)
Data are given as n (%), median interquartile range or mean ± SD.
Table 1 Demographic characteristics of study population of 76 fetal therapy specialists
For anterior placentae, the median lower gestational age (GA) limit for laser surgery 
treatment was 16+0 weeks (31/64; 48%), ranging from 14+0 to 20+0 weeks and the 
median upper limit was 26+0 weeks (31/64; 48%), ranging from 22+0 to 32+0 weeks. For 
posterior placentae, the median lower GA limit was 16+0 weeks (34/64; 53%), ranging 
from 14+0 to 20+0 weeks, and the median upper limit was also 26+0 weeks (31/64; 48%), 
ranging from 24+0 to 32+0 weeks. Fifteen of the centers (23%) offered laser surgery 
before 16 weeks and 22 (34%) after 26 weeks’ gestation.
The majority of centers preferred operating with the patient under local anesthesia 
with or without intravenous (IV) sedation (n=38 (59%)). In five (8%) of the centers, 
general anesthesia was the preferred form of anesthesia. The majority of procedures 
were performed in a general operating room (n=45 (70%)). Thirteen centers (20%) had a 
dedicated fetal surgery room and six (9%) a dedicated obstetric operating room available. 
Direct percutaneous trocar insertion was the preferred entry type in 50 (78%) centers 
and the Seldinger technique was preferred in 12 (19%) centers, although in three of the 
latter it was specified that, in certain circumstances, the direct percutaneous technique 
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was used; minilaparotomy was used in two (3%) centers as their preferred technique for 
trocar insertion. Cervical cerclage was never performed in the same session as the laser 
procedure in 20 (31%) of the centers and the majority considered cerclage only in cases 
with cervical shortening or dilatation (n=43 (67%)). Cerclage was part of the standard 
treatment procedure in only one center.
Table 2 presents the center-specific differences. 
Irrespective of the placental location, selective laser coagulation, in which all true 
anastomoses crossing the vascular equator are coagulated, was the preferred technique 
in 26 (41%) centers. A sequential technique, first lasering arteriovenous anastomoses 
from donor to recipient, and aiming to minimize hemodynamic fluctuation, was used in 
33 (52%) cases that had a posterior placenta and 30 (47%) that had an anterior placenta. 
The Solomon laser technique, i.e. lasering the complete vascular equator, was used 
in 18 (28%) cases that had a predominantly posterior placenta and in 15 (23%) cases 
that had an anterior placenta. Eleven (17%) centers combined sequential and Solomon 
techniques. Almost half  of the responding centers (n=29 (45%)) used placental dye 
injection postnatally to assess completeness of the laser procedure. 
A diode laser was used in 36 (56%) of the centers and a neodymium-doped yttrium 
aluminum garnet (Nd:YAG) laser in 23 (36%). Four (6%) centers used both diode and 
Nd:YAG lasers, and one center used potassium titanyl phosphate (KTP) laser in selected 
cases. Scope diameter used in procedures under 16 weeks’ gestation ranged from 1.0 mm 
(3 Fr) to 3.8 mm (11 Fr), with 51% between 1.0 mm and 1.4 mm (4 Fr). Sheath diameter 
used in procedures under 16 weeks’ gestation ranged from 1.0 mm to 3.8 mm, with 46% 
between 3.0 mm (9 Fr) and 3.4 mm (10 Fr). In procedures after 16 weeks’ gestation, 
scope diameter ranged from 1.0 mm to 3.8 mm, with 57% between 2.0 mm (6 Fr) and 2.4 
mm (7 Fr). Sheath diameter used in procedures after 16 weeks’ gestation ranged from 2.0 












Anesthesia  0.020 
Local with/without sedation 38 (59) 23 (70) 15 (48)
Regional (epidural/spinal) 19 (30) 8 (24) 11 (35)
General anesthesia 5 (8) — 5 (16)
Other (50% local, 50% regional) 2 (3) 2 (6) —
Entry type 0.263 
Percutaneous via direct trocar insertion 50 (78) 28 (85) 22 (71)
Percutaneous via Seldinger technique 12 (19) 5 (15) 7 (23)
Minilaparotomy 2 (3) — 2 (6)
Laser type 0.682 
Diode 36 (56) 19 (58) 17 (55)
Nd:YAG 23 (36) 10 (30) 13 (42)
KTP 1 (2) 1 (3) —
Both Nd:YAG and diode 4 (6) 3 (9) 1 (3)
GA upper limit > 26 + 0 weeks
Anterior placenta 18 (28) 12 (36) 6 (19) 0.130 
Posterior placenta 22 (34) 14 (42)  8 (26)  0.162 
GA lower limit < 16 + 0 weeks
Anterior placenta 12 (19) 7 (21) 5 (16) 0.603 
Posterior placenta 15 (23)  8 (24)  7 (23)  0.875 
Solomon laser technique
Anterior placenta 15 (23) 11 (33) 4 (13) 0.054 
Posterior placenta 18 (28) 13 (39)  5 (16)  0.039 
Sequential laser technique
Anterior placenta 30 (47) 16 (48) 14 (45) 0.790 
Posterior placenta 33 (52) 18 (55) 15 (48)  0.622 
Amnioreduction  1.000 
Until DVP 4 cm 4 (6) 2 (6) 2 (6)
Until DVP 6 cm 38 (59) 19 (58) 19 (61)
Until DVP 8 cm 21 (33) 11 (33) 10 (32)
Other 1 (2) 1 (3) —
Cerclage policy 0.891 
Never 20 (31) 10 (30) 10 (32)
Always 1 (2) — 1 (3)
When dilatation or shortening 43 (67) 23 (70) 20 (65)
BMI limit exclusion for laser 4 (6) 2 (6) 2 (6) 1.000 
Laser in MC twins with severe growth discordance 28 (44) 17 (52) 11 (35)  0.196 
Short cervix not an exclusion for laser treatment 37 (58) 22 (67) 15 (48)  0.139 
Placental dye injection 29 (45) 15 (45) 14 (45)  0.981 
Data are given as n (%).
* High-volume defined as centers carrying out ≥ 20 laser procedures/year.
†Low-volume defined as centers carrying out < 20 laser procedures/year.
BMI, body mass index; DVP, deepest vertical pocket; GA, gestational age; KTP, potassium titanyl 
phosphate (laser); MC, monochorionic; Nd:YAG, neodymium-doped yttrium aluminum garnet (laser).
Table 2 Fetal therapy center-specific differences, including comparison of high- vs low-volume centers
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Short cervical length was not considered as a contraindication to laser treatment in 
37 (58%) centers, nor was a large maternal body mass index (n=60 (94%)). A previous 
amnioreduction was a contraindication for laser in four (6%) centers and triplet 
pregnancies were a contraindication in six (9%) of the centers. In 35 (55%) centers selective 
termination of pregnancy via cord occlusion was offered as a first-line alternative to laser 
therapy in cases of TTTS. Of the 29 centers that did not offer termination of pregnancy, 
five stated that they could not offer this owing to legal restrictions. In monochorionic 
twins with severe growth discordance, defined as an estimated fetal weight below the 
10th percentile in the smaller twin and above the 10th percentile in the larger one11 in 
the absence of diagnostic criteria for TTTS, laser therapy was offered as a first-line 
treatment in 28 (44%) centers. 
We identified 33 high-volume and 31 low-volume centers, based on whether they 
performed ≥20 or <20 procedures annually, respectively. A striking difference between 
the two groups was their geographic location, low-volume centers being more 
frequently located in South America, Australia and the Middle East (P<0.01) (Figure 
1). The number of fetal surgeons per center was higher in high-volume centers than 
in low-volume ones (P=0.03). Data on the annual number of procedures performed 
per center, with respect to the number of fetal surgeons per center, are presented in 
Figure 3. Anesthetic technique was quite different between the groups (P=0.02), general 
anesthesia being used as first choice in only five (16%) of the low-volume centers. 
For posterior placentae, high-volume centers more frequently used a Solomon laser 
technique (in some centers combined with a selective sequential technique) than did 
low-volume centers (39% (13/33) vs 16% (5/31), respectively) (P=0.04). GA limits for 
treatment were less strict in the high-volume centers, with an upper limit of >26+0weeks 
in 42% (14/33), compared with 26% (8/31) in the low-volume centers, but these results 
were not statistically significantly different (P=0.16).




Box-and-whisker plots of number of surgeons per fetal therapy center according to number of procedures 
performed annually in centers offering laser treatment for twin–twin transfusion syndrome. Boxes represent 
median and interquartile range, whiskers are range excluding outliers and circles are outliers.
DISCUSSION
This is the first study to identify and compare differences in fetal therapeutic techniques 
and protocol for TTTS between centers worldwide. We demonstrate considerable 
variations in patient characteristics, instrumentation and techniques, which appear 
to be, at least partially, related to the volume of patients treated and geographical 
circumstances of the centers. 
Throughout the world, different criteria for laser therapy are used among established 
fetal medicine centers. In particular, there are differences in GA limits and cervical length 
at which laser therapy is offered. Differences in patient selection, referral and treatment 
options may significantly affect perinatal outcome data. These variations hamper the 
interpretation and comparability of results from single centers. 
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Sixty-three percent of fetal therapists and 48% of centers perform <20 procedures per 
annum. Even though there is limited evidence concerning the ideal number of procedures 
that should be performed to maintain high-quality results10, many studies have 
investigated the relationship between hospital volume data and postoperative surgical 
outcomes in other fields of surgery. Better outcomes have been reported in high-volume 
institutions for high-risk procedures.12–14 ‘Learning-curve’ and monitoring studies show 
that approximately 20–30 procedures per year (per operator) are needed to maintain a 
requisite skill level.9,10. To optimize surgical outcomes and to decrease the incidence of 
medical error, we propose the implementation of a continuous audit system, allowing 
timely feedback at each center. If  fewer surgical procedures are performed annually, 
lower-volume centers will be at risk of late recognition of substandard care or the 
incidence of complications. 
Concentration of care for this highly specialized procedure has been advocated,4 although 
geographical circumstances can justify the need for low-volume centers, since timely 
referral and treatment are associated with improved dual-twin survival and decreased 
neurodevelopmental delay.15 However, Tchirikov et al.16 showed that the advantages of 
state-of-the-art laser treatment in a specialized medical center outweigh the risks of long 
distance (air) transportation for TTTS patients. Since laser coagulation has been shown 
to be the treatment of choice for TTTS, the benefits of offering it, albeit in lower-volume 
centers, must be carefully weighed against offering only amnioreduction. In certain parts 
of the world, and for some patients, referral to larger, more experienced centers for laser 
treatment may not be possible. 
Regardless of the number of fetal surgeons or number of procedures performed, 
infrastructure in the management of TTTS is of major importance. Success rates depend 
on performance of the entire team in the management of TTTS patients, as well as 
post-procedure follow-up by referring specialists. Teamwork, discussion (including 
international audits), stimulation and continuity may be factors that could help to 
optimize outcomes. 
Since laser therapy was first introduced, several modifications have been described. 
Improvements in instrumentation and laser technique seem to have improved the 
success rate of placental dichorionization and thereby decreased the rate of subsequent 
complications. The use of smaller instruments to prevent iatrogenic damage to the 
membranes has been proposed once the learning curve has been overcome.17 Recently 
an international randomized trial showed that complete coagulation of the vascular 
equator using the Solomon technique reduces the risk of recurrent TTTS and TAPS.3 
In 55% of fetal medicine centers selective termination is available as an option, but it is 
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not clear whether this should be offered routinely, or only in specific situations (such as 
in cases of discordant lethal anomalies or a moribund cotwin). In some centers selective 
termination is not possible, often because of legal restrictions. Whether or not this 
modality is available obviously influences several of the outcome parameters, hampering 
comparison between centers.
Currently in the USA the Food and Drug Administration only permits the use of the 
Karl Storz fetoscopic set for the treatment of TTTS between the GA limits of 16 and 
26 weeks. This restricts the USA centers in using wider GA limits for treating TTTS or 
using laser treatment for other indications such as discordant growth restriction and 
TAPS. 
Interestingly, we found that despite the lack of evidence for its efficacy, a large proportion 
(44%) of centers offer laser therapy for severe discordant growth restriction without 
evidence of TTTS. Before this new treatment option becomes assimilated into our 
therapeutic armamentarium, we suggest that it be evaluated as a matter of urgency by 
an appropriately powered, international, multicenter randomized controlled trial.
Our study has some limitations. Despite the use of fetal medicine networks to select 
participants, small start-up centers might not have been included in this survey. However, 
with a response rate of 72% (76/106) of fetal medicine specialists at the forefront of fetal 
therapy, we think that the majority of centers are well represented. For this study, the 
number of questions was limited and we relied on self-reporting of respondents, rather 
than documentation of their practice. The study reflects current practice and is of value 
in generating hypotheses and identifying areas for future research, but cannot be used as 
a guideline, thus our results should be interpreted with caution. 
It should be borne in mind that many cases of TTTS worldwide go untreated, emphasizing 
the importance of ongoing education regarding TTTS. This study may serve as a starting 
point for further discussion regarding the optimal treatment strategies for TTTS and 
may provide a means of evaluating current therapeutic practices for patients with TTTS. 
Future studies should focus on the development of evidence-based guidelines for a 
standardized approach to the provision of laser treatment for TTTS.
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in twin-twin transfusion syndrome: 
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Background. The aim of this study was to assess the perinatal outcome of pregnancies 
with TTTS treated with laser therapy over the past 25 years and in relation to different 
techniques used in this time period.
Data Sources. A systematic review of studies reporting on perinatal outcome according 
to the MOOSE guidelines was conducted. MEDLINE, Embase and Cochrane databases 
were systematically searched. Comparisons were made in respect to time period, laser 
technique and Quintero stages.
Results. In total 34 studies reporting on 3.868 monochorionic twin pregnancies were 
included. Mean survival of both twins increased from 35% to 65% (p=0.012) and for 
at least one twin from 70% to 88% (p=0.009) over the past 25 years. Mean gestational 
age at birth remained stable over the years at 32 weeks’ gestation. Also we showed a 
significantly improved perinatal survival with the evolution of the laser technique from 
non-selective to selective, selective sequential and the Solomon technique (p=0.010).
Discussion. Since the inception of laser therapy for TTTS more than two decades ago, 
perinatal survival improved significantly. Improved outcome is associated with several 
factors including evolution of the laser technique, learning curve effect, better referral 




Monochorionic (MC) twin pregnancies are at a 10% risk of developing twin-twin 
transfusion syndrome (TTTS),1,2 due to vascular anastomoses on a shared placenta. 
Before De Lia et al. proposed fetoscopic laser coagulation of the placental vessels in 1990,3 
serial amnioreduction was considered the only treatment option of polyhydramnios, the 
most prominent feature of TTTS. Serial amnioreduction was associated with mortality 
rates up to 60%, a median gestational age at delivery around 28 weeks, and up to 50% 
severe neurodevelopment impairment in survivors.4
Survival significantly improved after the introduction of laser coagulation, by addressing 
the cause of the problem, making it the accepted treatment of choice for TTTS.5 
However, results are still far from satisfactory, with mortality rates varying from 20% 
to 48%, and significant complications including iatrogenic preterm premature rupture 
of membranes (PPROM)6 resulting in preterm delivery before 32 weeks gestation, twin 
anemia-polycythemia sequence (TAPS),7 recurrence or reversal of TTTS8 and adverse 
long-term neurodevelopmental outcome in 6-18% of survivors.9
Since the first publications on fetoscopic laser surgery, several technical modifications 
have been described. Coagulation of all vessels crossing the intertwin membrane was 
abandoned because it led to unnecessary placental loss.10 In 1998, Quintero et al. 
introduced the selective laser coagulation technique.11 This technique, which was rapidly 
adopted by most fetal therapy centers, aims to save as much functioning placenta tissue 
as possible by coagulating only true inter-twin vascular anastomoses, instead of every 
vessel crossing the membranous equator. In 2007 the same group proposed the sequential 
selective laser coagulation technique.12
Sequential selective laser is an adaptation whereby anastomoses are coagulated in 
a specific order. The aim is to obliterate the anastomoses in a sequence that allows, 
at least partly, an intraoperative correction of the hypoperfusion of the donor and 
hyperperfusion of the recipient. This is achieved by first closing the arteriovenous 
anastomoses from donor to recipient, starting with the largest ones, followed by the 
closure of the vein-to-artery anastomoses, (e.g. the vessels with a blood flow towards 
the donor) as the last part of the procedure. In 2008 the Solomon trial13 was started, 
introducing a new adaptation to the selective technique. The rationale of the Solomon 
technique is coagulation of the whole vascular equator from one placenta margin to the 
other. With the Solomon technique, all laser spots are connected by drawing a laser line, 
minimizing the chance of residual anastomoses. The study showed that this technique 
was associated with significantly less residual anastomoses, thereby reducing the risk for 
TAPS and recurrence of TTTS.
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This study focuses on perinatal outcome after laser therapy over the past 25 years, 
and the impact of the above-mentioned changes in laser treatment strategies on these 
outcome results. We systematically reviewed all published series since the inception of 
laser treatment of TTTS with respect to survival, gestational age at birth and procedural 
or post-operative complications in relation to the time and the laser technique used.
Data Sources
Before conduct of the systematic review a detailed protocol that included the search 
strategies, inclusion and exclusion criteria, outcome parameters, and methods of 
statistical analysis was created. This systematic review of literature was performed 
according to the Meta-Analysis of Observational Studies in Epidemiology (MOOSE)14, 
and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines15 
where applicable.
Literature Search
An initial literature search on survival after laser coagulation for TTTS was conducted 
in MEDLINE, Embase and the Cochrane Library using PubMed and OVID search 
engines without restriction on the language or type of publication. Keywords and free 
text searches were performed with combinations of the following keywords: survival, 
perinatal survival, twin-to-twin transfusion syndrome, TTTS, twin-twin transfusion 
syndrome, fetofetal transfusion, placental anastomoses, laser, laser therapy, laser 
ablation, SLPCV, SQLPCV, sequential laser, selective laser, fetoscopy, FLOC and 
photocoagulation. Additionally, reference sections of eligible studies were hand-reviewed 
for potential eligible studies. Our search included articles published up to May 2014 that 
reported on pregnancy outcomes after fetoscopic laser coagulation of placental vascular 
anastomoses.
Inclusion and Exclusion Criteria
Randomized trials and comparative studies, as well as prospective and retrospective 
case-series were considered eligible for inclusion. Reasons for exclusion were studies 
with insufficient or overlapping data, letters, conference abstracts, review articles and 
case reports. 
Selection and Data Extraction
All references were independently screened by two reviewers (J.A. and S.H.P.) 
Disagreement on eligibility of a study was resolved by discussion until consensus was 
reached. Studies presenting data on twin pregnancies with confirmed monochorionicity 
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by first trimester ultrasound, affected by TTTS according to the Eurofoetus criteria16, or 
the Quintero criteria17 treated with fetoscopic laser coagulation of vascular anastomoses 
were included. 
Studies were selected when presenting at least the number of patients treated and either 
survival rate of both twins, survival rate of one twin, survival rate of at least one twin 
or gestational age at birth. Other important parameters were complications, such as 
PPROM, gestational age at laser and laser technique used. In the sporadic event that 
study results contained also outcomes of triplets (e.g. monochorionic twins affected by 
TTTS and a singleton) we used the perinatal outcome results of the twins for analysis. 
To prevent double counting of cases, we excluded studies reporting outcomes from 
pregnancies that were treated in overlapping years with other published series from the 
same centers. 
Differences in dual survival, single survival and at least one survival, as well as gestational 
age at birth were analyzed on a timeline. Five-year intervals were chosen to analyze 
studies over time. For categorization we used the year the study was concluded as a 
cut-off  value. Survival was analyzed per laser technique used in the series to show the 
impact of the proposed technical adaptations of the laser treatment. Furthermore, we 
combined results of all series reporting on survival results per Quintero stage to evaluate 
stage-based outcome. 
Statistical Analysis
Continuous variables were reported as the median (range) or mean (SD), for synthesis 
of data medians (range) were recalculated as means (SD) using the method described by 
Hozo et al.18
Results of multiple groups were compared using analysis of variance (ANOVA) statistics. 
Results of categorical variables were compared using Fisher exact test or χ2 test, as 
appropriate. Student t test was used to compare normally distributed values between 
2 groups. The Mann-Whitney U test was used to compare nonparametric variables. 
A p value <0.05 was considered to indicate statistical significance.
Statistical analysis was performed using SPSS (IBM SPSS Statistics 20 for Windows, 
New York: IBM, 2011.) and MS Excel (Microsoft Excel 2010. Redmond, Washington: 
Microsoft, 2010). Being a literature review, no approval from our Ethics Committee was 
needed before performing this study. 
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RESULTS
Flow of study inclusion
Figure 1 shows a flow diagram according to the Quality of Reporting of Meta-analyses-
statement15 with the total number of citations retrieved by the search strategy and the 
number included in the review. After full-text analysis a total of 34 studies were included 
in the time-based analysis.10,12,13,19-49 Twelve studies5,50-60 presented data overlapping other 
series of which three presented data relevant for either the technique, or stage based 
analysis.56,59,60 These three studies did not overlap other series in stage-based or technique-
based analyses and were included in our analysis. 
Study Characteristics
The characteristics of all included studies are shown in table 1. One of the studies 
enrolled was a randomized controlled trial;13 there were 13 prospective single center 
cohort studies,10,12,19-21,23-27,29,31,33 18 retrospective single center cohort studies,28,30,32,34-45,47,48,60 
two prospective multicenter cohort studies22,59 and three retrospective multicenter cohort 
studies.46,49,56
The studies were from United States, Belgium, Australia, Canada, Spain, Poland, Italy, 
Taiwan, Germany, The Netherlands, Denmark, United Kingdom, France, Japan, Mexico, 
Brazil, China and Chile. The primary outcomes; perinatal survival of at least one or both 
twins and gestational age at birth, were well defined in all included studies.
There were three non-English language articles.35,36,41 Language skills of the authors and 
co-workers (Chinese) were sufficient to analyze the articles. 
Three authors described their series in two separate cohorts in order to display their learning 
curve.21,40,43 Eight studies compared different (adaptations of) laser techniques.12,13,21,22,31,47,49,59
Baud et al. compared outcomes of early, late and conventional selective laser surgery 
defined as performed before 17 weeks gestation, after 26 weeks gestation and between 17 
and 26 weeks.48 
For the stage-based analyses we replaced the Quintero stage I cases from the study by 
Middeldorp et al.26, with the series of Wagner et al.60 from our center to have the most 
current non-overlapping results. Furthermore the series of Quintero et al. was replaced 
by the study of Chmait et al. for this analysis because of overlap and the latter presenting 
more data.
For the overlapping series of Nakata et al.59 and Murakoshi et al.42, we used the latter 
for the time-based analysis and the selective series from Nakata for the technique-based 
analysis. For the study of Liu et al. it was unclear what technique was used and therefore 
it was excluded in the technique-based analysis.41
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A total of 3.868 women with a MC twin pregnancy complicated by TTTS treated with 
fetoscopic laser coagulation were included in the time-based analysis, the sample size per 
study ranged from 19 to 334 women. The median time span of study inclusion for all 
studies was 4 years (interquartile range (IQR): 2-6).
Mean gestational age at time of surgery was 20.9 weeks (±1.9).
Combining all series, the mean perinatal survival of both twins, one twin and at least one 
twin were respectively 53.7% (SD 14.8), 29.5% (SD 10.5) and 83.2% (SD 8.3). Overall 
survival of fetuses was 5.348/7.736 (69.1%). Figure 2 displays a timeline of the average 
perinatal survival of all studies based on their study period. 
For both twins, survival rates significantly increased from 35% (1990-1995) to 65% 
(2010-2014) (p=0.012) and survival rates for at least one twin significantly increased 
from 70% (1990-1995) to 88% (2010-2014)(p=0.009). No significant change in survival 
of one twin was seen between 1990-1995 (35%) and 2010-2014 (23%)(p=0.248). 
The overall mean gestational age at birth of all series was 32.4 weeks (SD 1.3). Figure 
2 shows a timeline of the mean gestational age at birth of all studies. Gestational age at 
























Survival over the past 25 years
 One twin survived (p=0.248)


















) Gestaonal age at birth (p=0.226)
Figure 2 Survival results over a 25-year period of laser therapy for TTTS and mean gestational age at birth 
development. 
Laser Technique
Thirty-four studies clearly specified their laser technique and eight of these studies 
compared two groups for which different laser techniques were used.12,13,21,22,31,47,49,59 These 
groups were analyzed separately resulting in 42 subgroups describing survival results for 
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different laser techniques. The non-selective laser technique was used in five series,10,19-22 
28 series used the selective laser technique,12,21-40,43,44,46-49,59 selective sequential technique 
was used in six series12,13,31,42,45,59 and three series used the Solomon technique.13,47,49
Figure 3 shows the results on perinatal survival for each technique. Survival of both twins 
improved significantly (p=0.010) over the course of introduction of new or modified 
techniques to the detriment of survival of only one twin (p=0.028). Overall a gradual 
























Survival per Laser Technique
 One twin survived (p=0.028)
Both twins survived (p=0.010)
Figure 3 Laser technique based perinatal survival results
Quintero Stage
Eleven series reported perinatal survival by Quintero stage with a combined number of 
1.451 pregnancies.23,24,26,27,29-32,42,44,56,60 Most series presented data for Quintero stage I to 
IV (n=6).24,26,32,42,44,56 Three studies presented data for stages II to IV.23,27,29 Ruano et al.30 
only reported on stages III and IV, and Wagner et al.60 only reported on stage I TTTS. 
The results for combined stage based outcomes after laser treatment are shown in figure 
4. Although a trend was seen in decrease of survival with higher stages, no significant 
differences exist between Quintero stages in respect to survival of both twins (p=0.072), 
only one twin (p=0.081) or at least one twin (p=0.277).
Complications
Reports on post-treatment complications after laser therapy were not readily available in 
all studies. Only 12 (33%) of the included studies reported data on PPROM. Definitions 
ranged from ‘<37 weeks gestation’ to ‘within 7 days after fetoscopy’ making comparison 

























Survival per Quintero Stage
 One twin survived (p=0.081)
Both twins survived (p=0.072)
Figure 4 Quintero stage based perinatal survival results of 1.451 laser treated MC pregnancies.
DISCUSSION
In this review of all published series reporting on outcomes after fetoscopic laser 
treatment for TTTS, we found a significant improvement of survival of both twins and 
at least one twin over the past 25 years. This study also shows a significant improvement 
in survival of both twins with the more recently developed laser techniques. In 1990, De 
Lia et al. published the first results of fetoscopic laser therapy as an alternative for serial 
amnioreduction for the treatment of TTTS.3 Since then the technique has undergone a 
variety of modifications. 
There are several hypotheses to explain the improvement in perinatal survival after laser 
treatment in time. First of all, adaptations in laser technique such as indicated above 
are likely to affect survival, however the only way to demonstrate this true effect is to 
perform a randomized controlled trial adequately powered for perinatal survival. 
Secondly, an important factor affecting treatment results is the learning curve effect. In 
principle, novice surgeons are assumed to perform surgery less safely and efficiently than 
more experienced colleagues. A learning curve represents the improvement of both the 
operators, from experience and practice, and, equally as important, the performance of 
the entire team at managing pregnancies with TTTS. Better teamwork, multidisciplinary 
discussion with colleagues from the neonatology department (including international 
audits), stimulation, controllability, and continuity may have been beneficial factors.58 
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Furthermore, since laser therapy has been accepted as the preferred treatment option 
knowledge and awareness in remote centers not offering this highly specialized 
treatment, has grown. Increased awareness may have resulted in improved timely referral 
and decreasing number of cases with advanced disease and poor outcomes.
With the acceptance of laser surgery as the best treatment thus far, over the years 
increasing number of centers started to offer this procedure. Since TTTS is rare, and 
both the surgical procedure as well as careful selection of cases and optimal timing 
of treatment is complex, concentration of care in specialized MFM centers has been 
advocated. With the most recent survival rates as a benchmark, (real time) monitoring 
and quality control are essential to prevent that a more widespread use of this technique, 
at least temporarily, leads to less favourable outcome due to learning curve effects and 
small numbers. 
The finding that newer techniques have better perinatal survival results could be 
attributable to a true improvement in the technique. However this effect could be 
positively affected by the fact that new techniques are, in general, introduced and adopted 
sooner by the more experienced therapists after completion of their learning curve and 
thus likely perform better. Another important factor influencing this improved survival 
is based on case selection in series comparing two techniques which was evident in some 
studies on the sequential laser technique.61
With this study we hope to set a benchmark level, which established and starting centers 
can use to compare their individual results with. Regular structural reflection on ones’ 
own practice is essential to prevent late detection of suboptimal performance. If  less 
favorable outcomes are noticed, a quality cycle including further education, supervision 
of practice and improvement of learning environment should be initiated. We encourage 
starting up centers, as well as established centers, to share their performance for peer 
review and publish their series in order to keep updating the benchmark for other 
centers.62 
Reviewing the Quintero stage-based outcome after laser treatment showed a non-
significant trend in decreased survival of both twins with progression of stage, except for 
stage IV disease. We hypothesize that this could be explained by the low number of stage 
IV cases per series and possible case selection of high-risk cases by more experienced 
therapists.
Unfortunately, data on post treatment complications such as TAPS, recurrent TTTS 
or PPROM, were often not available in the reported studies or lacked uniform 
definitions. Iatrogenic PPROM is generally assumed to be one of the most important 
causes of premature delivery after laser therapy.6 To gain better insight in the important 
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complications of laser treatment it is imminent that we use systematic methods of 
reporting. Incidences are low and knowledge is largely based on small series. In order to 
conduct systematic reviews in these areas definitions need to be uniform when it comes 
to perinatal survival (e.g. alive at 28 days after birth), PPROM (e.g. before 32 weeks 
gestation), TAPS and recurrent TTTS. 
This study has some limitations. Our findings could be influenced by publication bias. 
Centers that are still in their learning curve, or otherwise have less favorable results might 
be hesitant to publish their series when they underperform compared to the published 
series of established centers. 
The past decades have also shown significant improvements regarding (early) neonatal 
care resulting in overall better outcomes after preterm birth.63-65 The effect of the above 
mentioned factors are very difficult to quantify and should be taken into account when 
interpreting the results of this study.
Another limitation is the inclusion of series that have a large time span of data collection. 
This might have decreased the differences in survival over time when later series include 
the learning curve phase of the center. Evaluation of technical or other adaptations of 
surgical techniques using historic controls is hampered by bias caused by increasing 
experience over time, the learning curve effect and improved neonatal care. 
Treatment of TTTS yielded a fair improvement in perinatal survival with the introduction 
of laser surgery over two decades ago. This review shows a significant increase in perinatal 
survival since then. Combining all published series, as a benchmark, perinatal survival of 
at least one twin after laser therapy can be achieved in 83% of pregnancies, and survival 
of both twins in 54% of pregnancies. The median gestational age at delivery in these 
series was 32.4 weeks. Nevertheless, we believe significant improvement opportunities 
prevail and we see challenges in improving instrumentation and technology for the 
treatment of TTTS to increase survival of both twins and, almost equally important, in 
prolonging pregnancies beyond 34 weeks’ gestation. Survival and short-term neonatal 
morbidity should not be the only goals. The ultimate goal should be “disease-free 
survival” and focus on reducing the rate of neurodevelopmental impairment. We suggest 
institutions to focus on long-term pediatric neurodevelopmental outcomes. Follow-up 
into childhood is indispensable to determine outcome in terms of motor, cognitive and 
behavioral development.66 
Fetoscopic laser treatment is often hindered by technical difficulties such as reduced 
visibility due to stained amniotic fluid or poor accessibility of some anastomoses due to 
placenta location or the position of fetal parts on the vascular equator.67 Possibly, such 
limitations may affect the outcome results of the treatment. Technological innovations 
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may aid us to overcome these limitations and help us improve our outcomes. Remarkably, 
technological innovations in instrumentation and equipment, common in in the field 
of laparoscopic surgery, appeared to be virtually absent in the fetoscopic treatment of 
TTTS. The equipment used 25 years ago is almost identical to what we use today. A lack 
of interest from commercial companies paired with complicated licensing issues for use 
in pregnancy may play a role.
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ABSTRACT
Objective. This study aimed to analyze perinatal outcome in monoamniotic (MA) 
pregnancies that underwent antenatal surgical interventions for fetal complications.
Methods. Review of all MA pregnancies treated with antenatal surgical interventions 
in three fetal treatment centers between 2000 and 2013. Indications were twin–twin 
transfusion syndrome, twin reversed arterial perfusion sequence, discordant anomalies, 
or elective reduction. We analyzed associations between indication, type of intervention, 
perinatal survival, and gestational age (GA) at birth and compared our results with a 
systematic review of the literature.
Results. Fifty-eight MA pregnancies were included. Median GA at treatment was 18.0 
weeks (range: 13.1–33.0). Procedures included cord coagulation plus transection (n= 42), 
cord coagulation without transection (n = 7), laser coagulation of placental anastomoses 
(n = 7), and one case each with interstitial laser and radiofrequency ablation. Median 
GA at birth was 34 weeks (range 16.0–41.0), and 75% (53/71) of fetuses intended to 
survive indeed survived. Literature review included 20 articles, reporting on a total of 45 
cases of surgically treated MA pregnancies, showing similar outcome results.
Conclusion. We present the largest series concerning surgical interventions in complicated 
MA pregnancies. Despite being rare in experienced hands, a 75% survival is achieved. 





Monoamniotic (MA) twins account for approximately 1% of all monozygotic 
conceptions1–3 and are the result of late splitting of the developing embryo, 8 to 9 days 
after fertilization. The perinatal loss rate in MA twins varies from 8% to as high as 42%.4–
6 High perinatal loss rates have been attributed mainly to umbilical cord entanglement, 
intertwin transfusion syndromes (including twin reversed arterial perfusion), discordant 
fetal abnormalities or growth, and preterm birth.1,7,8
Compared with complicated monochorionic–diamniotic cases, MA pregnancies 
carry additional risks, which should be taken into account when considering invasive 
interventions.9,10 The most important factors being the presence of cord entanglement 
and the high incidence of proximate cord insertions.11 So far, only a few small studies have 
specifically reported on treatment and clinical outcome in MA pregnancies requiring 
fetal surgical procedures during pregnancy, and all concerned only a single type of 
intervention.12,13 Anecdotally, outcome in terms of survival and rate of prematurity 
appear disappointing.13,14
Fetal interventions performed in MA pregnancies mainly consist of laser coagulation 
of vascular anastomoses, selective feticide via interstitial laser, radiofrequency ablation 
(RFA), injection of vascular sclerosants, fetoscopic ligation, and umbilical cord occlusion. 
Cord transection has been proposed to improve the outcome of MA pregnancies by 
reducing the risk of fetal demise due to cord entanglement after cord occlusion.14
Specific series on technical details of these fetal interventions in relation to outcome are 
lacking. Therefore, we aimed to review relevant aspects of fetal surgical interventions in 
complicated MA pregnancies and to compare our experience with data obtained by a 
systematic review of the literature.
METHODS
Study population
All consecutive cases of fetal surgery in MA pregnancies performed at three major 
fetal treatment centers, the Leiden University Medical Center (The Netherlands), the 
University Hospitals, KU Leuven (Belgium), and the Jackson Fetal Therapy Institute, 
Miami (United States), between January 2002 and December 2012 were included in this 
retrospective study. All three fetal surgical centers have extensive experience in fetoscopic 
interventions. Chorionicity and amnionicity were established by ultrasound in the first 
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trimester of pregnancy. Detailed sonographic examination was performed in all fetuses 
at the treatment centers and continued on a weekly or biweekly basis. Indications for 
surgery included the following: twin reversed arterial perfusion sequence (TRAP), twin-
to-twin transfusion syndrome (TTTS), MA pair discordant for fetal anomaly, or elective 
selective reduction on request of parents. Triplet pregnancies, consisting of a singleton 
and an MA twin pair requiring an antenatal surgical intervention, were also included in 
analyses. TTTS was diagnosed by the recognition of absent bladder filling in donor and/
or polyuria in recipient and/or abnormal umbilical Doppler flows or signs of progressive 
TTTS. Iatrogenic MA pregnancies after fetal surgery in monochorionic diamniotic 
(MCDA) twin with (un)intentional perforation of the intertwin membrane that required 
additional antenatal intervention were also included in analyses.
Fetoscopic procedures
In MA pregnancies affected by TTTS, fetoscopic laser coagulation of the vascular 
equator was considered treatment of choice. The fetoscopic procedure was performed 
using (2 or 3.3 mm) fetoscope (Storz, Vianen, the Netherlands, or Richard Wolf Inc., 
Vernon Hills, IL, USA), for percutaneous introduction through a 3.3 or 3.8 mm shaft 
into the amniotic sac. Coagulation of the anastomoses was performed using a diode 
laser (Diomed Limited, Cambridge, UK) or ND: YAG laser (Dornier Medizin Technik, 
Germering, Germany) with an output of 15 to 70 W. In cases with discordant fetal 
anomalies or elective reduction on the parents’ request, selective feticide was performed 
using the following techniques: Fetoscopic laser was used for coagulation and transection 
to cut the umbilical cord of the affected fetus; although in cases with hydropic cord 
or such advanced gestational age (GA, >18 weeks) where laser was expected to fail, 
bipolar coagulation of the umbilical cord was performed using either a disposable 3-mm 
forceps (Everest Medical Maple Grove, MN) or reusable 2.4-mm or 3-mm forceps (Karl 
Storz, Vianen). A portion of the umbilical cord was grasped under ultrasound guidance 
and occluded or ligated and transected with the laser fiber (400–600 μm), set in the 
cutting mode (40 W). Some operators used additional fetoscopic verification of the 
coagulation. Technical details on the procedure were also described in detail in previous 
publications.14–16 Radiofrequency ablation and interstitial laser were only used in cases 
with TRAP at an early GA. The procedure used to arrest the flow toward the acardiac 
twin was performed by using a laser fiber through an 18G needle (Cook Medical, 
Limmerick, Ireland) or by a 17G radiofrequency needle (Cooltip RF ablation system; 




Operative technical data, including difficulties such as inability to transect the umbilical 
cord and suboptimal visualization due to bleeding, were recorded in all cases. After the 
procedure, patients remained in the hospital for 12 to 48 h. Ultrasound examination 
was performed within 24 h after surgery and then on a weekly or biweekly basis. After 
an initial follow-up in our centers, patients were often referred back to their local fetal-
medicine specialist for further follow-up. Intact MA twins were planned to be delivered 
by elective cesarean, after steroid administration, at 32 to 34 weeks of gestation. Elective 
admission was preferred at 26–28 weeks to allow daily fetal monitoring. Pregnancies 
with one remaining viable fetus were managed as singletons, at the discretion of the local 
obstetrician. After delivery, macroscopic examination of the placenta was performed to 
confirm the diagnosis of monoamnionicity.
Information regarding postsurgical complications and perinatal outcome was retrieved 
prospectively in all cases from referring physicians and patients, and written medical 
reports were available in most cases. Complications including vaginal blood loss, 
hypotension, bleeding from uterine vessels, pre-labor premature rupture of membranes 
(PPROM), and maternal fever were recorded. Primary outcome variables were perinatal 
survival rate, defined as survival up to discharge from neonatal unit and GA at delivery. 
Secondary outcomes included technical complications during procedure, PPROM 
before 32 weeks of gestation and birth weight.
Systematic review of literature
Publications between 2000 and March 2013 reporting data on interventions and perinatal 
outcome in MA pregnancies were reviewed. An electronic literature search using 
MEDLINE, EMBASE, and Cochrane database was performed to find all relevant articles 
reporting perinatal outcome and fetal interventions in MA twin pregnancies, using the 
following keywords ‘Twins, Monozygotic’ OR ‘Monoamnionicity’ OR ‘monochorionic’ 
OR ‘monochorionicity’ AND ‘Fetal Therapies’ OR ‘Obstetric Surgical Procedures’ 
OR ‘Electrocoagulation’ OR ‘electrocautery’ OR ‘thermocoagulation’ OR ‘diathermy’ 
OR ‘coagulation’ OR ‘coagulations’ OR ‘Laser Therapy’ OR ‘laser’ OR ‘Pregnancy 
Reduction, Multifetal’ OR ‘pregnancy reduction’ OR ‘selective fetal termination’ OR 
‘fetal reduction’ OR ‘Selective feticide’ OR ‘Umbilical Cord/surgery’ OR ‘occlusion’ 
OR ‘transection’ OR ‘surgical’ OR ‘Ligation’ OR ‘ligation’ OR ‘photocoagulation’. No 
language restrictions were applied. We accepted original articles, short communications, 
letters to the editor, and case reports. In addition, a search was performed from the 
reference list of all identified articles. When needed, we contacted authors for additional, 
unpublished information. Articles were included irrespective to their primary objective. 
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We included all reported cases of MA twin pregnancies assessed by first-trimester 
ultrasound or iatrogenic MA due to perforation of the intertwine membrane during 
fetal surgery (confirmed during surgery or ultrasound and after delivery) in MCDA 
pregnancies with a second intervention in the MA sac. Exclusion criteria were as 
follows: termination of pregnancy <12 weeks gestation, pseudomonoamniotic cases, 
conjoined twins, and medical amnioreduction (using sulindac or indometacin). Two 
of the authors (S. P. and J. M.) initially screened all the titles and abstracts of papers, 
identified by the review search strategy, for relevance. Only studies that were obviously 
irrelevant were excluded at this stage. All other studies were assessed on the basis of their 
full text for inclusion versus exclusion by two reviewers independently (S. P. and J. M.) 
using the aforementioned criteria. Data extracted from each article included indication 
for intervention and type of intervention. Primary outcomes were similar to our case 
series: perinatal survival rate, defined as survival up to discharge from neonatal unit, 
and GA at delivery. Secondary outcomes included birth weight and PPROM before 32 
weeks gestation. Statistical analysis was performed with SPSS version 21.0 (IBM SPSS 
Statistics for Windows, Armonk, NY: IBM Corp.).
RESULTS
During the study period, 58 complicated MA pregnancies were treated with antenatal 
surgical interventions (15 in Leuven, 25 in Leiden, and 18 in Miami, respectively). 
Fifty-one cases (88%) were true MA pairs and seven cases (12%) were iatrogenic MA 
pregnancies due to unintentional septostomy in a MCDA pregnancy after a fetoscopic 
procedure for TTTS. Seven triplets, including an MA twin pair requiring antenatal 
surgical intervention, were included in this study. The main indications for surgery were 
discordancy for a severe fetal anomaly (N = 23, 40%), TRAP-sequence (N = 13, 22%), 
and TTTS (N = 16, 28%). In two cases (3%) TTTS occurred in combination with a severe 
fetal anomaly in one of the twins. In one case complicated with selective intrauterine 
growth restriction resulting in fetal demise, a cord transection was performed to prevent 
cord related accidents. In three cases (5%), selective reduction of one of the viable MA 
twins was performed for elective reasons to prevent cord accidents. A summary of 
indications for fetal intervention in MA pregnancies included in this study and review of 
literature is displayed in Table 1.
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Characteristics Current study Literature
n/total (%) n/total (%)
Monoamnioticity
True MA 50/58 (88) 45/45 (100)
Iatrogenic MA after laser surgery 7/58 (12)
Triplets 7/58 (12) 1/45 (2)
Indication for intervention
TRAP 13/58 (22) 17/45 (38)
TTTS 16/58 (28) 4/45 (9)
TAPS 1/45 (2)
Discordancy for fetal anomaly 23/58 (40) 14/45 (31)
TTTS combined with discordant anomaly 2/58 (3) 1/45 (2)
Severe sIUGR 1/58 (2) 7/45 (16)
Elective to prevent cord accidents 3/58 (5) 1/45 (2)
Technical details
Gestational age at intervention in weeks (median, range) 18.0 (13.1–33.0) 20.0 (12.0–33.0)
Fetoscopic laser coagulation of equator 7/58 (12) 1/45 (2)
Cord occlusion 7/58 (12) 4/45 (9)
Cord occlusion + transection 42/58 (72) 21/45 (48)
RFA 1/58 (2) 6/45 (13)
Interstitial laser 1/58 (2) 7/45 (15)
Alcohol injection 2/45 (4)
Serial amniodrainage 3/45 (7)
Cord ligation 1/45 (2)
MA, monoamniotic; TRAP, twin reversed arterial perfusion; TTTS, twin-to-twin
transfusion syndrome; sIUGR, selective intrauterine growth restriction; RFA,
radiofrequency ablation; TAPS, twin anemia polycythemia sequence.
Table 1 Characteristics and technical details
In almost all twin cases, there was a single intended survivor (due to for example 
congenital anomalies), except for seven cases of MCMA twins affected by TTTS, in 
which the aim was to save both twins. Of seven triplet pregnancies, one case of TTTS 
included three intended survivors, four triplets contained two intended survivors, and 
two triplets included a single intended survivor (one case with double TRAP and one 
case of selective reduction of both MA twins). Giving the characteristics of these 
pregnancies, the total number of intended survivors in this series adds up to 71.
In 42 cases, cord transection was attempted, and this was successful in 38/42 (90%). Cord 
occlusion alone was carried out in 7/58 (12%), and fetoscopic laser coagulation of the 
equator was performed in 7/58 (12%). In our series, only two cases of MA pregnancies 
complicated by TRAP were treated with RFA and interstitial laser therapy, respectively. 
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Postoperative PPROM before 32 weeks of gestation occurred in 16/58 cases (28%). 
Median (range) GA at treatment was 18.0 (13.1–33.0) weeks. Surgery was performed 
under local (N = 30, 52%), regional (N = 12, 21%), or general (N = 16, 27%) anesthesia 
using an ultrasound-guided single port procedure, except for one case where a second 
port was necessary for access. Introduction was performed percutaneously, except for 
one case in which the combined open laparoscopy and fetoscopy for completely anterior 
placenta procedure was used.17 The procedure was uncomplicated in 43/58 (74%) cases 
with a median duration of 60 min (range 20–142 min). Technical difficulties included 
decreased visibility due to bleeding or blurred amniotic fluid (N = 7, 12%), severe cord 
entanglement preventing successful procedure (N = 3, 5%), and inability to perform 
complete coagulation of the vascular equator (N = 4, 7%). This series included one case 
in which fetoscopic laser coagulation of the vascular anastomoses was performed, with 
intraoperative demise of the donor then followed by cord transection. In another case 
operated at 16 weeks of gestation because of a severe congenital anomaly in one twin, 
the wrong cord was sectioned because of severe entanglement limiting visibility.
Furthermore, the procedure was complicated by perioperative rupture of membranes, 
and the parents decided to terminate the pregnancy.
In this study, 55/71 (77%) of fetuses were live-born, and 18/71 (23%) pregnancies were 
complicated by intrauterine fetal demise. Two of the 55 live-born babies died in the 
neonatal period (4%). Therefore, perinatal survival in this series was 53/71 (75%). Median 
GA at delivery was 34.0 weeks (range 16.0–41.0 weeks). The median birth weight of live-
born children was 2475 g (range: 745–4044 g). In none of the cases, maternal morbidity 
occurred. Details on pregnancy outcomes are summarized in Table 2. This study includes 
a few cases that were previously published.14,15,18–21
Current study Literature
n/total (%) n/total (%)
No. of pregnancies/no of fetuses (incl. TRAP) 58/123 49/91
No. of triplet pregnancies 7 1
No. of intended survivors 71 49
Perinatal survival at 28 days 55/71 (77) 41/49 (84)
IUFD 17/71 (23) 8/49 (16)
NND 2/55 (4) 4/41 (10)
Gestational age at birth in weeks (median, range) 34.0 (16.0–41.0) 33.5 (13.0–39.0)
Birth weight in grams* (median, range) 2475 (745–4044) 1890 (648–3050)
PPROM < 32 weeks 16/58 (28) 9/45 (20)
Preterm birth between 24 and 32 weeks 17/58 (29) 14/45 (29)
*Live births.
TRAP, twin reversed arterial perfusion; IUFD, intrauterine fetal demise; NND, neonatal death within 28 days 
after birth; PPROM, preterm prelabor rupture of membranes.
Table 2 Pregnancy outcomes
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Systematic review of the literature
Combination of the four search strategies revealed 820 references in MEDLINE, 964 in 
EMBASE, 647 references in ISI Web of Science, and none in the Cochrane library. A 
manual search revealed no additional studies for consideration. In total, after removal 
of duplicates, 32 relevant published reports were screened. Figure 1 provides a flow 
diagram with the number of studies screened, assessed for eligibility, and included for 
review according to our search strategies. Unfortunately, 12 articles failed to discuss 
amnionicity or included cases without surgical interventions. Because unpublished 
information could not be obtained, these cases were excluded from this study. To obtain 
the full range of research to date, we accepted case series (n= 5) and case reports (n = 
13) as well. A total of 20 articles met the inclusion criteria, and we identified 50 cases of 
MA pregnancies that underwent surgical interventions.4,7,13,22–38
Baseline characteristics of the study population and indications for surgery are 
summarized in Table 1 and clinical outcome in Table 2. Combination of our data and 
review of literature showed perinatal survival rates (of intended survivors) of 78% 
(25/32) in 20 cases of TTTS, 77% (24/31) in 30 cases of TRAP, 72% (28/39) in 37 cases 
of twins discordant for anomalies, 63% (5/8) in eight cases of IUGR, and 80% (4/5) in 
four cases in which selective reduction was performed only to prevent cord accidents. 
We pooled the data from the MA pregnancies treated with selective feticide (n = 74), 
and we compared cases that underwent umbilical cord occlusion without transection 
with cases in which the cord was successfully transected after occlusion. Survival and 
GA at birth tend to increase after transection compared with cases having intact cords. 
Perinatal survival of 56/64 (88%) and median GA at birth of 36 weeks was reached after 
transection of the cords compared with 9/15 (60%) and 28 weeks after cord coagulation 
alone. Analysis of these pregnancies outcomes is shown in Table 3.
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Medline, Embase
and Web of Science
879 tles and 
abstracts screened
54 arcles eligible 
for review
20 arcles included
32 arcles analyzed 
in full text 
Excluded: 22
Irrelevant topic: 9
Poster or conference abstract: 1
Review, editorial or leer: 12
Excluded: 12
Incomplete outcome available: 11
Possible overlap in series: 1
Figure 1 Flow with number of studies screened, assessed for eligibility, and included for review with 
exclusion criteria according to our search strategies.




n=74 n/total (%) n/total (%)
No. of pregnancies 60 14
No. of triplet pregnancies 5 2
No. of intended survivors 64 15
Perinatal survival at 28 days 56/64 (88) 9/15 (60)
IUFD 8/64 (12) 6/15 (40)
NND 3/56 (5) 2/9 (22)
Gestational age at birth in weeks (median, range) 36.0 (16.0–40.0) 28.0 (16.0–41.0)
Birth weight in grams* (median, range) 2775 (796–4044) 2150 (745–3325)
PPROM < 32 weeks 16/60 (27) 4/14 (29)
Preterm birth between 24 and 32 weeks 8/60 (13) 4/14 (29)
*Live births. 
IUFD, intrauterine fetal demise; NND, neonatal death within 28 days after birth; PPROM, preterm prelabor 
rupture of membranes




This paper reports on the largest series to date of antenatal surgical procedures in 
complicated MA pregnancies. Combining our data with the published literature, we can 
conclude that these complex procedures in this rare and highly complicated group of 
pregnancies, performed in highly specialized fetal treatment centers, can lead to good 
outcome in the majority of cases.
In case of a single intended survivor, our results suggest improved pregnancy outcomes 
in cases treated with cord transection. Diversity in indication and intervention makes it 
difficult to arrive at a consensus for an optimal strategy regarding fetal surgery in MA 
pregnancies. Individualization of cases is critical when determining the timing and type 
of intervention. Operator’s experience, preferences, and pregnancy details – such as an 
anterior placenta, a triplet pregnancy, or signs of TTTS – may all influence options and 
choices.
A few other studies reported on surgical interventions in MA pregnancies. If  anomalies 
affect only one twin, selective feticide is frequently offered as an intervention. The option 
of cord occlusion and transection in MA twin discordant for fetal anomalies to prevent 
fetal demise due to cord accidents was already proposed by Middeldorp et al.14 and 
Quintero et al.18 Valsky et al. showed that cord occlusion and transection in MA twins 
resulted in similar perinatal outcomes compared with those of diamniotic discordant 
twins treated with cord occlusion.13 Perinatal outcome after selective feticide was also 
reported by van den Bos et al.19 Preterm birth and adverse perinatal outcome appeared to 
occur more frequently with use of the fetoscopic laser coagulation compared with bipolar 
cord coagulation. However, authors stated that their population was inhomogeneous 
and therefore difficult to compare, and these results may be influenced by the GA at 
which the procedure is performed – before 18 weeks versus after 18 weeks gestation.
Although often performed with technical success, surgical procedures in MA pregnancies 
can be technically challenging. Especially, cord entanglement can be hazardous during 
fetoscopic interventions. Multiple loops of entanglement make identification of the 
correct cord difficult. Although rare, accidental coagulation of the wrong cord does 
occur, as presented in our series and previously reported.30
Another dilemma is the management of MA pregnancies diagnosed with TRAP. In 
addition to the threatened compromise of the pump twin, the risk of cord pathology 
seems to justify surgical intervention. Our data combined with literature data showed 
30 cases treated using several surgical approaches, but predominantly cord coagulation 
and transection, with perinatal survival rates of 77%. Previously published series of 
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a combination of MA and diamniotic TRAP pregnancies undergoing prophylactic 
surgery at 16–18 weeks showed survival rates from 74% up to 90%.15,39,40
Analysis of published studies over the last 20 years reported a lower but non-negligible 
incidence of TTTS in MA twins (6%), compared with MCDA pregnancies (10–15%).9 This 
is most likely due to the protective effect of arterio–arterial placental anastomoses.8,41,42 
The combined outcome from our series and the literature shows that perinatal survival 
using fetoscopic laser in MA twins with TTTS is 78%, similar to recent outcomes in 
MCDA twins.43 In addition, a case of twin anemia polycythemia sequence (TAPS) in 
an MA pregnancy was successfully treated with laser coagulation by Diehl et al.33
A remarkable discordance in the prevalence of TTTS (28% vs 9%) and selective 
intrauterine growth restriction (2% vs 16%) in MA twins could be noted when comparing 
the results of current study with previously published literature. This effect may be due 
to the matter how diagnoses were made. In addition, these numbers may reflect some 
degree of referral and publication bias.
Our study does have some limitations. Reports on MA pregnancies mainly consist of case 
reports or small case series; therefore, conclusions drawn from the literature are limited. 
Amnionicity is underreported in literature, perhaps under documented, especially in 
earlier years. Even though authors were personally approached to gain more data, the 
number of cases that could be included for this paper was limited. Because our centers 
are acknowledged as regional or national tertiary institutions for complex fetoscopic 
interventions, cases may reflect some degree of referral bias, and this may influence 
pregnancy outcomes. Our data should be interpreted with care due to the retrospective 
nature of this study, the relative small number of cases in each subgroup, and varying 
GAs at diagnosis and interventions.
In summary, all surgical interventions in MA twins, despite being minimally invasive 
techniques, carry a high risk of complications and require highly skilled operators. 
Survival and short-term morbidity were similar to rates reported in MCDA pregnancies. 
However, as in other areas of fetal intervention, there is a growing awareness that it 
is also essential to evaluate long-term outcome in survivors. The limited numbers and 
variety in pathology make prospective comparative studies, let alone randomized trials, 
extremely difficult to perform within a reasonable timeframe. To improve outcomes in 
these rare, high-risk pregnancies, international collaboration, sharing data on techniques 
and protocols, benchmarking, and setting standards for indications and interventions 
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ABSTRACT
Objective To evaluate management and outcome of iatrogenic monoamniotic twins 
(iMAT) compared with twins with intact intertwin dividing membranes after laser 
surgery for twin-to-twin transfusion syndrome (TTTS).
Methods This was a retrospective analysis of twins with and without iatrogenic rupture 
of the intertwin membranes that had been treated for TTTS with laser surgery at our 
center between 2004 and 2012. Primary outcomes were perinatal survival and severe 
neonatal morbidity. Secondary outcomes were mode of delivery, gestational age at birth 
and cord entanglement.
Results In total, 338 pregnancies were included. In 67/338 (20%) pregnancies, iMAT 
was suspected antenatally. In 47 of these 67 (70%), a preterm Cesarean section was 
performed for monoamnionicity. Perinatal survival was 108/134 (81%) vs 396/542 (73%) 
in twins with intact intertwin membranes (P=0.13). Mean gestational age at birth in 
iMAT was 31 completed weeks, compared to 33 weeks in twins with intact membranes 
(P<0.01). At birth, cord entanglement was present in 8/67 (12%) iMAT pregnancies. 
Severe neonatal morbidity was assessed in 106/110 (96%) in iMAT cases and 392/416 
(94%) in controls. The incidence of severe neonatal morbidity was 28/106 (26%) in iMAT 
vs 72/392 (18%) in controls (P=0.25). Severe cerebral injury was significantly increased 
in the iMAT group as compared with controls, at 16/106 (15%) vs 18/392 (5%) (P<0.01).
Conclusions Iatrogenic rupture of intertwin membranes was suspected in 20% of 
pregnancies treated with laser therapy for TTTS and was associated with a lower 




Twin-to-twin transfusion syndrome (TTTS) is a serious complication of monochorionic 
twin gestations, with a high risk of perinatal morbidity and mortality. Fetoscopic laser 
photocoagulation of the vascular anastomoses is the preferred treatment, with an overall 
survival of up to 74%.1 As it is an invasive procedure, perioperative complications of 
laser surgery itself  increase the risk of adverse outcome.2 One of these complications 
is unintentional perforation of the intertwin dividing membranes, thereby creating an 
iatrogenic monoamniotic twin (iMAT) pregnancy. 
Rupture of intertwin membranes can occur as a consequence of perforation of the 
donor’s collapsed membrane at the trocar insertion site, which may be invisible on 
ultrasound. Another mechanism for perforating the membranes is by coagulation of 
vascular anastomoses through the membrane, which is sometimes unavoidable. iMAT is 
reported to occur in 1.3–8.7% of cases and is associated with preterm prelabor rupture 
of membranes (PPROM), premature delivery, pseudo-amniotic band syndrome and 
complications due to cord entanglement, as seen in spontaneous monoamniotic twins.2–4
There have been only a few reports on iMAT as a complication of invasive procedures.2–4 
Clinical implications of iMAT and optimal management strategies in these pregnancies 
have not been established. Since perforation is not always detected during or directly 
after surgery, this diagnosis can be easily missed, unless specific attention is given to its 
features during follow-up examinations. 
If  iMAT is suspected, pregnancies are often more closely monitored, hospitalization 
after viability is considered and a preterm, elective Cesarean section is scheduled between 
32 and 34 weeks’ gestation to prevent cord accidents. Uncomplicated monochorionic 
twin pregnancies after laser surgery are often allowed to continue to around 36 weeks. 
We therefore hypothesized that iMAT could be associated with a lower gestational age 
at birth as compared with twins with intact intertwin membranes after laser treatment, 
with concomitant adverse effects on neonatal morbidity.5
The aim of this study was to investigate the incidence of iMAT after laser surgery for 
TTTS and compare management and perinatal outcomes of suspected iMAT cases with 
those of twins with intact intertwin membranes.
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METHODS
At Leiden University Medical Center, the Dutch national tertiary referral center for 
invasive fetal therapy, fetoscopic laser surgery has been the preferred treatment modality 
for all pregnancies complicated by TTTS Quintero stage II or higher, and for selected 
cases with Quintero stage I with symptomatic polyhydramnios, since August 2000. 
Chorionicity and amnionicity are established by sonographic examination in the first 
trimester of pregnancy. The diagnostic (established) criteria for TTTS are defined 
according to the Eurofoetus protocols.6
In this study fetoscopic surgery was performed by one of four specialized surgeons 
after written consent of the patient had been obtained. All procedures were performed 
through a single percutaneous port in the recipient sac, except for a few cases with 
completely anterior placenta, in which introduction of the shaft in the posterior uterine 
wall was assisted by open-entry laparoscopy under general anesthesia, a technique that 
was used until 2009.7
Fetoscopic procedures were performed using a 1.3-mm or 2.0-mm semi-rigid or rigid 
fetoscope or a 1.0-mm embryoscope (Storz, Vianen, The Netherlands), introduced 
through operative fetoscopic sheaths and trocars with maximum external diameters of 8 
or 10 French, depending on placental location and gestational age. If  necessary, Ringer’s 
lactate warmed to body temperature was infused to improve distention or visualization. 
Coagulation of the anastomoses was performed using a diode laser (Diomed Limited, 
Cambridge, UK) or Nd:YAG laser (Dornier Medizin Technik, Germering, Germany). 
The technique used for the laser procedure was adapted over the years; selective 
sequential laser was performed from 2006. The ‘Solomon technique’ (coagulation of 
the complete vascular equator after selective sequential laser) was introduced in March 
2008. A subset of the patients (n=141) included in this study also participated in the 
Solomon trial.1 At the end of the procedure, amniotic fluid was drained until the deepest 
amniotic fluid pocket was<6 cm on ultrasound examination.
Complications and technical difficulties such as (un)intentional perforation of the 
intertwin membranes, significant intra-amniotic bleeding or incomplete procedure 
were documented directly after surgery. Ultrasound examination was performed within 
24 h after surgery to detect early iMAT and then at least biweekly at our center by 
highly specialized sonographers or by shared care with referring centers. A standardized 
ultrasound follow-up protocol was used from 2004 for all patients treated with laser 




Perforation of the intertwin membranes was diagnosed either by direct observation of 
a gradual filling of the donor sac at the time of the fetoscopic procedure or during the 
follow-up ultrasound examination (on the first postoperative day, or later) if  increased 
amniotic fluid was noted in the donor sac in conjunction with free-floating intertwin 
membrane and a non-cycling donor bladder and/or entanglement of the cords was 
suspected.8
After delivery, the presence of cord entanglement was noted, and macroscopic 
examination of the placenta and membranes was performed to confirm the diagnosis 
of monoamnionicity.
For this study we performed a retrospective analysis of prospectively collected data on 
perinatal outcome and management of all pregnancies with TTTS treated at our center. 
Data on obstetric and neonatal outcomes were derived from medical charts. In cases 
in which the delivery did not take place at our center, data were provided by outcome 
reports from the referring obstetricians and pediatricians.
Since iatrogenic rupture of the membranes was underreported in the first years after 
the start of laser therapy, we included only cases from 2004 (after we started using a 
standardized follow-up protocol) until 2012, to exclude reporting bias. We included all 
monochorionic twin pregnancies complicated by TTTS treated with fetoscopic laser 
coagulation, not clinically in labor at the time of the procedure. Triplet pregnancies, 
twins with one or more major congenital anomalies or chromosomal abnormalities, 
sonographic evidence of perforation of intertwin membranes prior to laser therapy and 
spontaneous monoamniotic pregnancies were excluded from this study. None of the 
pregnancies was excluded from analysis once the fetoscope had been introduced into the 
amniotic cavity, even if  laser coagulation was not possible.
Primary outcomes were perinatal survival at 4 weeks of age and severe neonatal 
morbidity. Secondary outcomes included PPROM, gestational age at birth, birth weight 
and the need to perform a re-intervention. Severe neonatal morbidity was defined as 
the presence of at least one of the following: respiratory distress syndrome (requiring 
medical ventilation and surfactant), patent ductus arteriosus (requiring medical 
therapy or surgical closure), right ventricular outflow tract obstruction, renal failure, 
necrotizing enterocolitis ≥Grade 2, amniotic band syndrome, ischemic limb injury or 
severe cerebral injury. Severe cerebral injury included at least one of the following: 
intraventricular hemorrhage ≥Grade III, cystic periventricular leukomalacia ≥Grade II, 
ventricular dilatation above 2 SDs (including posthemorrhagic ventricular dilatation), 
intraparenchymal echodensities, porencephalic or parenchymal cysts, arterial infarction, 




Patients were categorized into one of two groups: pregnancies in which perforation of 
the intertwin membranes was antenatally suspected (iMAT) and pregnancies with intact 
intertwin membranes. Intentional perforation of the intertwin membranes was applied 
only in a few exceptional cases, however all cases with intentional or unintentional 
membrane perforation were included in the analysis. Continuous variables were reported 
as median (range) or mean (SD); group differences were compared using the Mann–
Whitney U-test or independent Student’s t-test. Proportions were compared using the 
chi-square test or Fisher’s exact test, as appropriate. All analyses per fetus or neonate 
were performed using the generalized estimated equation module to account for the 
effect that observations between cotwins are not independent. Statistical analysis was 
performed with SPSS version 21.0 (SPSS IBM, New York, NY, USA), and P<0.05 was 
considered to be statistically significant.
RESULTS
Laser coagulation was performed in 338 pregnancies fulfilling the inclusion criteria. 
iMAT was suspected antenatally in 67/338 (20%) cases; in 39/67 (58%), this was within 
24 h after surgery. No significant differences in perioperative variables (i.e. maternal 
age, severity of TTTS, location of placenta, introduction technique, laser technique or 
fetoscopy time) were detected, except for mean gestational age at surgery, which was 
21 weeks in iMAT and 20 weeks in cases with intact membranes (P<0.01). Detection 
of iMAT was not associated with laser surgery performed after 26 weeks’ gestation; 
4/67 (6%) vs 14/271 (5%) (P=0.76). Visibility was reduced by significant intra-amniotic 








Maternal age (years, mean (range)) 30 (20–41) 31 (19–42) 0.28
Placental location 0.24
Anterior 34 (51) 116 (43)
Posterior 33 (49) 155 (57)
Quintero stage 0.32
I 3 (4) 25 (9)
II 17 (25) 88 (32)
III 44 (66) 146 (54)
IV 3 (4) 12 (4)
Introduction technique 0.16
Percutaneous 59 (88) 254 (94)
Mini-laparotomy — 2 (1)
Combined open laparotomy for anterior placenta 8 (12) 15 (6)
Laser technique 0.31
Selective 53 (79) 198 (73)
Solomon 14 (21) 73 (27)
GA at laser (weeks, mean (range)) 21 + 0 (15 + 3 to 29 + 5) 19 + 6 (13 + 3 to 29 + 1) < 0.01
Laparoscopy time (min, median (range)) 30 (5–100) 29 (8–113) 0.29
Significant intra-amniotic bleeding during procedure 6 (9) 20 (7) 0.73
Re-intervention necessary 12 (18) 19 (7) < 0.01
Indication for re-intervention 0.79
Recurrence/reversal 8/12 (67) 10/19 (53)
TAPS 2/12 (17) 5/19 (26)
Severe cerebral injury 1/12 (8) 1/19 (5)
Other 1/12 (8) 3/19 (16)
Type of re-intervention 0.78
Laser 3/12 (25) 3/19 (16)
Amniodrainage 2/12 (17) 4/19 (21)
IUT 3/12 (25) 5/19 (26)
Selective feticide 3/12 (25) 7/19 (37)
Laser + IUT 1/12 (8) —
Data given as n (%) unless indicated.
GA, gestational age; TAPS, twin anemia–polycythemia sequence; IUT, intrauterine transfusion.
Table 1 Baseline characteristics of 338 pregnancies treated for twin-to-twin transfusion syndrome, according to 
whether laser surgery perforated the intertwin membrane (iatrogenic monoamniotic twin (iMAT)) or not
Overall perinatal survival rate in this cohort was 504/676 (75%), with a mean gestational 
age at birth of 31+6 (range, 24+0 to 41+2) weeks. Perinatal survival at 4 weeks was 
not significantly different between the groups: 108/134 (81%) in iMAT cases vs 396/542 
(73%) in cases with intact membranes (P=0.13). Fetal demise occurred in 24/134 (18%) 
in the iMAT group and 126/542 (23%) in the group with intact membranes (P=0.27). In 
the iMAT group, there was one case of double fetal demise, which occurred at 25 weeks’ 
gestation, in which cord entanglement was the most likely cause of death. In the control 
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group none of the cases of fetal demise was related to cord entanglement. Neonatal 
death was observed in 2/110 (2%) and 20/416 (5%) in the iMAT group and the intact-
membranes group, respectively (P=0.17). Details of pregnancy outcomes per group are 
summarized in Table 2.
In the iMAT group, PPROM before 32 weeks’ gestation occurred more frequently; 32/67 
(48%) vs 74/271 (27%), although the difference did not reach statistical significance 
(P=0.15).
Pregnancies complicated by iMAT had a significantly higher rate of preterm birth 
before 32 weeks of 39/67 (58%), compared with 101/271 (37%) in pregnancies with 
intact membranes (P<0.01). Accordingly, the birth weight of liveborn children was 
significantly lower in the iMAT group (1524 (range, 607–2765) g) than in the intact-
membranes group (1936 (range, 585–4190) g; P<0.01). Iatrogenic preterm delivery 
before 32 weeks in cases of iMAT occurred in 10/67 (15%), compared with 22/67 (33%) 
cases with spontaneous preterm delivery and seven cases of immature delivery or double 
fetal demise. Additionally, in 16 cases, iatrogenic preterm delivery was induced between 
32 and 35 weeks’ gestation because of iMAT.
Twenty-eight of the 526 (5%) liveborn neonates were lost to follow-up and excluded 
from the analysis of morbidity. Severe neonatal morbidity was assessed in 106/110 
(96%) iMAT cases and 392/416 (94%) controls. Severe neonatal morbidity was more 
frequently observed in the iMAT group than in the twins with intact membranes (28/106 
(26%) vs 72/392 (18%), respectively), but the difference was not statistically significant 
(P=0.25). Severe cerebral injury was significantly more common in the iMAT group 
(16/106 (15%) vs 18/392 (5%); P<0.01), as well as the occurrence of respiratory distress 
syndrome (RDS) (23/106 (22%) vs 43/392 (11%); P=0.05) and necrotizing enterocolitis 
(5/106 (5%) vs 1/392 (0.3%); P=0.01). Amniotic band syndrome was diagnosed in four 








Perinatal survival (at 28 days)* 108/134 (81) 396/542 (73) 0.13
IUFD* 24/134 (18) 126/542 (23) 0.27
Double IUFD 7/67 (10) 28/271 (10)
NND* 2/110 (2) 20/416 (5) 0.17
PPROM < 32 weeks 32/67 (48) 74/271 (27) 0.15
Preterm birth < 32 weeks 39/67 (58) 101/271 (37) < 0.01
Mode of delivery† < 0.01
Vaginal 20/67 (30) 197/262 (75)
Cesarean section 47/67 (70) 62/262 (24)
1st vaginal, 2nd Cesarean section — 3/262 (1)
GA at birth (weeks)‡ 31 + 0 (26 + 0 to 36 + 5) 33 + 4 (24 + 0 to 41 + 2) < 0.01
Birth weight (g)*, ‡ 1524 (607–2765) 1936 (585–4190) < 0.01
Severe neonatal morbidity*, §, ¶ 28/106 (26) 72/392 (18) 0.25
Severe cerebral injury*, ¶, ** 16/106 (15) 18/392 (5) < 0.01
RDS* 23/106 (22) 43/392 (11) 0.05
PDA* 5/106 (5) 7/392 (2) 0.18
RVOTO* 1/106 (1) 3/392 (1) 0.87
Renal failure* 1/106 (1) 2/392 (1) 0.63
NEC* 5/106 (5) 1/392 (0.3) 0.01
Amniotic band syndrome†† — 4/392 (1) 0.50
Ischemic limb injury†† — 2/392 (1) 0.14
Only comfort care because of severe prematurity†† — 9/392 (2) 0.84
Data given as n /N (%) or mean (range).
* Measured per fetus using the generalized estimated equation module.
† Mode of delivery was unknown in 9/271 cases in the intact-membranes group.
‡ Live births.
§ Severe neonatal morbidity includes at least one of the following: respiratory distress syndrome (RDS) 
(requiring medical ventilation and surfactant), patent ductus arteriosus (PDA) (requiring medical therapy or 
surgical closure), right ventricular outflow tract obstruction (RVOTO), renal failure, necrotizing enterocolitis 
(NEC) ≥ Grade 2, amniotic band syndrome, ischemic limb injury or severe cerebral injury.
¶ Denominator is number of liveborn neonates (excluding those lost to follow-up).
** Severe cerebral injury includes at least one of the following: intraventricular hemorrhage ≥ Grade 
III, cystic periventricular leukomalacia ≥ Grade II, ventricular dilatation (including posthemorrhagic 
ventricular dilatation) above 2 SD, intraparenchymal echodensities, porencephalic or parenchymal cysts, 
arterial infarction, congenital brain malformation or other severe cerebral lesions associated with adverse 
neurological outcome.
†† Measured using the method of Firth.20 GA, gestational age; IUFD, intrauterine fetal demise; NND, 
neonatal death within 28 days after birth; PPROM, preterm prelabor rupture of membranes.
Table 2 Outcomes of 338 pregnancies treated for twin-to-twin transfusion syndrome, according to whether 
laser surgery perforated the intertwin membrane (iatrogenic monoamniotic twin (iMAT)) or not
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Details of pregnancies in which iMAT was suspected are summarized in Table 3. In 
29/67 (43%) of cases the operator was already aware of perforation during the procedure. 
In 39/67 (58%) iMAT was observed at the first ultrasound scan within 1 day after the 
procedure. If  iMAT was suspected at a later stage of pregnancy (28/67 (42%)), this 
occurred after a mean of 28 (range, 5–68) days after the procedure. Fetal monitoring 
was offered in cases with suspected iMAT in 28/67 (42%), starting at a mean gestational 
age of 28+2 weeks. Monoamnionicity could be confirmed postnatally in 38/67 (57%) 
cases with suspected iMAT. Medical charts did not provide information on (mono)
amnionicity at birth in 29/67 (43%). After birth, cord entanglement was observed in 8/67 
(12%) iMAT cases. In none of the cases without antenatal evidence of iMAT was cord 
entanglement observed after birth. 
Patients delivered by Cesarean section in 47/67 (70%) cases. Eight twins with suspected 
iMAT and two survivors delivered vaginally, because perforation of the intertwin 
membranes was not communicated to the referring specialist or very early spontaneous 
delivery occurred (<30 weeks).
Parameter                                  Value
Operator aware of perforation during procedure 29/67 (43)
Time from procedure to detection
< 1 day 39/67 (58)
> 1 day 28/67 (42)
Days if detection > 1 day 28 (5–68)
Fetal monitoring 28/67 (42)
Outpatient clinic > once/week 3/28 (11)
Hospitalization 25/28 (89)
GA at start of fetal monitoring(weeks) 28 + 2 (22 + 0 to 33 + 3)
Mode of delivery
Elective Cesarean section 39/67 (58)
Emergency Cesarean section 8/67 (12)
Vaginal delivery in case of twosurvivors 8/50 (16)
MA confirmed at birth 38/67 (57)
Cord entanglement
Confirmed at birth 8/67 (12)
No entanglement 23/67 (34)
Unknown 28/67 (42)
Single IUFD directly after laser not related 8/67 (12)
Data given as n/N (%) or mean (range). GA, gestational age; IUFD, intrauterine fetal demise; MA, 
monoamnionicity.




In this study, antenatal suspected iMAT was found in 20% of TTTS pregnancies treated 
with laser therapy. Patients with iMAT were more likely to deliver prematurely than 
were patients with twins with intact membranes, and this was associated with increased 
neonatal morbidity.
Fetal surgeons need to be aware of this common and clinically relevant complication, and 
take the utmost care to prevent it from happening. Once iMAT occurs, close monitoring 
and adaptation of management are required. 
A lower incidence than we observed, 7.2%, was described in a prospective cohort study 
by Cruz-Martinez et al.4 Habli et al.3 reported a rate of occurrence of iMAT of 1.3% 
(2/152) in a single-center retrospective study. Chmait et al.2 found an incidence of 8.7% 
with a significant association with preterm birth<32 weeks. All authors mention the 
importance of careful routine evaluation of the intertwin membranes at every follow-up 
ultrasound examination.
Previous studies have indicated that unintentional perforation due to intrauterine 
interventions, such as amniodrainage, may give a false impression of improvement in 
TTTS.10,11 This study supports the idea that septostomy as a primary treatment for TTTS 
is not to be advised, and should be avoided owing to the subsequent surgical challenges 
that it creates if  an operative laser procedure later becomes necessary.11–13 
An association of iMAT with the risk of pseudoamniotic band syndrome and PPROM 
was found in previous studies but could not be confirmed in this one despite the higher 
reported incidence of iMAT.4,14 Only four cases of amniotic band syndrome were detected 
in our cohort but, surprisingly, they were only found in the group with intact intertwin 
membranes. Free-floating fibrous strings of the membranes could increase the risk of 
pseudo-amniotic band syndrome, but at present the true etiology of this complication 
has yet to be established. Although, before starting a procedure, the insertion site is 
carefully chosen, in some cases perforation of the membrane is unavoidable while 
entering the amniotic cavity. Even more common is the need to coagulate anastomoses 
on the other side of the membrane, thereby occasionally creating a defect. In some cases 
the defect in the membranes seems small at first, but can lead to complete rupture of the 
intertwin membrane.4 However, using the laser to coagulate anastomoses through the 
membranes does not necessarily mean the membranes will be perforated. Amniotic fluid 
and the absorbing capacities of vessels and blood, together with the wavelength of the 
laser used, have an influence on absorption of the laser energy and its capacity to effect 
coagulation.15 These effects allow the surgeon to coagulate the vessels without damaging 
the membranes. 
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Signs of iMAT should be actively sought after laser surgery for TTTS, since awareness 
of this complication may influence obstetric management. Accurate evaluation of 
the intertwin membranes, especially after a laser procedure, may be challenging. 
Chorioamniotic separation, remnants of ruptured membranes, amniotic bands, 
intrauterine synechia or placental interposition may give the false impression of an 
‘uncomplicated’ diamniotic twin pregnancy.14 Although when perforation occurs it is 
likely that it happens during the intervention, in our study this was noticed at the time 
of the surgery or within 1 day after the procedure in only 58% of cases. Close attention 
to the intertwin membranes is advised during all follow-up ultrasound examinations in 
these twins. It is important to realize the pitfalls in the diagnosis of amnionicity.16
Re-interventions after laser therapy were performed more frequently in cases of iMAT. 
We therefore hypothesize that iMAT can serve as an indicator for technically difficult 
procedures. This was also recently advocated by Chmait et al.2 If  perforation occurs 
during surgery, the leakage of fluid behind the membranes often reduces visibility and 
makes coagulation of the complete vascular equator in that area challenging. Residual 
anastomoses after incomplete coagulation are the most common cause of severe 
complications such as recurrence of TTTS or TAPS, and should be prevented.17
We found that pregnancies complicated by iMAT are more likely to deliver prematurely, 
a finding that is in agreement with those of previous studies.2,4 In this study, 
monoamnionicity was confirmed at birth in 58% of cases and cord entanglement could 
be detected in 12%. Possible explanations for this increased risk are the intensive fetal 
surveillance and preterm elective Cesarean sections that are carried out in this group 
in order to prevent cord accidents. Since cord entanglement could be confirmed in 
12% of iMAT cases after birth, while observed in almost all true monoamniotic twin 
pregnancies, the increased risk of adverse perinatal outcome in iMAT pregnancies may 
not only be related to cord entanglement or monoamnionicity itself. It is likely that other 
factors such as a technically difficult procedure, need for re-intervention and aggressive 
perinatal management play a role.
An important difference in severe neonatal morbidity in this study was related to the 
occurrence of RDS and severe cerebral injury. In iMAT cases 23/106 (22%) neonates 
suffered from RDS compared with 43/392 (11%) in the control group (P=0.05). The 
criteria for a diagnosis of RDS in this study were restricted to the most severe form 
of respiratory failure (requiring mechanical ventilation and surfactant). Severe RDS is 
associated with an increased risk of chronic lung disease and a concomitant increase in 
rates of adverse long-term outcomes.18,19
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A limitation of this study is its retrospective design. Despite extensive follow-up 
according to antenatal care protocols and prospective data collection with specific 
attention to perforation of the intertwin membranes during the Solomon trial1, in 
this study monoamnionicity was confirmed at birth in 40/67 (60%) and not reported 
in 27/67 (40%) of cases. Therefore, the percentage of true iatrogenic monoamniotic 
pregnancies after laser treatment is estimated to be at least 12%, but is likely to be higher. 
Furthermore, some cases with iMAT might have been missed, thereby the rate of iMAT 
would even be underestimated. While short-term neonatal morbidity could be assessed 
in 97% of cases, long-term follow-up was not available for this cohort. These endpoints 
will be a focus of future investigations. 
In conclusion, rupture of the intertwin membranes after invasive antenatal interventions 
is associated with an increased rate of preterm birth, low birth weight and neonatal 
morbidity. Prospective studies should focus on prevention, detection and optimal 
management strategies to reduce these risks.
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Monochorionic triplets complicated 
by fetofetal transfusion syndrome: 
A case series and review of the literature






Fetal Diagnosis and Therapy 2012;32(4):239-45.
110
ABSTRACT
Objective To compare perinatal outcome in monochorionic (MC) triplets with twin-to-
twin transfusion syndrome (TTTS) versus dichorionic (DC) triplets with TTTS.
  
Study Design Retrospective analysis of all triplets with TTTS treated at our center and 
all cases reported in the literature between 1990 and 2010. Survival and gestational age 
at birth of MC and DC triplets were compared and stratified by type of intervention. We 
excluded triplets with one or more fetal deaths <16 weeks’ gestation and those with one 
or more fetuses with congenital anomalies.
  
Results MC triplets were affected by TTTS in a total of 27 cases, and overall survival 
was 51% (38/75 fetuses) compared to 105 DC triplets with a survival of 76% (220/291 
fetuses) (p < 0.05). Mean gestational age at birth in MC triplets was 28 weeks, compared 
to 31 weeks in DC triplets (p < 0.05). Perinatal survival of at least one fetus in MC 
triplet and DC triplet pregnancies was 70% (19/27) and 91% (96/105) (p < 0.05). In DC 
triplets, survival after laser therapy was significantly improved compared to expectant 
management, amniodrainage or selective feticide (p < 0.05). 
Conclusion MC triplets with TTTS are at a considerably higher risk for perinatal mortality 
and preterm birth than DC triplets. The optimal strategy to manage MC triplets with 





Twin-to-twin transfusion syndrome (TTTS) is a serious complication of monochorionic 
(MC) twin gestations and is the result of an unbalanced exchange of blood due to 
vascular anastomoses that connect the circulations. If  untreated, this condition is 
associated with high perinatal mortality and morbidity rates. Survival is improved with 
fetoscopic laser coagulation of the placental anastomoses.1 TTTS is not only seen in MC 
twins, but can also occur in MC and dichorionic (DC) triplet gestations.
Spontaneous triplets occur in about 1 in 7,000 deliveries, but incidences have increased 
over the past decades, mainly because of assisted reproductive technologies.2 Depending 
on the type of placentation, triplet pregnancies can be trichorionic triplets (i.e. 3 fetuses 
with separate placentas and amniotic cavities), DC triplets (i.e. monochorionic twins 
and a singleton with a separate placenta) and MC triplets (i.e. 3 fetuses with one shared 
placenta and three amniotic cavities). Only a few cases of MC (triamniotic) triplets 
have been reported, with estimated incidences of 1–1.6 in 100,000 deliveries.3,4 Since 
trichorionic triplets have no placental vascular anastomoses, TTTS may only occur in 
MC and DC triplets. The incidence of TTTS in MC twins is approximately 9% of all 
cases5, and this is probably similar for DC triplets. However, the incidence of TTTS in 
MC triplets, in which all 3 fetuses shared a common circulation, is not well known.
Management options and survival of triplets with TTTS are frequently discussed in the 
literature.2,6-9 Because an MC twin pair can also be part of any other high-order multiple 
pregnancy, survival rates of MC triplets are often confused with DC triplets, with one 
pair of MC twins affected by TTTS and one singleton. The prognosis of TTTS for MC 
triplets is considered to be different from that for DC triplets and has been reported to 
be severe, with higher rates of mortality and preterm birth, despite interventions.7, 10 
However, the literature on triplets and higher-order multiple births with TTTS consists 
mainly of case reports and small series, most of which fail to discuss placentation.3,11-19
In this study, we aim to compare the perinatal outcomes of all the MC and DC triplets 
with TTTS treated at our center and reported in the literature in the last two decades.
METHODS
At the Leiden University Medical Center (LUMC), the national tertiary referral center 
for invasive fetal therapy, fetoscopic laser surgery has been the preferred treatment 
modality for all pregnancies complicated by TTTS Quintero stage II or higher, and for 
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selected cases with Quintero stage I with symptomatic polyhydramnios since August 
2000.20
Cases in LUMC
We performed a retrospective analysis of prospectively collected data on perinatal 
outcome and management of all MC and DC triplet pregnancies with TTTS treated at 
our center. An MC triplet pregnancy was diagnosed when the 3 fetuses shared the same 
MC placenta, and a DC triplet pregnancy was determined when 2 fetuses shared one 
MC placenta, whereas the third fetus had an independent single placenta.
Detailed sonograpic examination was performed in all fetuses at the referral center and 
continued on a weekly or biweekly basis at our center. Chorionicity and amnioniticy 
were established by sonographic examination in the first trimester of pregnancy. The 
diagnostic (established) criteria for TTTS in triplets were similar to that for twins. 
Details on sonographic criteria and details on procedures for fetoscopic laser surgery 
and umbilical-cord coagulation have been described previously.20 Once the diagnosis 
of TTTS was established, parents were counseled regarding the outcome and offered 
the options of expectant treatment, termination of the whole pregnancy, serial 
amniodrainage, selective termination of (one of) the MC twins in cases of DC triplets, 
or one of the fetuses in the case of lethal prognosis or fetoscopic coagulation of the 
communicating vascular anastomoses. After written informed consent was obtained 
from the parents, the procedure was performed by one of the four operators, specialized 
in fetoscopic surgery, as previously reported20, using a fetoscope (2 mm; Storz, Vianen, 
the Netherlands) for percutanous introduction through a 3.3-millimeter shaft into the 
amniotic sac of the recipient(s). Coagulation of the anastomoses or umbilical cord was 
performed using a diode laser (Diomed Limited, Cambridge, UK) or Nd:YAG laser 
(Dornier Medizin Technik, Germering, Germany) with an output of 15–70 W. If  there 
were two recipients in MC triplets, the fetoscope was introduced into both cavities via 
two different uterine entries, but if  there were two donors, only the vascular anastomoses 
between the recipient and both donor fetuses were coagulated.
After the procedure, patients remained in the hospital for 12–48 h. Complications 
including vaginal blood loss, hypotension, bleeding from uterine vessels, prelabor 
premature rupture of membranes (PPROM) and maternal fever were recorded. 
Ultrasound examination was performed within 24 h after surgery and then on a weekly 
or biweekly basis. The data on obstetric and neonatal outcomes were derived from 
medical charts. In cases where the delivery did not take place in our center, data were 
provided by outcome reports from the referring obstetricians and pediatricians.
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Meta-analysis of cases reported in the literature
An electronic literature search using MEDLINE, EMBASE and the Cochrane Database 
was performed to find all relevant articles reporting perinatal outcome and management 
in MC and DC triplet pregnancies with TTTS. A search in PubMed was performed to 
find relevant articles reporting outcomes of MC and DC triplet pregnancies complicated 
by TTTS using the following keywords ‘fetofetal transfusion’ AND ‘triplet’, ‘survival 
rate’, ‘monochorionic’ AND ‘laser therapy’ OR ‘intervention’. No language restrictions 
were applied. We accepted original articles, short communications, letters to the editor 
and case reports. In addition, a search was performed from the reference list of all 
identified articles. When needed, we contacted authors for additional, unpublished 
information. Articles were included irrespective of their primary objective. We included 
all reported cases of MC and DC triplet pregnancies assessed by 1st-trimester ultrasound 
and complicated by TTTS. TTTS was diagnosed with standard criteria (polyhydramnios 
>8 cm in the recipient(s) sac(s) and oligohydramnios <2 cm in the donor sac). Exclusion 
criteria were one or more fetal deaths <16 weeks’ gestation and pregnancies with 1 or 
more fetuses with congenital anomalies. Cases in which artificial termination of the 
whole pregnancy was performed were not included.
Two of the authors (S.H.P.P. and D.O.) initially screened all the titles and abstracts of 
papers, identified by the review search strategy, for their relevance. Only studies that were 
obviously irrelevant were excluded at this stage; they independently assessed all other 
studies independently (on the basis of their full text) for inclusion or exclusion, using the 
above criteria. Discrepancies were to be resolved by discussion with a third reviewer, but 
this proved unnecessary.
Data extracted from each article included survival, gestational age at birth, intervention, 
and, if  reported, long-term perinatal outcomes in donors and recipients. A p value ≤0.05 
was considered to indicate statistical significance. A χ2 test and an independent Student 
t test were used to compare survival and gestational age between triplets. Statistical 
analysis was performed with SPSS version 18.0 (SPSS, Inc., Chicago, Ill., USA).
RESULTS
Cases in LUMC
During the 10-year study period from 2000 to 2010, 10 fetoscopic procedures in 2 MC 
and 8 DC triplet pregnancies were performed in our center. All triplet pregnancies were 
triamniotic.
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A total number of 340 laser surgeries were performed for all twin and triplet pregnancies 
affected by TTTS during this 10-year period. Details on gestational age at procedure, 
type of intervention and outcome in triplet pregnancies are described in table 1.
Fetoscopic laser coagulation was performed in 9 cases, including 1 case of MC triplets 
with percutaneous entry into two amniotic sacs. In 1 case of MC triplets, umbilical cord 
coagulation with selective reduction of the recipient was carried out. The procedure 
was performed at a median gestational age of 18 weeks (range 14–26 weeks). Three 
cases were classified as Quintero stage II and 7 cases Quintero stage III. Fetal demise 
occurred in 9 of 30 fetuses (30%) (including 2 cases of selective feticide) and neonatal 
demise in 1 neonate (3%). Overall perinatal survival was 70% (20/30). In the DC triplets, 
perinatal survival of both children involved in the monochorionic twin pair was 50% 
(4/8). Median gestational age at delivery was 31 weeks’ gestation (range 21–36 weeks). 
Median birth weight in live-born neonates was 1,661 g (range 845–2,780 g).
A procedure-related complication occurred in 1 case (table 1, case No. 3) where laser 
coagulation of a DC triplet was performed. During uterine entry, an umbilical artery of 
the donor was perforated and massive bleeding occurred, with the result of intrauterine 
fetal demise of the donor. The recipient twin and the singleton were born at 34 weeks’ 
gestation. No maternal complications occurred.
In one of the DC triplets (table 1, case No. 7) treated with laser surgery at 20 weeks’ 
gestation, intrauterine fetal demise of the donor was assessed at 22 weeks. PPROM 
occurred at 27 weeks’ gestation and corticosteroids, antibiotics and atosiban were 
administered to prevent preterm labor. Nevertheless, the patient went into spontaneous 
labor at 29 weeks and 6 days. The MC twin in this pregnancy was delivered at 30 weeks’ 
gestation, including the stillborn donor, but the recipient died 4 days after birth due to 
intracranial hemorrhage grade IIb and sepsis due to group B streptococcus. The delivery 
of the third child took place on the same day and it was alive and well at discharge.
In 1 case of DC triplets (table 1, case No. 9) fetoscopic laser coagulation was performed 
with intentional perforation of the intertwin membrane because of the presence of 
vascular anastomoses in the other amniotic cavity, thereby creating a monoamniotic 
twin and one singleton. Unfortunately MRI scans that were performed during follow-
up of the pregnancy showed severe brain damage with ventriculomegaly and ischemic 
lesions of the former recipient. A reintervention was performed and selective feticide of 




From 1990 to 2010, 22 articles met the inclusion criteria and we identified 25 MC and 
97 DC triplet pregnancies with TTTS.2,3,6-19,21-25 Quintero stage, in the reported cases 
including the cases in this study, was stage I in 7% (2/27) stage II in 15% (4/27), stage 
III in 45% (12/27) and stage IV in 33% (9/27) of the MC triplets. In the DC triplets, 
Quintero stage I was classified in 2% (2/105), stage II in 23% (24/105), stage III in 68% 
(72/105) and stage IV in 7% (7/105).
Survival rates of all triplet pregnancies complicated by TTTS reported in the literature 
(including the cases in our center) – classified according to chorionicity – are presented 
in table 2. Perinatal survival of at least 1 fetus in MC and DC triplet pregnancies was 
70% (19/27) and 91% (96/105), respectively (p = 0.004). Overall perinatal survival of 
MC and DC triplets was 51% (38/75) and 76% (220/291), respectively (p = 0.018). 
Median gestational age at delivery was 28 weeks (range 18–40 weeks) for the MC 
triplets, compared to 31 weeks (range 20–39 weeks) in the DC triplets (p = 0.016). In DC 
triplets, survival after laser therapy was significantly improved compared to expectant 
management, amniodrainage or selective feticide (p = 0.007). Neonatal death within 4 
weeks after birth occurred in 8% (6/75) of MC cases and in 8% (24/291) of DC cases (p 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Survival (fetuses) GA at birth wks (range)
Intervention MC triplets n DC triplets n MC triplets DC triplets
Laser 26/48 (54%) 16 184/237 (78%) 79 28 (18-34) 31 (20-36)
Selective feticide 1/6 (17%) 2 11/24 (46%) 8 31 (22-40) 32 (25-37)
Amniodrainage 4/9 (44%) 3 20/39 (51%) 13 26 (23-27) 29 (24-39)
Expectant 7/18 (39%) 6 5/15 (33%) 5 28 (23-35) 26 (23-29)
Total 38/81 (47%) 27 220/315 (70%) 105 28 (18-40) 31 (20-39)
Table 2. Survival rates and gestational age at birth of MC and DC triplet pregnancies according to type of 
intervention
Figures 1 and 2 demonstrate the difference between a triplet pregnancy with an MC 
placenta with vascular anastomoses and a DC placenta of an MC twin (and one 
singleton) complicated by TTTS and treated with laser coagulation.
Figure 1. Placenta of MC triplets with vascular anastomoses.
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Figure 2. Placenta of DC triplet with MC twin complicated by TTTS and treated with laser surgery and one 
singleton. As is common in dichorionic placentas, the placenta of the singleton is fused together with the 
monochorionic twin placenta. The thick intertwin membrane indicates dichorionicity.
DISCUSSION
This study shows that perinatal morbidity and mortality in MC triplets with TTTS 
is higher than in DC triplets. Of the 81 fetuses involved in fetofetofetal transfusion, 
only 38 (51%) survived. In addition, median gestational age at delivery in MC triplet 
pregnancies is significantly shorter than in DC triplets (28 vs. 31 weeks’ gestation). This 
outcome could be due to the technical difficulties of interventions in MC triplets because 
all three circulations are connected, therefore making fetoscopic treatment much more 
challenging.
The data in this study also demonstrate that fetoscopic laser coagulation of communicating 
vascular anastomoses in DC triplet pregnancies complicated by TTTS is a feasible 
treatment option with increasing survival rates and more advanced gestational age at 
birth. Perinatal survival rates of at least one survivor (91%) appear comparable to MC 
twins (around 90%).26,27 Although treatment appears to be associated with an improved 
perinatal outcome for DC triplets, survival rates are still limited for MC triplets.
120
Various therapeutic measures have been proposed for triplets with TTTS. Amnioreduction, 
to decrease the pressure of the amniotic cavity with polyhydramnios, is not a permanent 
solution and is associated with a high risk of mortality and morbidity to the cotriplets 
due to the presence of vascular anastomoses in the case of intrauterine fetal demise. 
Serial amnioreduction is therefore considered, at best, a temporary treatment and does 
not correct the underlying problem.
Fetoscopic laser coagulation is the only causative treatment option because, provided 
that all anastomoses can be visualized on the chorionic surface, this operation will 
separate the fetal circulations.28 This technique potentially avoids perinatal mortality 
and the high morbidity rate attributed to vascular accidents mainly after intrauterine 
death of one of the multiplets.7 Loss of cotyledons following laser ablation could either 
cause or exacerbate placental insufficiency in the normal triplets; however, according to 
Chmait et al.29, twin weight discordance and donor fetus intrauterine growth restriction 
appear to improve after laser therapy. In DC triplet pregnancies with severe TTTS, the 
technique for fetoscopic laser coagulation is the same as in MC twins with this condition. 
Comparable to Sepulveda et al.7, survival rates appear similar to that of MC twins when a 
successful procedure was performed. Conversely, in MC triplet pregnancies the outcome 
was poor. In 6 cases of MC 3,6,9,11,15,22 and 5 cases of DC 6,23,24 triplets complicated by 
TTTS, only 12/33 (36%) survived with expectant management. Although based on small 
numbers, these results strongly suggest that laser coagulation is preferable to expectant 
management or amniodrainage.17 Five successful cases of MC triplet gestations (with 
3 survivors) treated with laser coagulation were reported (including the cases in our 
study),2,7-10,21 but 11 other cases were not successful.
Most likely, this is due to the technical difficulties of the fetoscopic treatment because 
of the identification and coagulation of vascular anastomoses between all 3 fetuses. To 
reach the appropriate location of the interfetal communicating vessels, it is necessary to 
have two uterine entries with the fetoscope into two different sacs. In addition, complete 
ablation of the intercommunications can be technically impossible to achieve because 
of placental location, the presence of multiple fetal parts that hamper visualization of 
the placental anastomoses and oligohydramnios in the sac of the donor. Incomplete 
separation could result in the intrauterine death or severe morbidity of the remaining 
fetus(es) after the procedure, because of retrograde hemorrhage of the live fetuses into 
the dead placental tissue.
Selective feticide of the affected triplets [i.e. the MC pair in a DC triplet or a compromised 
triplet(s)] offers the potential advantages of interrupting the circulatory imbalance with 
a single procedure and provides a maximal placental volume for the remaining fetus. 
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Umbilical cord coagulation has proven beneficial in conditions such as twin-reversed 
arterial perfusion or MC twins discordant for a major anomaly, with survival of 78% of 
co-twins and an excellent long-term outcome; therefore, it may also be used in triplets 
with these kinds of conditions.30 Furthermore, some parents could consider selective 
reduction of 1 or more healthy fetuses, to improve the survival and long-term follow-up 
of the remaining children.
Care should be taken when interpreting these results due to the limited data on perinatal 
outcome in triplets with TTTS, particularly MC triplets. Only 27 cases of MC triplet 
pregnancies with TTTS have been reported in the literature. The actual number of 
MC and DC triplets with TTTS may be higher due to underreporting/publication 
bias. Several cases in which the pregnancy was terminated or fetal demise occurred 
spontaneously have probably not been reported. Irrespective of zygocity, triplets are 
high-risk pregnancies due to the high incidence of preterm delivery, intrauterine growth 
restriction and congenital anomalies.31 Only 1 case of fetofetal transfusion syndrome 
in MC quadruplets has ever been reported. Laser ablation of vascular anastomoses 
between one donor and two recipients was carried out at 20 weeks’ gestation and fetal 
demise of one quadruplet occurred shortly after procedure. Delivery occurred at 25 
weeks after the recurrence of TTTS. Only the sole survivor, not affected by transfusion, 
was born alive.32 
In conclusion, this case series and review of the literature demonstrates that, although 
technically more challenging, fetoscopic surgery is feasible in triplets. In cases of MC 
triplets where fetoscopic laser coagulation is technically impossible, parents should be 
counseled on the increased likelihood of unfavorable outcome. However, the rarity of 
these conditions, the required operator and prenatal diagnostic skills, the variety of 
management options and the requirement of in-depth counseling of patients currently 
limit the availability of such interventions to referral centers for fetal medicine. Further 
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ABSTRACT
Objective. To determine, by expert consensus, the essential substeps of fetoscopic laser 
surgery (FLS) for twin–twin transfusion syndrome (TTTS) that could be used to create 
an authority-based curriculum for training in this procedure among fetal medicine 
specialists.
Methods. A Delphi survey was conducted among an international panel of experts 
(n = 98) in FLS. Experts rated the substeps of FLS on a five-point Likert-type scale to 
indicate whether they considered them to be essential, and were able to comment on each 
substep, using a dedicated online platform accessed by the invited tertiary care facilities 
that specialize in fetal therapy. Responses were returned to the panel until consensus 
was reached (Cronbach’s α ≥ 0.80). All substeps that were rated  ≥ 4 by 80% of the experts 
were included in the evaluation instrument.
Results. After the first iteration of the Delphi procedure, a response rate of 74% (73/98) 
was reached, and in the second and third iterations response rates of 90% (66/73) and 
81% (59/73) were reached, respectively. Among a total of 81 substeps rated in the first 
round, 21 substeps had to be re-rated in the second round. Finally, from the initial list of 
substeps, 55 were agreed by experts to be essential. In the third round, the 18 categorized 
substeps were ranked in order of importance, with ‘coagulation of all anastomoses that 
cross the equator’ and ‘determination of fetoscope insertion site’ as the most important.
Conclusions. A total of 55 substeps of FLS for TTTS were defined by a panel of experts 
to be essential in the procedure. This list is the first authority-based evidence to be used 




A randomized trial, published in 2004, established fetoscopic laser surgery (FLS) as the 
best treatment modality for twin–twin transfusion syndrome (TTTS).1 With an incidence 
of 10% in monochorionic twin pregnancies, TTTS is rare and treatment is offered in a 
limited number of specialized maternal–fetal medicine (MFM) expert centers around 
the world.2 With the economic growth of developing countries and the identification 
of new potential indications for FLS, such as twin anemia–polycythemia sequence and 
selective fetal growth restriction, the expectation is that, in the future, a greater number 
of FLS procedures will be performed. Objective assessment of technical performance is 
essential for such complex procedures. In order to maintain optimal performance and 
quality of care, increasing attention is being given to the teaching, training, retention 
of skills and quality control of FLS. Even large fetal treatment centers have limited 
numbers of TTTS cases,3 therefore the teaching and training of this procedure are 
challenging. Currently, standardized surgical training programs for FLS are unavailable. 
As surgical errors and suboptimal technique are also yet to be defined, teachers often 
base their training on personal experience and individual preference. Learning technical 
skills from an experienced mentor will probably continue to play a significant role in 
future training. However, there is an increasing need for a standardized tool to train and 
evaluate trainees. Similar issues have been raised in other invasive obstetric procedures 
and surgical areas, such as endoscopy.4,5
An essential first step towards the creation of a training curriculum is to determine the 
items that need to be assessed, preferably by using quality indicators.6 These indicators 
can be derived from the outcomes of studies, historical data and expert opinions. The 
elements need to be measurable, so they can be used in the assessment of trainees during 
their learning process, to monitor performance and maintain quality control. Authority-
based indicators for FLS can be obtained using the Delphi method for international 
expert consensus. The Delphi methodology is an internationally-accepted tool that 
allows a group of individuals to achieve consensus on a complex problem effectively, by 
structuring the group communication process.7,8
The aim of this study was to achieve expert consensus regarding the substeps that 
are considered to be essential in performing FLS for TTTS, which can be used as a 
framework for standardized training. Furthermore, we aimed to create an instrument 
that could be used to evaluate a surgeon’s technical performance during FLS, both in a 





This study is part of the SILICONE project (SImulator for Laser therapy and 
Identification of Critical steps of Operation: New Education program), conducted with 
the aim of developing a standardized training program for FLS in cases of TTTS. In 
the first part of the project, we intended to develop an evaluation instrument based on 
the essential steps of treatment. In the second part of the project, not included in this 
study, the instrument will be validated and used to evaluate a training session that uses 
a SILICONE simulator.
The Delphi methodology was used to achieve expert consensus on which substeps of 
FLS performed for TTTS are essential. The Delphi methodology is, in essence, a series 
of sequential questionnaires or ‘rounds’, followed by controlled feedback, that seeks 
to gain the most reproducible consensus among a panel of experts.9 Consensus occurs 
because the views of the participants converge through a process of informed decision-
making.8 The Delphi method was first developed by the Research ANd Development 
(RAND) Corporation, a non-profit global policy think-tank, formed in 1950 to offer 
research and analysis to the USA armed forces.10-12 It is an anonymous process in which 
ideas are expressed to the participants in the form of a questionnaire. In repeated 
rounds, respondents are questioned individually, with self-administered surveys. In each 
subsequent round, the results of the previous round are provided, thus enabling the 
range of answers to converge towards a consensus. An overview of the study design is 
presented in Figure 1.
A panel of experts in FLS was presented with a list of substeps of the procedure and 
asked to rate each substep, using a Likert scale from 1 (strongly disagree) to 5 (strongly 
agree), with the level at which they believed the step should be included in an evaluation 
tool. In addition, all participants were encouraged to clarify their ratings in a comments 
box. Each round started with a new questionnaire consisting of a list of these substeps. 
The participation of the FLS experts was not disclosed to the other experts (quasi-
anonymity). The total response rate was based on the number of fully completed surveys.
We identified an initial list of possible substeps of FLS during the first iteration of the 
survey from three sources: expert opinion, textbooks on fetal therapy and published 
peer-reviewed literature. Each substep of FLS that was identified from any of these three 
sources was included in the survey. Before the first iteration of the study, an international 
pilot panel meeting took place that consisted of senior FLS experts from several large 
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international centers, with extensive experience in fetoscopic surgery. They assessed the 
survey for comprehensiveness and integrity. After taking into account their comments, 
invitations to participate in the survey were sent out.
Figure 1. Overview of study design to achieve expert consensus on substeps of fetoscopic laser surgery 
(FLS) for twin–twin transfusion syndrome (TTTS) that are essential to the procedure.
Selection of experts
All FLS experts included in the study were selected through membership lists of MFM 
organizations (Society for Maternal-Fetal Medicine (SMFM), Eurofoetus, USFetus, 
North American Fetal Therapy Network (NAFTnet), International Fetal Medicine 
and Surgery Society (IFMSS), International Society of Ultrasound in Obstetrics 
and Gynecology (ISUOG), World Association of Perinatal Medicine (WAPM), The 
American Congress of Obstetricians and Gynecologists (ACOG), North American 
132
Society of Obstetrics Medicine (NASOM) and Society of Obstetric Medicine of 
Australia and New Zealand (SOMANZ)). We defined an expert as someone who 
currently performs FLS for TTTS. Furthermore, all experts were identified as leaders in 
the field of fetal therapy as evidenced by their role as opinion leaders within their MFM 
organizations and supported by their track record of publications in peer-reviewed 
literature. The expert panel was selected specifically to represent a wide geographic area 
including Australia, Asia, Canada, Europe, South America and the USA. We invited 
98 individuals from 23 different countries to participate. The size of Delphi panels can 
vary widely and there is disagreement about what constitutes an appropriate panel size. 
Panel size in Delphi studies is considered to be researcher- and situation-specific. For 
this study, we aimed to contact the entire international community of MFM specialists 
who had extensive experience with FLS.
Surveys
Delphi round 1
At the start of the first round, an e-mail was sent to all FLS experts that included: the 
invitation, background, short instructions and the link to the first survey. Later, for each 
round, multiple reminders were sent out to non-responders. The first survey consisted 
of two parts: in Part I (Appendix S1), the participants were asked to rate each possible 
substep of FLS for TTTS; in Part II, the experience and surgical practices of the survey 
respondent and of their center were obtained. The estimated time to complete Round 1 
was 15 min.
The first round of data was analyzed and results were pooled. Two of the authors 
(M.W. and S.P.) independently categorized the comments on the basis of the presence 
of essential elements. For each substep we ascertained if  the essential element of the 
comment consisted of an addition or a substitution to the substep. A third author 
(J.A.) assessed the categorized comments and the revised substeps independently for 
clarification and to make sure all further areas were explored. Figure 2 shows how the 
comments were incorporated into the second round of the survey.
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Figure 2. Method of incorporating survey respondents’ comments for development of second round of 
Delphi survey.
Delphi round 2
In the second round, the results of the first round were made available to the FLS experts 
(Appendix S2).
The second Delphi round was sent out 1 month after the first, to optimize the response 
rate and ensure that participants remained interested in the process. In accordance with 
the Delphi method, participants were asked to re-rate substeps for which no consensus 
had been achieved. In this round, some of the substeps were altered on the basis of the 
feedback of the FLS experts from the first round. The substeps for which consensus had 
been achieved in the first round could not be re-rated in the second questionnaire, but 
were available for review.
Delphi round 3
Based on the results from the first two rounds, a list of all essential substeps of FLS 
for TTTS was defined. In order to use this final list for evaluation and training with 
the SILICONE simulator, a third round of the Delphi procedure was carried out to 
determine the appropriate distribution of importance of the steps. For the purpose 
of Part 2 of the SILICONE project, only the substeps that could be simulated were 
included in this round. The included substeps were categorized into 18 items, and those 
categorized within the domains ‘diagnostic procedure’, ‘presurgical management’ and 
‘follow-up ultrasound examination’ were excluded. All respondents rated the level of 
importance of the 18 categorized substeps on a Likert scale of 0–10, with respect to 
each other. With this order of importance, we were able to give a certain value to each 
separate substep, and we incorporated this into the evaluation tool.
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Statistical analysis
For this study, the concept of consensus was predefined as a condition of homogeneity 
or consistency within the opinions of the FLS experts. There are no established criteria 
for determining consensus using a Delphi methodology.6,12
Cronbach’s α was chosen as the statistical index for quantifying the reliability of a 
summation of entities, in this case the view of the experts in FLS. In this study, an 
α-value of 0.80 defined an acceptable and high level of consensus.6,13
Rate of agreement
To ascertain whether consensus was reached for each substep separately, the rate of 
agreement (RoA) was used. The RoA is defined as:
    (strongly) agree (n) - (strongly) disagree (n)
RoA (%) =            x 100%
(strongly) agree (n) + (strongly) disagree (n) + indifferent (n)
Scaled responses to the categorical items (strongly disagree to strongly agree) were 
analyzed as percentages (Appendix S2). Feedback to the panel of experts included 
providing the Cronbach’s α score of the previous round, percentages and means of the 
answers to all items and the RoA for each item separately. After reaching a consensus 
(Cronbach’s α ≥ 0.80), only the substeps with an RoA of 80% or higher were included in 
the final evaluation tool. Substeps with an RoA of less than 20% were not reassessed and 
were removed from the evaluation tool.
In the second round of the Delphi procedure, the substeps with 20% < RoA < 80% were 
re-rated. After the final round, only items with an RoA ≥ 80% were included in the final 
evaluation tool. The other substeps were excluded from the list.
Data were collected using our online survey tool,  www.deltafetus.nl, and analyzed 
using SPSS version 21.0 (IBM SPSS Statistics for Windows, Version 21.0, IBM Corp., 
Armonk, NY, USA).
The study was performed by the Departments of Obstetrics and Pediatrics at the Leiden 
University Medical Center, Leiden, The Netherlands, in association with Hospital 
Italiano de Buenos Aires, Buenos Aires, Argentina; Jackson Fetal Therapy Institute, 
Miami, FL, USA; University of Southern California, Keck School of Medicine, Los 
Angeles, CA, USA; Liverpool Hospital, Liverpool, Australia; and the University 





In the first round, a response rate of 74% (73/98) was reached. Table 1  presents a 
summary of characteristics of the FLS experts. The majority of the participants (77%; 
56/73) worked at university hospitals. Most of the responding experts were MFM 
specialists, a minority (7%; 5/73) were pediatric surgeons. All the experts also performed 
other antenatal procedures besides FLS for TTTS. Almost all had more than 5 years’ 
experience performing FLS, except for two who had been performing the procedure 
for only 2 and 4 years, respectively. The mean length of experience with FLS of the 
participating experts was 10.2 years. The most frequently mentioned teaching centers 
for FLS were King’s College Hospital, London, UK (n = 15); University Hospitals KU 
Leuven, Belgium (n = 15); University Hospital Center Paris - Hôpital Necker-Enfants 
Malades, Paris, France (n = 10); and Jackson Fetal Therapy Institute, Miami, FL, USA 
(n = 7).
In the subsequent rounds of the survey, the response rate was 90% (66/73) for round 2 
and 81% (59/73) for round 3.
Substeps
After the first round of the Delphi procedure, a Cronbach’s α score of 0.911 was reached, 
and consensus was attained, on 52 of the 81 substeps (Figure 3). In the second round 
(Appendix S2), the 28 substeps for which no consensus was reached were merged and 
rephrased into 21 substeps, because, according to most FLS experts, these substeps were 
not well formulated. One clearly inappropriate substep, ‘mark recipient with laser spot 
on left upper leg’, was purposely incorporated into the first survey round as a check for 
validity. This item was excluded after the first round. After the second round, consensus 
was reached on another four substeps (RoA ≥ 80%). One substep was removed from the 
final list owing to duplication. Table 2 shows the list of substeps that were included in 
the evaluation end tool.
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Experts n/N (%)
Type of hospital  
university hospital 56/73 (77%)
private hospital/tertiary care facility 11/73 (15%)
public hospital 5/73 (7%)
other 1/73 (1%)
Medical specialty  
obstetrics and gynecology 6/73 (8%)
pediatric surgery 5/73 (7%)
Maternal Fetal Medicine (MFM) 62/73 (85%)
Antenatal invasive procedures  
amniocentesis 69/73 (95%)
chorionic villus sampling 59/73 (81%)
intrauterine transfusion 64/73 (88%)
fetal shunt placement 62/73 (85%)
bipolar cord occlusion 50/73 (68%)
open fetal surgery 16/73 (22%)
Experience  
years currently working as MFM specialist (mean; range) 17.3 (5.0 - 36.0)
years performing FLS for TTTS (mean; range) 10.2 (2.0 - 25.0)
Number of lasers performed annually  
<10         12/73 (16%)
10-25     27/73 (37%)
25-50     18/73 (25%)
50-100   12/73 (16%)
>100      4/73 (5%)
Centers n/N (%)
Number of lasers performed annually  
<10         11/73 (15%)
10-25     23/73 (32%)
25-50     18/73 (25%)
50-100   18/73 (25%)
>100      3/73 (4%)
Experience  
years laser performed at center (mean; range) 10.5 (1.0 - 25.0)
no. of surgeons performing laser (median; range) 2 (1 - 5)
no. of trainees (median; range) 1 (0 - 9)
Table 1. Experience and surgical practice and center characteristics of the 73 experts in fetoscopic laser surgery 
(FLS) who responded to the survey.
MFM: maternal fetal medicine FLS: fetoscopic laser surgery TTTS: twin-to-twin transfusion syndrome
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Figure 3. Flowchart of the selection of substeps determined by expert consensus to be essential in 
fetoscopic laser surgery (FLS) for twin–twin transfusion syndrome to be included in an evaluation 
instrument. RoA, rate of agreement.
Some substeps were considered more important than others. ‘Coagulation of all 
vascular anastomoses that cross the vascular equator’ and ‘determine site of insertion of 
fetoscope’ were items that were considered as most important during FLS. Table 3 shows 
a list of the 18 most important substeps that can be used for training and evaluation in 
order of importance.
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No. Domain and substeps
1. Diagnostic procedure
1.1 Make sure advanced ultrasound scan is performed to exclude fetal anomalies
1.2 Confirmation of monochorionicity, diagnosis, Quintero stage of TTTS
1.3 Consider cervical length measurement
1.4 Consider risk of complications (cervix shortening, fetal deterioration etc)
1.5 Determine whether laser is best treatment option (and consider alternatives)
1.6 Determine whether laser procedure should be performed as soon as possible or expectant 
management can be an option
1.7 Obtain full informed consent
2. Pre-surgical management 
2.1 Blood group and Rhesus typing should be known, respect local protocols concerning Rh-D 
prophylactics
2.2 Prescribe all procedure-related medications (tocolytics, antibiotics etc)
2.3 Determine and arrange type of anesthesia
3. Preparation in operating room 
3.1 Knowledge of technical equipment (ultrasound, scopy tower, laser, instruments)
3.2 Positioning of screens, assistants and lights
3.3 Determine laser modus and power settings 
3.4 Positioning of patient
4. Ultrasound examination (together with sonographer) 
4.1 Identification of both fetuses, presentation and position
4.2 Visualize placenta localization, umbilical cord insertions
4.3 Assess deepest pockets of amniotic fluid
4.4 Determine expected position of vascular equator
4.5 Determine site of insertion of fetoscope
4.6 Choose type of introduction (set) and type of fetoscope
5. Sterile procedure and anesthesia
5.1 Surgical briefing (time out) about (complete) procedure to fetal therapy team
5.2 Aseptic procedure for surgeon, scrub nurse and sonographer 
5.3 Monitoring maternal condition (during complete procedure)
5.4 Placement of sterile covers over patient and instruments
6. Positioning and connection of instruments (pre-insertion) 
6.1 Connection of fetoscope (orientation, focus and white balance)
6.2 Connection of laser fiber to laser machine, insertion of fiber in fetoscope
7. Insertion 
7.1 Performance of all manipulations under ultrasound visualization
7.2 In case of local anesthesia: administer anesthetic to skin and peritoneum
7.3 Make adequate-size skin incision with surgical knife
7.4 Correct use of (Seldinger or trocar) technique for insertion
7.5 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion




8.1 Assess visibility (optional: score visibility)
8.2 Determine need for amniotic exchange
8.3 Confirm position of placenta, fetuses and cord insertions
8.4 Identification of intertwin dividing membrane (and use for reference)
8.5 Mapping of placental surface and vascular equator
9. Laser coagulation
9.1 Coagulation of all vascular anastomoses that cross the vascular equator
9.2 Prevent the unnecessary sacrifice of placental tissue
10. Assessment during procedure 
10.1 Prevent unnecessary delay during procedure
10.2 Check for complications(e.g. bleeding, rupture intertwin membranes
10.3 Identify and record number and type of anastomoses coagulated 
11. Amniodrainage
11.1 Controlled drainage of polyhydramnios
11.2 Assess adequate drainage (ultrasound guided) until pre-defined level to decrease uterine distention 
and promote patient comfort
12. Closure 
12.1 Closing skin incision (suture or suture free adhesive product) 
13. Direct post-operative management 
13.1 Inform patient, partner/family and referring specialist
13.2 Administration (surgical report, fetal therapy database)
13.3 Instructions for monitoring of maternal and fetal condition
14. Follow up ultrasound examination 
14.1 Knowledge of follow-up until delivery of (un)complicated monochorionic pregnancies
14.2 Assessment of fetal condition including bladder filling, deepest vertical pockets and Doppler flows
14.3  Knowledge of MCA-PSV measurement to detect post-laser TAPS
14.4 Signs of iatrogenic perforation of the intertwin membrane
14.5 Signs of amnion-chorionic separation
14.6 Record which fetus is former donor and recipient, respectively
14.7 Knowledge of signs and options with regards to iatrogenic PPROM
Table 2. The 55 essential substeps of fetoscopic laser surgery (FLS), performed in cases of twin–twin transfusion 
syndrome (TTTS), to be included in an evaluation and training instrument.
FLS: fetoscopic laser surgery TTTS: twin-to-twin transfusion syndrome PPROM: preterm premature rupture 
of membranes, MCA-PSV: middle cerebral artery peak systolic velocity, TAPS: twin anemia polycythemia 
sequence.
140
1 Coagulation of all vascular anastomoses that cross the vascular equator
2 Determine site of insertion of fetoscope
3 Ultrasound identification of placenta, fetuses, umbilical cord insertions and expected vascular equator
4 Mapping of placental surface and vascular equator
5 Identification of intertwin dividing membrane (and use for reference)
6 Prevent the unnecessary sacrifice of placental tissue
7 Confirm position of placenta, fetuses and cord insertions
8 Choose and prepare type of introduction (set) and type of fetoscope
9 Connection of fetoscope and laser equipment (including white balance and orientation of the scope)
10 Prevent unnecessary delay during procedure
11 Controlled amniodrainage until pre-defined level (to decrease uterine distention and promote patient 
comfort)
12 Placement of sterile covers over patient and instruments
13 In case of local anesthesia: administer anesthetic to skin and/or peritoneum
14 Identify and record number and type of anastomoses coagulated 
15 Performance of all manipulations under ultrasound visualization
16 Make adequate-size skin incision with surgical knife
17 Assess visibility (optional: score visibility)
18 Closing skin incision (suture, or suture free adhesive product)
Table 3. The 18 substeps of fetoscopic laser surgery (FLS) for twin–twin transfusion syndrome, determined to 
be essential by expert consensus, in order of importance.
DISCUSSION
We achieved an international expert consensus on the technical approach and 
identification of the essential steps of FLS for TTTS. We produced a list of 55 
substeps that are deemed to be essential during FLS. All items were ranked in order 
of importance, with ‘coagulation of all vascular anastomoses that cross the vascular 
equator’, ‘determination of site of insertion of fetoscope’ and ‘ultrasound identification 
of placenta, fetuses, umbilical cord insertions and expected vascular equator’ as the 
most important substeps. This list can be used as a reference guide to improve the 
standardization of training in fetoscopic techniques.
A large number of FLS experts participated in our Delphi procedure; 74% of all FLS 
experts worldwide took part in the first round. We were pleasantly surprised by how 
involved and interested the international group of FLS experts was. The high Cronbach’s 
α score – 0.911 – after the first round of the Delphi procedure confirms homogeneity 
within the panel of experts.
In 1988, Julian De Lia first performed laser therapy as treatment for severe TTTS.14 Over 
the last two decades, the procedure has undergone many changes. The era in which a 
handful of pioneers performed and personally adjusted fetoscopic laser surgery in their 
own centers has now moved into a time in which there is a need for a more standardized 
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approach, enabling the training of many next-generation fetal surgeons worldwide with 
comparable quality of work. The curriculum suggested here, based on expert consensus, 
provides the best available basis for such a training program.
Specific operative situations may require deviation from the recommended standard 
technique. Therefore, strict adherence to the teaching instrument developed may not 
always be desirable. We suggest that these guidelines should be used primarily as an 
instrument for training.
Similar research has not been performed previously in fetal therapy. However, in other 
surgical fields the Delphi methodology has been used to create an authority-based 
curriculum for evaluation and training.5,6 As such, the Delphi methodology has been an 
effective method of achieving expert consensus in the first phase of developing a training 
model for laparoscopic surgery.6,15
In this study, FLS items were ranked to determine their order of importance. In the 
eyes of an expert, some substeps are a natural part of the procedure and are performed 
automatically, however, for a novice, attention to these substeps is vitally important. By 
assigning value to the specific elements, we were able to emphasize certain substeps in 
the list of objectives to attain during training.
The Delphi methodology can be used to develop a curriculum that reflects international 
consensus as opposed to simply local expertise. Studies employing Delphi make use of 
individuals who are presumed to have the best knowledge of the topic being investigated. 
Usually, consensus is only achieved among experts after protracted discussions. 
The Delphi method does not require the panel to meet, and thus largely avoids these 
discussions. Also, experts from different geographic locations can be recruited,11 as 
in this study, which recruited a large panel from 23 different countries. In the Delphi 
methodology, participants have access to the group’s responses, and may change their 
views in line with what others are saying.16 Providing a summary of opinions ensures that 
consensus is reached quickly, by two, or at most three, rounds.8 The web-based design 
speeds up the process, improves feasibility and lowers associated costs. In addition, 
the anonymous nature ensures that outcomes are not influenced inappropriately by a 
single dominant group member and allows the opportunity to re-evaluate one’s own 
‘answers’.11
It is important to note that the existence of a consensus does not mean that the correct 
answer, opinion or judgment has been found,16 however, by using an expert panel, an 
acceptable accuracy is created. A potential limitation of the methodology is that the 
significance of each step, in terms of outcome, is not addressed. Although consensus 
was reached for a specific substep, this study does not provide information on whether 
this substep is associated with better or worse outcomes when performed.
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One of the substeps that did not meet our consensus criteria concerned the laser 
technique used. In a recent multicenter randomized controlled trial, the Solomon laser 
technique (complete dichorionization of the vascular equator) was shown to reduce 
postoperative fetal morbidity in severe TTTS.17 Although this study provides the highest 
level of evidence, which might imply that all centers should adopt this new technique, 
not all experts considered this step to be essential in an evaluation instrument for future 
fetal surgeons. Moreover, steps such as ‘check for limb abnormalities of recipient’ 
and ‘determine placental sharing’ were considered to be time-consuming rather than 
contributory, and therefore were not included.
Another limitation is that it is lengthy and quite time-consuming for the facilitator 
and the participant to take part in a Delphi procedure, compared to a single-round 
survey. Even though each round took only 5–15 min to complete, not all panel members 
maintained interest and responded in the second and third rounds of our survey, which 
is probably related to the relatively time-consuming process and the fact that it was a 
web-based questionnaire that participants can ignore or avoid more easily.
In summary, attention must be paid to the evaluation and training of fetal surgeons, to 
maintain a high standard of clinical performance. This study provides a first step towards 
an authority-based training curriculum and an evaluation tool for FLS performed in 
cases of TTTS. Further research should focus on the applicability of the instrument in 
simulator training as well as in real-life situations.
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ABSTRACT
Objective. Fetoscopic laser surgery for twin-twin transfusion syndrome is a procedure 
for which no objective tools exist to assess technical skills. To ensure that future fetal 
surgeons reach competence prior to performing the procedure unsupervised, we 
developed a performance assessment tool. The aim of this study was to validate this 
assessment tool for reliability and construct validity. 
Methods. A procedure-specific evaluation instrument containing all essential steps of 
the fetoscopic laser procedure was created using Delphi methodology. Eleven experts 
and 13 novices from three Fetal Medicine centers performed the procedure on the 
same simulator. Two independent observers assessed each surgery using the instrument 
(maximum score: 52). Inter-observer reliability was assessed using Spearman correlation. 
We compared performance of novices and experts to assess construct validity.
Results. Inter-observer reliability was high (r=0.974, p<0.001). Checklist scores for 
experts and novices were significantly different: median score for novices was 28/52 
(54%) while for experts 42/52 (81%) (p<0.001). Procedure time and fetoscopy time 
were significantly shorter (p<0.001) for experts. Residual anastomoses were found in 
1/11 (9%) procedures performed by experts and in 9/14 (64%) performed by novices 
(p=0.006). Multivariate analysis showed that the checklist score independently from age 
and gender predicted competence. 
Conclusions. The procedure-specific assessment tool for fetoscopic laser surgery shows a 
good inter-observer reliability and discriminates experts from novices. This instrument 
may therefore be a useful tool in the training curriculum for starting fetal surgeons. 
Further intervention studies with reassessment before and after training may increase 




Fetoscopic laser therapy is the preferred treatment modality for twin-twin transfusion 
syndrome (TTTS),1-3 but is only offered in a few highly specialized Fetal Medicine 
centers around the world.4 Although fetoscopic laser surgery is a complex procedure 
that has been in use for more than two decades, standardized surgical training programs 
for fetoscopic interventions are nonexistent and performance is often authority based, 
i.e. on personal experience, belief  and individual preferences. Also, the learning curve is 
ill-defined, and varies between 21 to 75 cases (based different survival outcome measures 
such as minimal double survival rates of 54% or at least one survivor in 70% of cases) to 
acquire the necessary skills.5-8 Therefore, there is a need for a reliable assessment tool of 
technical performance. Such a tool would be useful to monitor progress, provide constant 
feedback along the learning curve, to serve as an instrument for (re-)certification and 
offer standardized training.
We previously reported on a list of steps judged essential to the laser procedure based 
on the Delphi methods.9 These steps were consensus based by a sample of international 
experts, making the final tool representative of international, rather than local practice. 
The aim of this prospective cohort study was to assess reliability and validity of this 
instrument in the context of simulated operating room performance. We hypothesized 
that, based on the systematic manner in which this tool was created; we would obtain an 
acceptable level of inter-observer reliability and that the instrument would discriminate 
the performance of experts from that of novices. 
METHODS
Participants and study design
This study is part of the SILICONE project (SImulator for Laser therapy and 
Identification of Critical steps of Operation: New Education program), conducted to 
develop a standardized training program for fetoscopic laser surgery for TTTS. In the 
first part of the project we determined the essential steps of treatment to develop an 
assessment instrument.9 In the current part of the project, this instrument was validated 
using a silicone simulator involving the complete laser procedure.
This study was conducted in three Fetal Medicine centers: Leiden University Medical 
Center (the Netherlands), University Hospitals KU Leuven (Belgium) and Karolinska 
Institutet, Stockholm (Sweden) from September 2014 until December 2014. We recruited 
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24 volunteers with special interest in fetal therapy to participate in the study. All 
participants completed a questionnaire to establish baseline demographic characteristics 
and previous experience in fetoscopic surgery to measure potential confounding factors 
that affect performance. Participants were stratified into 3 groups with regard to the level 
of previous experience; expert or novice or intermediate. 
An expert was defined as a physician who currently practices fetoscopic laser surgery 
for TTTS and has performed at least 25 fetoscopic laser procedures independently.8 
Novices included fetal medicine specialists without practical fetal therapy experience 
OR obstetricians attending a fellowship in perinatology OR senior residents with special 
interest in perinatology and minimal invasive therapy. All novices were experienced 
sonographers and had appropriate knowledge of TTTS and its treatment options, 
but had never performed a fetoscopic laser procedure and had little or no previous 
experience with other ultrasound-guided invasive procedures (amniocentesis, chorionic 
villus sampling and/or intrauterine transfusion). Participants with an intermediate level 
of experience (e.g. performed between 1-25 fetoscopic laser procedures) were excluded. 
 
Assessment
All participants (irrespective of the level of expertise) performed a similar assignment 
on the simulator. The scenario involved a patient of 17 weeks’ gestation with stage 3 
TTTS referred for laser therapy. The assignment included the complete fetoscopic laser 
procedure; starting from the moment the operation room is entered, until the surgery was 
finished and direct post-operative management was ordered. Three different items were 
scored: ‘time’, ‘checklist with essential steps of procedure’ and ‘complete identification 
of vascular equator’.
All participants were evaluated by 2 independent observers (S.P. and J.A.), using the 
assessment instrument created by the Delphi consensus.9 This list of essential steps was 
modified into a checklist adjusted to the simulated scenario. A detailed description of 
the instrument is available in the appendix. Each item was awarded 1 point if  it was 
done properly (range 0-52). Procedure time, defined as ‘the moment the surgeon enters 
the operating room until the moment that direct post-operative management is ordered’ 
and fetoscopy time, defined as ‘the moment the fetoscope is introduced for the first time 
until final removal’ were recorded. A map of the placental architecture was used by the 




To explain the task, all participants were shown a standardized multimedia presentation 
outlining the background and aim of the study, as well as the performance metrics 
(time, missed essential steps and complete coagulation of the vascular equator). Finally, 
the context of the scenario (including patient characteristics, findings of diagnostic 
procedure and pre-surgical management) was presented. 
Simulator characteristics 
The simulator used for this study has previously been described10 (Francis LeBouthillier, 
Surgical touch, Toronto, Canada), but was modified with a highly realistic silicone copy 
of a 17 week monochorionic twin placenta and twin fetuses (R. Bakker, Manimalworks, 
Rotterdam, The Netherlands). The silicone topping on the model mimics the abdominal 
wall. Inside there is a mimic of a uterus, which contains water and the placenta. The 
individual layers of the abdominal wall, the uterus and placenta have sonographic and 
compliance properties that mimic the clinical situation. The model allows an operator 
to practice ultrasound examination of a monochorionic pregnancy, required to select 
the best site for introduction of the instruments. The model also provides a realistic 
intrauterine environment, optimal to practice manual dexterity skills and to train 
navigation along the placental surface. Moreover, the addition of a “stuck” donor twin 
on the placenta simulates the inability to oversee the complete vascular equator. The 
addition of a “free-floating” recipient simulates a realistic complex situation of floating 
fetal extremities and umbilical cord in the recipients’ sac. All necessary instruments 
(i.e. fetoscope, introduction set, endoscopy tower etc.) were used from the local Fetal 
Medicine center so that participants perform their tasks in a setting that was identical to 
what would be their clinical environment. Figure 1 shows a participant performing the 
procedure on the simulator model.
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Figure 1 Participant performing procedure on simulator for fetoscopic laser surgery
Statistical analysis 
Demographics, procedure- and fetoscopy time, checklist score and presence of residual 
anastomoses were compared between experts and novices. Due to the small sample size 
and non-normality of the data, the Mann Whitney U test was used to test for differences 
between groups for the continuous variables. To test for differences between groups on 
non-ordinal categorical outcomes, such as presence or absence of experience, Fisher’s 
exact test was used. 
Spearman correlation coefficient was used to measure the inter-observer reliability. A 
correlation of 0.9 or higher was considered to be indicative of an excellent agreement. 
We used a multivariate regression analysis to determine independent predictors for the 
construct validity of the instrument. Construct validity refers to the degree to which any 
measurement approach or instrument succeeds in describing or quantifying what it is 
designed to measure. Moreover, to evaluate the accuracy with which scores on a given 
instrument can classify groups that are already known to differ on a criterion measure 
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(i.e. experts and novices). In other words, if  experts are the ones with the construct 
(surgical skills) and the novices are the ones without the construct; construct validity 
determines whether the instrument identifies the presence or absences of the construct 
(surgical skills). 
A two-sided p-value <0.05 was considered to indicate statistical significance. Statistical 
analyses were performed with IBM. SPSS version 21.0 (IBM SPSS Statistics for Windows, 
Version 21.0 Armonk, New York: IBM Corp.) Since no patients were involved, no formal 
ethical approval and written informed consent was needed for this study.
RESULTS
In this study, 24 fetoscopic simulated laser surgeries were analyzed. They were performed 
by 11 (46%) experts and 13 (54%) novices. Eleven participants were male, 13 were female. 
Although 4/13 (31%) of the novices in the study had previous limited experience with 
invasive obstetric procedures (e.g. amniocentesis, chorionic villus sampling, intrauterine 
transfusion etc.) none had previously performed the fetoscopic laser procedure for TTTS. 
In the group of experts, 5/11 (45%) had performed >100 procedures with a median of 
10 procedures (range 8-20) annually. The demographics of the participants are shown 
in table 1. 
Overall median procedure time was 40 minutes (range: 26-50 minutes). Experts were 
able to complete the procedure in 32 minutes, versus 43 minutes (p=0.003) by novices. 
Fetoscopy time was also significantly different between the groups. Median fetoscopy 
time for all participants was 17 minutes, (range: 10-27 minutes): 11 minutes for experts 
versus 20 minutes for novices (p<0.001). Residual anastomoses were found in 10/25 
(40%) procedures, 1/11 (9%) performed by experts and in 9/14 (64%) performed by 
novices (p=0.005). 
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Demographics Expert Novices p value
 n/N (%) n/N (%)  
Gender    
Male 8/11 (73) 3/13 (23) 0.015
Female 3/11 (27) 10/13 (77)  
Age    
  (median in years, range) 52 (35-59) 32 (28-42) <0.001
Experience with invasive obstetric procedures    
Has experience with invasive obst. procedures 11/11 (100) 4/13 (31) 0.001
years (median, range) 15 (7-23) 3 (1-8) 0.003
Type of invasive obstetric procedures  
Amniocentesis 11/11 (100) 3/13 (23)  
Chorionic villus sampling 11/11 (100) 3/13 (23)  
Intrauterine transfusion 8/11 (73) 1/13 (8)  
Fetal shunt placement 8/11 (73) 0  
Bipolar cord occlusion 11/11 (100) 0  
Open fetal surgery 4/11 (36) 0  
Other 4/11 (36) 0  
No. of FLS attended (incl. assisting or watching procedure)   
None 0 2/13 (15) 0.001
< 10 procedures 0 7/13 (54)  
10-25 procedures 0 0  
25-50 procedures 1/11 (9) 2/13 (15)  
50-100 procedures 1/11 (9) 0  
>100 procedures 9/11 (82) 2/13 (15)  
Experience with simulator training    
Never 2/11 (18) 1/13 (8) 0.447
A few times 4/11 (36) 8/13 (62)  
Regularly 5/11 (46) 4/13 (30)  
Table 1 Demographics of study participants
Reliability
The overall inter-observer reliability of the two raters’ total scores (J.A. and S.P.) for the 
fetoscopic laser procedure was excellent (rs): 0.974 (p<0.001) (Figure 2).
Agreement was less but still strong in the domains concerning ‘direct post-operative 
management’ (rs: 0.722; p<0.001) and ‘assessment during procedure’ (rs: 0.789; p<0.001) 
as displayed in table 2. The inter-observer variability did not significantly change over 
time (data not shown). 
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Figure 2 Correlation of checklist scores of the two observers
 Domain No. of steps Rs p value
A Preparation in operating room 7 0.956 <0.001
B Ultrasound examination (together with sonographer) 7 0.862 <0.001
C Pre-operative preparations 7 0.943 <0.001
D Positioning and connection of instruments (pre-insertion) 6 0.977 <0.001
E Insertion 5 0.947 <0.001
F Orientation 8 0.857 <0.001
G Laser coagulation 4 0.862 <0.001
H Assessment during procedure 3 0.789 <0.001
I Amniodrainage 2 1.000 <0.001
J Closure 1 0.845 <0.001
K Direct post-operative management 2 0.722 <0.001
 Overall 52 0.974 <0.001
Table 2 Inter-observer reliability by domain
R
s
 : Spearman correlation coefficient
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Construct validity
Rater 1’s median score for novices on the assessment tool was 29/52 (56%) (range: 20-43), 
compared to an median expert score of 47/52 (90%) (range: 44-50) (p<0.001). Rater 2’s 
median novice score similarly demonstrated statistically significant differences between 
novice and expert performance [30/52 (58%) (range: 19-45) versus 48/52 (92%) (range: 
43-52)] (p<0.001). 
The overall median checklist scores (combining the scores of the two raters) were 
28/52 (54%) 20-44) in novices versus 42/52 (81%) (44-51) in experts (p<0.001) and were 
significantly associated with the presence of residual anastomoses as demonstrated in 
figure 3 (p=0.002). Sensitivity-specificity analysis showed an area under the curve of 
0.861. Multivariate analyses showed that age (b1: 0.203; p= 0.351) and gender (b1: 0.088; 























This study assessed the inter-observer reliability and construct validity of a procedure-
specific evaluation tool for fetoscopic laser surgery of TTTS, created using the Delphi 
methodology.9 Our instrument effectively distinguished performance of experts and 
novices with an acceptable level of inter-observer reliability.
Any discussion of evaluation or assessment must address issues of validity and reliability. 
The instrument will only be useful to educators or surgeons as a measure of competence 
when it does measure the construct that it intends to measure (validity) and when the 
results that are obtained are consistent and therefore meaningful (reliability). Inter-
observer reliability refers to a degree to which difference in score on the tool reflects a 
difference in quality of performance rather than a difference between the raters. A high 
level of inter-observer reliability allows evaluation of skills by different observers and 
will be minimally affected by the variability of the rater.11 
Till today, trainees in fetal surgery are educated according to the “master–apprentice” 
principle. Direct observation by experts alone may not be a reliable method of assessment 
and may lead to recall bias due to the retrospective nature of the evaluation. Use of fixed 
criteria such as a validated checklist by observing experts can address these concerns.12,13 
Additionally, task-specific checklists provide trainees with detailed methods on how 
to perform the procedure and enable formative feedback and deliberate practice. To 
achieve standardization and wide implementation, an assessment tool must be reflective 
of practice among many institutions; therefore we included participants from three 
major Fetal Medicine centers. 
Validation of assessment tools for training has been done frequently in other medical 
areas,14-17 but never in the field of fetal therapy. Observation of surgical skills without 
structured criteria has poor reliability and will result in a low level of agreement among 
the raters.18 The values for inter-observer reliability in this study indicate that our 
evaluation tool reaches the cut-off  of 0.8 deemed acceptable for assessment.11
The purpose of this study was to validate the evaluation tool for surgeon’s technical 
performance using a highly realistic simulator. Objective feedback to fetal surgeons 
on their performance based on highly reliable assessment tools could also be of great 
value for ongoing assessment and lifelong learning. Developing similar assessment 
tools for other invasive obstetric procedures will make it possible to teach and evaluate 
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procedures using disseminated learning materials. Since we want to make the curriculum 
competency based, it is also important to define expert benchmark levels of proficiency 
for the final curriculum.
Procedure-specific checklists have been shown to be less reliable and less construct valid 
than global rating scales19 However, a global assessment scale can make an instrument 
indistinctly and have an apparent precision, since items are rated on scales (e.g. 1-10) 
instead of ‘achieved’ or ‘failed’. For feedback purposes it is sufficient to know at a glance 
which elements need improvement (instead of adding values to the assessed items).
Procedure time and fetoscopy time were significantly lower in the expert group 
compared to novices. This may be explained by the often interrupted flow of thoughts 
when performing a procedure for the first time. Surgical steps need to be carried out 
consciously for novices, as opposed to automatically for experts, making a procedure-
specific tool even more valuable for training purposes and combines efficacy (closing all 
anastomoses) with safety (avoid complications). 
A limitation of this study is that a few items identified through the prior Delphi consensus 
could not be analyzed during the simulator experiments since they take place in the 
diagnostic and pre-operative phase of the procedure. These steps include: “diagnostic 
procedure” (e.g. ultrasound examination at out-patient clinic confirming diagnosis 
and determine treatment options), “pre-surgical management” (e.g. prescription of 
procedure related medication etc.) and “follow-up ultrasound examination”. Therefore 
the construct validity and reliability measurement of this tool does not include these 
particular steps. 
Due to nature of the procedure, we were unable to assess the validity of the instrument in 
surgery on real patients; therefore the simulator was used. Even though the simulator was 
regarded highly realistic, clinical features such as ‘tissue reaction after firing the laser’ and 
‘complications such as bleeding’ could not be simulated. On the other hand, assessment 
using a simulator model can also be advantageous, since the lack of standardization 
in real patients makes consistent assessment of technical skills difficult. Advantages of 
the simulator model include the fact that tasks can be presented consistently to many 
trainees, who can operate independently, objective assessment by more than one faculty 
member is possible and there is no intrusion on operating room time, which has financial 
and ethical advantages.20
For this study, participants were assessed live in the operating room, therefore observers 
were able to oversee all steps, in contrast to only fetoscopic view or single camera 
position. This allowed us to evaluate the complete procedure, including all its facets such 
157
8
as sterility and handling of the instruments. Unfortunately, this element of our study 
prevented blinding the raters for the level of experience. 
The construct validity of the instrument could be further assessed with a study with a 
pre- and post-training design. Correlation with a learning curve would further support 
its validity. Future studies should focus on the development and validation of a training 
curriculum aimed at improving the operative and technical skills of trainees in fetal 
therapy. Finally, additional studies should be performed to assess how well instructors 
can evaluate clinical skills when observing surgeons working with real patients and how 
to implement this into clinical practice. 
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No. Domain and substeps Score
A Preparation in operating room 7
1 Ultrasound correct settings  
2 Endoscopy tower settings  
3 Positioning of screens  
4 Adjusting lights  
5 Correct laser modus  
6 Correct power settings  
7 Positioning of patient  
B Ultrasound examination (together with sonographer) 7
8 Identification of donor  
9 Identification of recipient  
10 Identification localization placenta  
11 Identification cord insertions  
12 Assess deepest pockets  
13 Determine expected position equator  
14 Determine insertion site fetoscope  
C Pre-operative preparations 7
15 Surgical briefing (time out) about (complete) procedure to fetal therapy team  
16 Aseptic procedure for surgeon, scrub nurse and sonographer  
17 Mention maternal condition  
18 All instrumentation remains sterile  
19 All is sufficiently covered  
20 Pre-insertion connection scope - shaft  
21 Pre-insertion connection light cable  
D Positioning and connection of instruments (pre-insertion) 6
22 Choose fetoscope  
23 Fetoscope: orientation  
24 Fetoscope: focus  
25 Fetoscope: white balance  
26 Connection of laser fiber  
27 Correct loading of laser fiber in fetoscope  
E Insertion 5
28 Preparation of introduction method  
29 Performance of all manipulations under ultrasound visualization  
30 Correct administration of local anesthetic  
31 Make adequate-size skin incision with surgical knife  
32 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion
F Orientation 8
33 Assess visibility (optional: score visibility)  
34 Determine need for amniotic exchange  
35 Fetoscopic view of placenta  
36 Fetoscopic view of donor  
37 Fetoscopic view of cord insertion recipient  
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38 Identification of placental edges  
39 Difference between artery and vene  
40 Find (part of ) vascular equator  
G Laser coagulation 4
41 Coagulation of all vascular anastomoses that cross the vascular equator  
42 Laser fiber correct position in fetoscope  
43 Laser fiber correct distance from vessel during coagulation  
44 Prevent the unnecessary sacrifice of placental tissue  
H Assessment during procedure 3
45 Prevent unnecessary delay during procedure  
46 Check for complications(e.g. bleeding, rupture intertwin membranes)  
47 Identify and record number and type of anastomoses coagulated  
I Amniodrainage 2
48 Controlled drainage of polyhydramnios  
49 Assess adequate drainage (ultrasound guided) until pre-defined level  
J Closure 1
50 Closing skin incision (suture or suture free adhesive product) 
K Direct post-operative management 2
51 Inform patient, partner/family and referring specialist  
52 Instructions for monitoring of maternal and fetal condition  
Appendix 1 Evaluation instrument

Chapter 9
Simulator training in fetoscopic laser surgery 





















Objective: To evaluate the effect of a newly developed training curriculum on 
performance of fetoscopic laser surgery for twin-twin transfusion syndrome (TTTS) 
using an advanced high-fidelity simulator model.
Methods: Ten novices were randomized to receive verbal instructions and skills training 
using the simulator (study group, n=5) or no training (control group, n=5). Both groups 
were evaluated with a pre-training test and post-training test. Assessment was performed 
by two independent observers and compromised a 52-item checklist for surgical 
performance (SP score), measurement of procedure time and number of anastomoses 
missed. Face validity, educational value and user friendliness of the simulator were 
assessed using a questionnaire. Eleven experts from three fetal therapy centers set the 
benchmark level of performance.
Results: Both groups showed an improvement in SP score compared to the pre-training 
test. The simulator-trained group significantly outperformed the control group with a 
median SP score of 28 (52%) in the pre-test and 46 (88%) in the post-test versus 25 (48%) 
and 36 (69%) (p=0.008). Procedure time decreased 11 min in the study group versus 1 
min in the control group; to 32 min versus 38 min, respectively (p=0.69). The number 
of missed anastomoses was not different between the groups (1 versus none). Feedback 
provided by the participants indicated that training on the simulator was perceived as a 
useful educational activity.
Conclusion: Proficiency-based simulator training improves performance on surgical 
performance score for fetoscopic laser therapy. Practice on a simulator is recommended 




Twin–twin transfusion syndrome (TTTS) is a serious complication affecting 
approximately 10% of monochorionic (MC) twin pregnancies.1 Treatment is offered 
in specialized fetal therapy centers around the world.2 Fetoscopic laser surgery enables 
both twins to survive in 60–70% of cases, and at least one twin survives in 80–90%.3 Only 
a few studies have been performed to gain more insight in the learning curves and pitfalls 
of this complex procedure.4-8 
In the coming years, we anticipate an increasing number of fetal surgeons to start 
training for fetoscopic laser surgery. With the economic growth in developing countries, 
and increasing knowledge of this treatment option through internet information, the 
interest of both patients and doctors in fetoscopic laser surgery will continue to grow. 
In addition, the next generation of fetal surgeons will gradually start to take over 
practice from the pioneers in the established centers. Therefore, attention is gradually 
shifting from pregnancy outcomes per center towards appropriate training and exposure 
of surgeons to a sufficient number of procedures. This will secure proper skills and 
satisfactory results. To support this process, an evidence-based training curriculum and 
continuous process of reporting and monitoring of outcomes is highly valuable.
Since fetoscopic procedures are performed on an infrequent basis, a surgeon-in-training 
is forced to a lengthy and expensive stay in a (often distant) fetal therapy center to 
accumulate at least some hands-on experience. Even large centers have limited numbers 
of cases, therefore teaching and training this procedure is challenging. A growing need 
for alternative methods to train surgical skills through simulation has been recognized.4,5,9 
Several attempts have been made to develop simulators for invasive fetal procedures with 
various levels of physical resemblance and functional task alignment.9-13 Most reported 
simulators were used for teaching in absence of well-planned and comprehensive training 
curricula. 
A procedure-specific simulator for fetoscopic laser surgery has not yet been developed 
before and standardized surgical training programs are nonexistent. Therefore, the 
aim of this study was to demonstrate face and construct validity of a highly realistic 




For this study we recruited volunteers with special interest in fetal therapy and no 
practical experience with the fetoscopic laser procedure (novices), and all currently 
active fetal therapy experts in three Fetal Medicine centers: Leiden University Medical 
Center (the Netherlands), University Hospitals KU Leuven (Belgium) and Karolinska 
University Hospital, Stockholm (Sweden) from September 2014 until December 
2014. All participants completed a questionnaire to establish baseline demographic 
characteristics, previous experience in surgical/obstetrical skills in order to exclude 
potential confounding factors that may affect performance. Participants were eligible 
to take part in this study if  they were: fetal medicine specialists without practical fetal 
therapy experience OR obstetrician/gynecologists attending a fellowship perinatology 
OR senior OBGYN residents with special interest in perinatology and/or minimal 
invasive therapy; AND had a high level of skills in diagnostic ultrasound, appropriate 
knowledge of TTTS and its treatment options, but little or no previous experience with 
other ultrasound-guided invasive procedures (amniocentesis, chorionic villus sampling, 
cordocentesis and/or intrauterine transfusion). 
A training curriculum using a simulator for fetoscopic laser surgery was generated 
based on a previously developed evaluation instrument.5 We conducted a non-blinded 
randomized controlled trial using a parallel study design. For randomization, we used a 
block randomization list (non-stratified, with the same block lengths), generated by 
www.random.org sequentially. Novices were randomly assigned to either the training 
group (study group) or the no-training group (control group). Because of the nature of 
the intervention, blinding for randomization allocation was not possible. Lack of data 
regarding training for fetoscopic laser surgery prevented a formal sample size calculation. 
Giving the rarity of the procedure and the estimation that in the coming years two 
eligible trainees per fetal center will be trained, a sample size of 12 was chosen for this 
study. A pre-test/post-test research design was used to evaluate the effect of simulator-
based training on surgical performance. Performance was assessed with an assignment 
involving the complete fetoscopic laser procedure, comparing the two groups before and 
after training. A flowchart of participant enrolment is shown in figure 1.
All currently practicing experts (n=11) from the three MFM centers were asked to 
complete the same assignment to define a benchmark level. An “expert” was defined 
as an individual who is currently practicing fetoscopic laser surgery for TTTS and has 
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independently performed >25 fetoscopic laser procedures.4 Baseline characteristics of 
all study participants are listed in table 1. 
Demographics Experts Novices Novices p value
  (no training) (training)  
 n/11 (%) n/5 (%) n/5 (%)  
Gender    
Male 8/11 (73) 2/5 (40) 0 0.44
Female 3/11 (27) 3/5 (60) 5/5 (100)  
Age    
(median in years, range) 52 (35-59) 30 (30-34) 34 (30-37) 0.15
Experience with invasive obstetric procedures    
Has experience with invasive obstetric  procedures 11/11 (100) 0/5 (0) 2/5 (40) 0.44
Years of experience (median, range) 15 (7-23) 0 2 (1-2)  
Type of invasive obstetric procedures    
Amniocentesis 11/11 (100) 0 2/5 (40)  
Chorionic villus sampling 11/11 (100) 0 2/5 (40)  
Intrauterine transfusion 8/11 (73) 0 0  
Fetal shunt placement 8/11 (73) 0 0  
Bipolar cord occlusion 11/11 (100) 0 0  
Open fetal surgery 4/11 (36) 0 0  
Other 4/11 (36) 0 1/5 (20)  
No. of FLS attended (incl. assisting or watching procedure)    
None 0 2/5 (40) 0 0.28
< 10 procedures 0 2/5 (40) 4/5 (80)  
10-25 procedures 0 1/5 (20) 0  
25-50 procedures 1/11 (9) 0 0  
50-100 procedures 1/11 (9) 0 1/5 (20)  
>100 procedures 9/11 (82) 0 0  
Experience with simulator training    
Never 2/11 (18) 1/5 (20) 0 1.00
A few times 4/11 (36) 2/5 (40) 3/5 (60)  
Regularly 5/11 (46) 2/5 (40) 2/5 (40)  
FLS: fetoscopic laser surgery
Table 1. Demographics of study participants
Simulator characteristics 
An advanced simulator (Francis LeBouthillier, Surgical Touch, Toronto, Canada) that 
was previously used for the training of amniocentesis 11 was modified. A monochorionic 
twin placenta model and realistic models of twin fetuses were inserted. (R. Bakker, 
Manimalworks, Rotterdam, The Netherlands). Placenta and fetuses had a size 
comparable to 17 weeks of gestation. The silicone interface at the top of the model 
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mimicked the abdominal wall. The simulator contained water and had appropriate 
sonographic properties. The model allowed an operator to perform ultrasound 
examination of the monochorionic pregnancy and to select the site for introduction of 
the instruments. The model provided a realistic intrauterine environment, optimal to 
practice manual dexterity skills and to train navigation along the placental surface. The 
“stuck” donor twin was positioned on the placenta. The addition of a “free-floating” 
recipient simulated the floating fetal extremities and umbilical cord in the recipients’ 
sac. Besides the simulator model, all standard equipment (i.e. fetoscope, introduction 
set, ultrasound machine, endoscopy tower etc.) clinically used in the participating fetal 
therapy centers was used to perform the assignment. 
Figure 1. Flowchart of the stu y showing participant enrolment, randomization, alloca ion of interventions 
and follow-up. 
 
Assessed for eligibility (n=14) 
Excluded (n=2) 
�   Not meeting inclusion criteria due to 
previous experience (n=2) 
Analyzed (n=5) 
 
Discontinued intervention (n=1) 
�   Unable to complete post-test within 2 weeks 
due to technical difficulties with endoscopy 
tower (n=1) 
Allocated to simulator-based training  
(study group, n=6) 
Lost to follow-up (n= 1) 
�   Unable to complete post-test within 2 weeks 
due to busy work schedule 
Allocated to no-training 









Participants and experts were evaluated by 2 independent observers (S.P. and J.A.), using 
the evaluation instrument created by the Delphi consensus.5 The list of essential steps 
was modified into a surgical performance score (SP score) adjusted to the simulated 
scenario. This 52–item list consisted of ‘achieved’ and ‘failed’ items in 11 domains 
pertaining specifically to the fetoscopic laser procedure for TTTS. (Appendix 1) Each 
item was awarded 1 point if  it was done properly (range 0-52). Procedure time, defined 
as ‘the moment the surgeon enters the operating room until the moment that direct post-
operative management is ordered’ and fetoscopy time, defined as ‘the moment the trocar 
was introduced until final removal’ was recorded. A map of the placental architecture 
was used by the observers to mark the coagulated anastomoses (total n=8). Since there 
was no international consensus on the Solomon technique3 at the time of development 
of the checklist, participants were instructed to coagulate all vascular anastomoses (that 
connected the circulation of the donor and the recipient twin) one by one; referred to as 
the ‘selective laser technique’.
The structured fetoscopic laser surgery skills training and evaluation consisted of five 
phases:
Phase 1: Introduction
Each participant was familiarized with the simulator by a member of the study team 
(SP or JA). 
All participants were shown a standardized multimedia presentation outlining the 
background and aim of the study to explain the task; including the assessed performance 
metrics. Finally, the context of the scenario was presented. No assistance was provided 
during completion of the assignment unless the participant was unable to proceed with 
the procedure. In that case (for example: ‘switch on the laser’) the item was appointed 
but scored as ‘failed’.
Phase 2: Pre-training test
All subjects in the study participated in a pre-training test to assess baseline competency 
and technical skills in fetoscopic surgery. The participants performed an assignment in 
the simulator, including the complete fetoscopic laser procedure for a patient of 17 weeks’ 
gestation with stage 3 TTTS; starting from the moment the operation room is entered, 
until the surgery was finished and direct post-operative management was ordered.
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Phase 3: Training
After the pre-training test, novices who were randomized to the training curriculum 
were trained in a 1 day session by a fetal therapy expert who was not involved in the 
evaluation process. The curriculum comprised two components: a theoretical part and 
practical session. The procedure-specific instrument served as a framework for curricular 
development. An instructor script and multimedia presentation including step-by-step 
actions and decisions required to perform the fetoscopic laser surgery, were developed 
by DO, RD and SP. 
The theoretical part of the training consisted of a multimedia presentation outlining 
the indication for surgery, relevant anatomy, control of the instruments including the 
fetoscope, and a video demonstration of the simulated steps. The purpose of this session 
was to allow participants to understand the flow of the procedure and to conceptualize 
how to plan and execute the fetoscopic laser surgery.
The training continued with a practical session using the simulator with three subsequent 
practice rounds. In round 1, an attending fetal expert showed how to perform the procedure 
step-by-step, in round 2 the trainee performed the procedure under supervision of the 
expert provided with direct verbal feedback. In the last round, the complete procedure 
was performed by the trainee and evaluated directly afterwards with the expert.
The participants that were allocated to the control group did not receive feedback with 
regard to their performances. They were also not involved in the training sessions. 
Phase 4: Post-training test
Within 2 weeks after the training, all novices (study group and control group) performed 
a post-training test, evaluated by the same independent observers (J.A. and S.P.). The 
post-training test included a different assignment (regarding the location of the placenta 
and the fetuses), but was performed on the same simulator. 
Phase 5: User experience evaluation
Participants completed a survey to collect qualitative data regarding participant 
perceptions of the value of the simulation and training. Face and content validities were 
assessed concerning participants’ opinions about realism (9 items), usefulness (5 items), 
and overall opinion about the simulator (3 items). All items were scored on an ordinal 




Demographics, SP score, procedure time, fetoscopy time and presence of residual 
anastomoses, of both pre-training and post-training tests, were compared for the 
groups. For the SP score, a higher score is better; therefore an improvement is reflected 
by a positive pre- and post-test difference. For procedure time and fetoscopy time, 
improvement was calculated as pre-training test minus post-training test value. 
Due to the small sample size and non-normal distribution of the data, the Mann Whitney 
U test was used to test for differences between groups for the continuous variables. To 
test for differences between groups on non-ordinal categorical outcomes, Fisher exact 
test was used. For ordinal outcome such as a Likert agreement scale the χ2 test was used. 
Spearman correlation coefficient was used to measure the inter-observer reliability. A 
correlation of 0.9 or higher was considered to be indicative of an excellent agreement. 
A p value ≤ 0.05 was considered statistical significant. Statistical analysis was performed 
with IBM SPSS version 21.0 (IBM SPSS Statistics for Windows, Version 21.0. Armonk, 
NY: IBM Corp.).
RESULTS
Participant enrolment, randomization and follow-up are illustrated in figure 1. Within 
the three participating centers 12 volunteers were included in the trial and randomized. 
One participant was lost to follow up, another was not able to complete the test due 
to technical difficulties, therefore we were able to analyze the results of 10 participants 
(study group n=5 and control group n=5).  
The randomized study group (with training) and control group (without training) were 
well balanced for baseline characteristics (Table 1). Analysis revealed no differences 
between the groups regarding prior knowledge of the procedure or experience with 
other obstetric invasive procedures or simulators. In the expert group, 9/11 (82%) of 
participants had attended > 100 laser procedures and 5/11 (45%) had performed >100 
procedures themselves. A median of 10 procedures per expert (range 8-20) was performed 
annually. 
Experts
The expert benchmark level was set with a median SP score of 44/52 (85%) (range: 
44-51), a procedure time of 32 minutes (range: 26-46 minutes) and fetoscopy time of 
11 minutes (range: 10-18 minutes). One expert missed a small AV anastomosis at the 
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margin of the placenta (1/11, 9%). In table 2 results of performance of all participants 
are shown. 
 Expert (benchmark) Novices (study group) Novices (control group) p value
 n=11 range n=5 range n=5 range  
SP score (max 52)        
pre-training test 48 (92%) (44-51) 28 (52%) (27-41) 25 (48%) 20-44 0.55
post-training test  46 (88%) (43-51) 36 (69%) 30-41 <0.01
difference  plus 18 plus 11  
Procedure time (minutes)        
pre-training test 33 (26-46) 44 40-50 39 33-45 0.06
post-training test  33 29-44 38 27-49 0.69
difference  minus 11 minus 1  
Fetoscopy time (minutes)        
pre-training test 12 (10-18) 22 18-25 18 16-20 0.06
post-training test  14 (10-20) 14 (11-24) 0.69
difference  minus 8 minus 4  
Missed anastomoses        
pre-training test 1/11 (9%) 4/5 (80%) 2/5 (40%) 0.52
post-training test  1/5 (20%) 0 (0%) 1.00
SP score: surgical performance score
Table 2. Performance of experts and study participants
Pre-training test
The median SP score for the study group was 28/52, 54% (range: 27-41) versus 25/52, 
48% (range: 27-41) in the control group (p=0.55). Median procedure time in the study 
group was 44 minutes (range: 40-50 minutes) versus 39 minutes (range: 33-45 minutes) 
in the control group (p=0.06). Fetoscopy time was 22 minutes (range: 18-25 minutes) in 
the study group versus 18 minutes (range: 16-20 minutes) in the control group (p=0.06). 
In the study group 4/5 (80%) participants did not coagulate all anastomoses versus 2/5 
(40%) in the control group (p=0.52). In the study group 3 participants missed 2 out of 
8 anastomoses and 1 participant 1 out of 8 anastomoses, all located on the placenta 
margin. In the control group one participant missed 3 anastomoses in the center of the 
placenta and one participant 2 anastomoses on the placenta margin.
Post-training test
Novices in both groups showed an improvement in SP scores and performed the 
procedure in less time compared to the pre-training tests. The study group outperformed 
the control group after the training session significantly with median SP scores 46/52 
88% (range 43-51) versus 36/52 69% (range 30-41) (p=0.008).
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Median procedure time decreased 11 minutes in the study group versus 1 minute in 
the control group, to 32 minutes (range: 29-44 minutes) and 38 minutes (range: 27-49) 
respectively. Median fetoscopy time improved to 14 minutes in both groups; study group 
range: 10-20 minutes, control group range: 11-24 minutes (p=0.69). In the post-training 
test one participant (1/5 (20%)) in the study group missed 1 (out of 8 anastomoses) 
located on the placenta margin versus none in the control group (p=1.00).
Figure 2 shows the performance of both groups in the pre-training test and post-
training test on SP scores, procedure time and fetoscopy time plotted against the expert 
benchmark level. 
Figure 3 shows that experts felt that the simulator was very useful in training to identify 
the vascular equator and to practice the complete laser procedure. (score of 9 on Likert 
scale 1-10) All experts stated that training with the simulator provided good preparation 
before starting to operate on real patients. Except for the sonographic properties, the 
simulator was judged highly realistic. 
The overall inter-observer reliability of the two raters’ total scores (J.A. and S.P.) for 
the fetoscopic laser procedure was excellent (Spearman correlation coefficient: 0.984 
p<0.001).
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Figure 3. Performance of both groups in the pre-test and post-test on checklist scores, procedure time 
and fetoscopy time plotted against the expert benchmark level. 
 
Checklist score (52-items) medians per group 
 









































Figure 2 Performance of both groups in the pre-test and post-test on checklist scores, procedure time and 




Figure 4.  Expert responsens to questionnaire regarding: face validity, educational value and 

























This study shows that training in a lifelike environment significantly increases 
performance for fetoscopic laser surgery in a standardized simulator model. The effect 
of the training was evaluated using a surgical performance score designed specifically 
for the evaluation of performance of therapists performing this procedure. In this study 
we found no difference in time taken or the presence of missed anastomoses between the 
groups. We defined expert benchmark levels for the curriculum to make it proficiency 
based. Feedback provided by the participants indicated that simulator training was 
perceived as a useful educational activity. 
Fetoscopic laser surgery is a rarely performed, invasive procedure that is associated with 
a relatively high rate of fetal loss. The outcomes are shown to be operator and experience 
dependent.4,8 Since the number of procedures per center is limited, organizing appropriate 
training and providing sufficient exposure is difficult.2 To date, a standardized training 
curriculum is lacking. The main advantage of our simulator is that it enables to train 
fetal surgeons and trainees to gain experience in laser surgery without jeopardizing 
patient safety. In addition, it is readily available and allows training the entire procedure; 
including instrumentation set-up, which could be beneficial for a smooth workflow.
In other surgical fields, simulation based ex-vivo training has already been successfully 
integrated into different levels of education.14-16 Several attempts have been made in 
the last years to develop simulators for invasive obstetrical procedures.11,12,17,18 Most of 
these simulators are designed primarily to assess performance during critical parts of 
a procedure, rather than a complete operation. In this study we used a highly realistic 
simulator with the aim that the operators would treat the model like a real patient. There 
is evidence that physical resemblance can be reduced with minimal loss of educational 
effectiveness, provided there is appropriate correspondence between the functional 
aspects of the simulator and the applied context.19 However, the choice of physical 
resemblance for the maximal training effectiveness depends on a number of factors, 
including the context within the simulator is used, kind of task that is trained, level of 
learning involved, abilities and capabilities of the trainee, difficulty of the task and effect 
of various instructional features.20 
Most reported simulations are used for teaching in absence of well-planned and 
comprehensive curricula. A structured curriculum is designed with a logical sequence 
of learning objectives and associated activities.21 The combination of our surgical 
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performance score and simulator appeared useful for training novice fetal surgeons. 
In addition, the set-up can be used to assess performance of practicing surgeons. 
Furthermore, it is an ideal environment to test new equipment or new techniques for 
experienced surgeons in a safe environment.22
Another objective of this study was to set a performance standard for the laser 
surgery assignment by using the parameters of the experts’ performance. We expected 
no differences in these parameters since they had already achieved proficiency as 
demonstrated by other simulation studies23, therefore experts performed the task 
only once. This performance standard can be used for training purposes and also for 
assessment or even certification in order to enhance patient safety. Performance was 
quite consistent as expressed by the small ranges in scores and procedure time. 
The process of skills acquisition may demonstrate individual differences between trainees 
depending on cognitive capacity, perceptual speed, and psychomotor abilities.24 Setting 
a certain number of procedures performed on simulator or actual patients to form an 
option for fetoscopic proficiency may cause bias. Furthermore, initial improvement 
in performance cannot be retained without regular repetition.25 Therefore simulators 
provide a useful tool for the attainment and maintenance of trainees’ surgical skills and 
for immediate or late assessment of their proficiency in those skills. However, a validation 
study of the simulator is always important to determine its capacities for training and 
objective assessment of the surgeons’ performance with different levels of experience.
The current enthusiasm for validation of training and assessment tools and strategies 
is relatively new in the fetal therapy community. Before implementing a simulator in 
training curricula, it should be evaluated whether it trains what it is supposed to train, 
also known as its construct validity. In the design of a curriculum to train surgical skills, 
specification of the training objectives, including identification of the procedural steps 
and analysis of pitfalls, is essential. 
Some limitations were notable in this study. While groups were not significantly different 
in gender demographics and previous technical skills training, the small number of 
participants makes it difficult to classify the groups as fully equivalent. In our study, 
participants were not matched according to demographics and technical capabilities. 
We emphasize that not only ‘number of procedures attended’, ‘experience with other 
invasive obstetric procedures’ and ‘simulation training’, but also sonographic experience, 
minimally invasive skills, and intrinsic qualities (such as spatial awareness) are of major 
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importance when selecting a cohort for training fetoscopic laser surgery. It is important 
to note that future fetoscopic surgeons in training are not compatible to a general 
population of residents. 
Before training, we noticed a shorter procedure and fetoscopy time in the control group. 
We emphasize this illustrates that differences in baseline characteristics are probably 
related to many other factors than represented in our questionnaire. Therefore our 
results should be interpreted with care. Even though a greater number of participants in 
the study may have provided further evidence of significant differences in outcomes and 
increased study power, this would not reflect reality. 
This simulator training can be an effective tool for improvement of technical skills under 
a safe learning environment before performing fetoscopic laser surgery in the operating 
room.
Certainly, future studies would be required to establish reliability and implementation 
of such a training in a more expanded setting. Research should be focused on validation 
of the curriculum to make sure that trainees that go through this curricular training 
process, actually perform better in the operating room with more technical proficiency. 
Above all, monitoring of quality of care is of utmost importance. 
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APPENDIX
No. Domain and substeps Score
A Preparation in operating room 7
1 Ultrasound correct settings  
2 Endoscopy tower settings  
3 Positioning of screens  
4 Adjusting lights  
5 Correct laser modus  
6 Correct power settings  
7 Positioning of patient  
B Ultrasound examination (together with sonographer) 7
8 Identification of donor  
9 Identification of recipient  
10 Identification localization placenta  
11 Identification cord insertions  
12 Assess deepest pockets  
13 Determine expected position equator  
14 Determine insertion site fetoscope  
C Pre-operative preparations 7
15 Surgical briefing (time out) about (complete) procedure to fetal therapy team  
16 Aseptic procedure for surgeon, scrub nurse and sonographer  
17 Mention maternal condition  
18 All instrumentation remains sterile  
19 All is sufficiently covered  
20 Pre-insertion connection scope - shaft  
21 Pre-insertion connection light cable  
D Positioning and connection of instruments (pre-insertion) 6
22 Choose fetoscope  
23 Fetoscope: orientation  
24 Fetoscope: focus  
25 Fetoscope: white balance  
26 Connection of laser fiber  
27 Correct loading of laser fiber in fetoscope  
E Insertion 5
28 Preparation of introduction method  
29 Performance of all manipulations under ultrasound visualization  
30 Correct administration of local anesthetic  
31 Make adequate-size skin incision with surgical knife  
32 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion
F Orientation 8
33 Assess visibility (optional: score visibility)  
34 Determine need for amniotic exchange  
35 Fetoscopic view of placenta  
36 Fetoscopic view of donor  
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37 Fetoscopic view of cord insertion recipient  
38 Identification of placental edges  
39 Difference between artery and vene  
40 Find (part of ) vascular equator  
G Laser coagulation 4
41 Coagulation of all vascular anastomoses that cross the vascular equator  
42 Laser fiber correct position in fetoscope  
43 Laser fiber correct distance from vessel during coagulation  
44 Prevent the unnecessary sacrifice of placental tissue  
H Assessment during procedure 3
45 Prevent unnecessary delay during procedure  
46 Check for complications(e.g. bleeding, rupture intertwin membranes)  
47 Identify and record number and type of anastomoses coagulated  
I Amniodrainage 2
48 Controlled drainage of polyhydramnios  
49 Assess adequate drainage (ultrasound guided) until pre-defined level  
J Closure 1
50 Closing skin incision (suture or suture free adhesive product)  
K Direct post-operative management 2
51 Inform patient, partner/family and referring specialist  
52 Instructions for monitoring of maternal and fetal condition  









Learning curve and current practice
The concept of a “learning curve” is being used increasingly in surgical training and 
education to denote the process of gaining knowledge and improving skills. An often 
arising question in all types of surgery is the actual number of procedures an individual 
operator has to perform to achieve and maintain satisfactory outcome results. This is 
even truer for complex and rare interventions, such as fetoscopic surgery. Fetoscopic 
surgery is a surgical technique that is used to treat fetus(es) that are still inside the 
pregnant uterus. The most commonly performed procedure is laser surgery for twin-
twin transfusion syndrome. 
 
Twin-twin transfusion syndrome (TTTS) is one of the most common major complications 
of monochorionic (MC) twin pregnancies and carries a high risk of perinatal mortality 
and morbidity. Fetoscopic laser coagulation is the treatment of choice offered in 
approximately 100 specialized centers around the world. TTTS is rare and fetoscopic 
laser treatment is complex. With an increasing number of centers offering this procedure 
there is concern that, at least temporarily, less favorable outcomes will be seen because of 
limited experience in new centers and learning curve effects. 
In chapter 1 of this thesis we used the cumulative sum analysis to assess the learning 
curves and monitor ongoing performance of four operators performing fetoscopic laser 
therapy. This study shows an increase in survival rates with growing operator experience. 
The number of procedures required to reach an adequate level of performance ranged 
between 26 and 35 surgeries. The minimal individual variation in learning profiles that 
we found may be explained by the “group” learning effect, by influence of general 
expertise and exchange of experience.
Fetoscopic laser surgery was first performed in a few centers in the United States and 
Europe. These pioneer centers have made several modifications to the technique, making 
it difficult to compare results between centers. In chapter 2 we conducted an international 
survey and took an important first step in the process of developing evidence-based 
international guidelines, by evaluating differences between international fetal centers in 
their treatment of TTTS. Considerable variations were found in patient characteristics, 
instrumentation and techniques, which appeared to be, at least partially, related to the 
volume of patients treated and geographical circumstances of the centers.
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In chapter 3 we reviewed the early years of practice compared to current practice. Since 
the first publications on fetoscopic laser surgery, survival rates have increased from 35% 
survival of both twins to 65%, with a consistent mean gestational age of 32 weeks. The 
evolution of the laser technique is likely to have significantly impacted this. Learning 
curve effects and improved early neonatal care may be other attributing factors. Even 
though we showed a significant increase in neonatal survival in 25 years, results are still 
far from optimal. We see challenges in improving the treatment of TTTS to increase 
survival of both twins and in prolonging pregnancies beyond 34 weeks of gestation.
Challenges in monochorionic pregnancies
Some MC pregnancies are more challenging than others. Fetoscopic laser surgery may 
then either not be considered as the first treatment of choice or may fail due to technical 
limitations in identifying anastomoses. Identification of those challenging subgroups is 
important to determine the best management options. 
In chapter 4 we focused on antenatal surgical interventions in monoamniotic (MA) 
pregnancies. Compared with complicated diamniotic cases, MA pregnancies carry 
additional risks. We studied MA pregnancies complicated by TTTS, twin reversed arterial 
perfusion, discordant anomalies, or request for reduction. We investigated relevant 
technical aspects of several fetal surgical interventions in complicated MA pregnancies 
and compared our experience with data obtained by a systematic review of the literature. 
We concluded that these complex procedures in this rare and highly complicated group 
of pregnancies, can lead to good outcome in the majority of cases, when performed 
in highly specialized fetal treatment centers. In case of a single intended survivor, our 
results suggest improved pregnancy outcomes in cases treated with cord transection (e.g. 
cutting the cord of the affected twin to prevent entanglement). Considering the rarity 
and complexity of these pregnancies, it remains crucial to individualize each case when 
determining the timing and type of intervention.
As it is an invasive procedure, perioperative complications of laser surgery itself  increase 
the risk of adverse outcome. One of these complications is unintentional perforation of 
the intertwin dividing membranes, thereby creating an iatrogenic monoamniotic twin 
(iMAT) pregnancy. If  iMAT is suspected, pregnancies are often more closely monitored, 
hospitalization after viability is considered and a preterm, elective Cesarean section is 




In chapter 5 we investigated the incidence of iMAT after laser surgery for TTTS and 
compared management and perinatal outcomes of suspected iMAT cases with those of 
twins with intact intertwin membranes. Patients with iMAT were more likely to deliver 
prematurely, and this was associated with increased neonatal morbidity. Moreover, 
iMAT may serve as an indicator for technically difficult procedures. 
Another group in which laser therapy can be more difficult includes triplet pregnancies. 
Because a MC twin pair can be part of any other high-order multiple pregnancy, survival 
rates of MC triplets are often confused with dichorionic (DC) triplets, with one pair of 
MC twins affected by TTTS and one singleton. This situation is different to MC triplets 
that share a single placenta with three fetuses and therefore all three, instead of two 
fetuses, are connected by vascular anastomoses. 
In chapter 6 we compared the perinatal outcomes of all MC and DC triplets with TTTS 
treated at our center and reported in the literature in the last two decades. Perinatal 
morbidity and mortality in MC triplets with TTTS was higher and gestational age at 
birth earlier than in DC triplets. The data demonstrate that fetoscopic laser coagulation 
in DC triplet pregnancies complicated by TTTS is a feasible treatment option with 
increasing survival rates and more advanced gestational age at birth.
Model for training laser therapy Knowing that laser therapy is a complex procedure and 
there is an increased need for training, the final part of this thesis is dedicated to development 
of a training curriculum for this procedure. The SILICONE project: SImulator for Laser 
therapy and  Identification of  Critical steps of  Operation:  New  Education program; 
consists of three parts: 
Part 1: Development of an evaluation instrument for fetoscopic laser surgery. 
Part 2: Validation of this instrument. 
Part 3: Validation of a training curriculum based on the instrument. 
 
A first essential step towards a training curriculum was determining the applicable items 
to assess. In chapter 7 we used the Delphi methodology to achieve expert consensus 
regarding the substeps that are considered essential in performing laser surgery for 
TTTS. The majority of fetal surgery experts participated. We produced a list of substeps 
deemed essential. Items were ranked in order of importance. This study provides a 
first step towards an authority-based training curriculum and evaluation tool for laser 
surgery for TTTS.
In the second part of the project we assessed the reliability and construct validity of 
the evaluation instrument in the context of fetoscopic operating room performance. 
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(chapter 8) We developed a silicone simulator for laser therapy and asked experts and 
novices to perform the laser procedure on the simulator. The assignment was evaluated 
by two independent observers using the evaluation instrument. An acceptable level of 
inter observer reliability was demonstrated. The instrument effectively distinguished 
between performance of experts and novices. 
In order to evaluate whether simulator training could be attributable to gain and 
retain skills in fetal therapy, in the third part of the project we performed a prospective 
randomized controlled trial and assessed a comprehensive training curriculum (based on 
the essential steps defined in part 1) for fetoscopic laser surgery. (chapter 9) Novices who 
participated in the curriculum showed better performances during an ex vivo assignment 
on the high fidelity simulator for laser therapy for TTTS, compared to novice without 




Dit proefschrift beschrijft de behandeling van ongeboren kinderen door een kijkoperatie 
in de baarmoeder; dit noemt men foetoscopische chirurgie. Het tweeling transfusie 
syndroom, een zeldzame ziekte bij ééneiige tweelingen, is één van de aandoeningen 
waarvoor deze operatie nodig is. Deze zeldzame ingreep wordt op dit moment uitgevoerd 
in slechts honderd gespecialiseerde centra wereldwijd, maar zal komende jaren in steeds 
meer centra worden verricht. Dit proefschrift richt zich daarom op de kwaliteit en het 
aanleren van deze operatie. 
Tweelingen
Ongeveer twee op de honderd zwangerschappen betreft een tweeling. Er bestaan twee 
soorten tweelingen: een- en twee-eiige. Twee-eiige tweelingen ontstaan na de bevruchting 
van twee eicellen. Bij twee-eiige tweelingen heeft ieder kind een eigen placenta 
(moederkoek) en een eigen vruchtzak. Dit wordt een “dichoriale” tweeling genoemd. 
Een-eiige tweelingen ontstaan na de bevruchting van één eicel, waarna splitsing in twee 
embryo’s plaatsvindt. Een-eiige tweelingen zijn genetisch identiek. Van de eeneiige 
tweelingen heeft 30% ook een eigen placenta en vruchtzak (en is dus dichoriaal). Echter 
de meerderheid (70%) van de eeneiige tweelingen deelt een placenta, waarbij ieder kind 
een eigen vruchtzak heeft. Dit wordt “monochoriaal (MC) diamniotische” tweeling 
genoemd. Bij 1% van de eeneiige tweelingen delen de kinderen zowel de placenta als de 
vruchtzak. Dit heet “monochoriaal monoamniotisch” (MA). Het moment van splitsing 
na de bevruchting bepaalt of de kinderen placenta en vruchtzak gemeenschappelijk 
hebben. Vroege splitsing (binnen 3 dagen na bevruchting) leidt tot een dichoriale 
tweeling, latere splitsing (tussen dag 3 en 9) leidt tot MC diamniotische tweeling en 
splitsing na dag 9 leidt tot een MA tweeling.
Tweelingen hebben een hogere kans op complicaties dan eenlingen. MC tweelingen 
hebben op hun beurt weer een hoger risico dan dichoriale tweelingen. Dit verschil wordt 
met name veroorzaakt door vaatverbindingen op de gemeenschappelijke placenta. Deze 
vaatverbindingen zijn aanwezig bij vrijwel alle MC tweelingen. Via deze vaatverbindingen 
zijn de bloedsomlopen van beide kinderen aan elkaar verbonden en kan gedurende elk 
moment tijdens de zwangerschap en bevalling bloeduitwisseling plaatsvinden.
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Bij negen van de tien MC tweelingen stroomt even veel bloed van het ene kind naar het 
andere als andersom. Hiermee is de bloedstroom in balans en ontstaan er meestal geen 
problemen. Als de bloedstroom tussen beide kinderen echter niet in balans is, ontstaan 
er complicaties zoals het tweeling transfusie syndroom (TTS).
Tweeling tranfusie syndroom
Bij TTS stroomt meer bloed door de vaatverbindingen van het ene kind (de “donor”) 
naar de ander (de “recipiënt” of “ontvanger”), dan omgekeerd. Bij de donor ontstaat 
hierdoor een tekort aan bloed, waardoor hij eerst minder en later helemaal niet meer 
plast (doordat de nieren al het vocht dat er nog is vasthouden) en daardoor uiteindelijk 
geen vruchtwater meer heeft. Het vlies van zijn vruchtzak zit dan strak om hem heen. De 
ontvanger krijgt juist te veel bloed en gaat hij steeds meer plassen. Hij krijgt daardoor te 
veel vruchtwater in zijn vruchtzak. De grootte van de baarmoeder neemt door dat vele 
vruchtwater in korte tijd fors toe, waardoor er een grote kans is op vroegtijdige weeën, 
het breken van de vliezen en vroegtijdige geboorte. Beide kinderen worden in korte tijd 
ernstig ziek. 
Als TTS niet wordt behandeld dan is de sterfte 80-100%. De beste behandeling voor 
TTS is foetoscopische laser behandeling waarbij de vaatverbindingen tussen de kinderen 
worden dicht gebrand. Bij deze behandeling wordt tijdens de zwangerschap (via de buik 
van de moeder) in de baarmoeder een klein instrument met een camera (de foetoscoop) 
ingebracht waarmee de vaatbindingen kunnen worden opgespoord en één voor één dicht 
gebrand met laserlicht. Na een succesvolle behandeling zijn de twee bloedsomlopen 
volledig van elkaar gescheiden.
TTS is zeldzaam en foetoscopische laserbehandeling is complex. Wereldwijd wordt 
op dit moment de foetoscopische laser behandeling aangeboden in ongeveer 100 
gespecialiseerde centra. Het Leids Universitair Medisch Centrum (LUMC) is het 
nationaal verwijscentrum voor invasieve foetale therapie (chirugische behandelingen 
van ongeboren kinderen) in Nederland. Sinds 2000 wordt hier de laserbehandeling 
uitgevoerd. Jaarlijks worden in Leiden 50-70 gevallen van TTS behandeld. 
Dit proefschrift richt zich op het in kaart brengen van de laser behandeling voor TTS. In 
het eerste deel beschrijven we hoe op dit moment de laser behandeling wordt uitgevoerd, 
hoeveel kinderen overleven na deze behandeling en hoeveel ingrepen een beginnende 




In het tweede deel beschrijven we een aantal groepen zwangerschappen met TTS waarbij 
de laser behandeling technisch lastig is, te weten MA zwangerschappen en drielingen.
In het derde deel van dit proefschrift hebben we ons gericht op het ontwikkelen van een 
gestandaardiseerde training voor deze ingreep en hebben deze getest op een simulator. 
Leercurve en huidige stand van zaken
Recent gepubliceerde studies over TTS laten ondanks de vooruitgang op gebied van de 
foetale therapie nog steeds een relatief  hoog sterftepercentage en vroeggeboortes zien. 
De publicaties over de resultaten van de laserchirurgie komen vooral van de grote, meest 
ervaren centra. Het is aannemelijk dat in kleinere of meer recent geopende centra de 
resultaten minder succesvol zijn. Met de verbeterde economische situatie in een aantal 
niet-westerse landen zoals China, Brazilie en India zal het aantal centra dat deze ingreep 
aanbiedt toenemen. Door deze ontwikkelingen is er vraag naar training, evaluatie van 
leercurven, mentoring en andere vormen van ondersteuning van nieuwe centra.
Een veel gestelde vraag binnen het vakgebied is: Wat is het gewenste aantal procedures 
dat een individuele operator moet verrichten om de huidige resultaten van de ervaren 
centra te bereiken en behouden?
In hoofdstuk 1 van dit proefschrift hebben we de leercurve van de laserbehandeling 
voor TTS onderzocht. Voor dit onderzoek hebben we de resultaten van vier operateurs 
geanalyseerd. Deze studie toont een stijging van de overlevingskansen van de kinderen 
naarmate de operateur meer ervaring heeft. Het aantal procedures dat nodig is om 
minimaal in 36% van de ingrepen overleving van twee kinderen te bereiken varieerde 
tussen de 26 en 35 operaties. We vonden slechts minimale variatie in leerprofiel tussen de 
verschillende operateurs. Dit kan mogelijk verklaard worden doordat men de procedure 
als groep heeft geleerd en betrokkenen hun ervaringen en kennis regelmatig uitwisselden.
Foetoscopische laser behandeling werd 25 jaar geleden voor het eerst uitgevoerd in enkele 
centra in de Verenigde Staten en Europa. Deze pioniercentra hebben onafhankelijk van 
elkaar diverse wijzigingen aangebracht in de techniek, waardoor het moeilijk is om de 
resultaten tussen de centra te vergelijken. In hoofdstuk 2 hebben we een internationaal 
vragenlijst onderzoek uitgevoerd om de verschillen in behandelingen tussen centra in 
kaart te brengen. Dit onderzoek vormt een belangrijke eerste stap in het ontwikkelen van 
internationale evidence-based richtlijnen voor deze behandeling. Aanzienlijke verschillen 
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werden gevonden in de karakteristieken van patienten die in aanmerking kwamen voor 
een behandeling, de gebruikte instrumenten en techniek van de behandeling. Deze 
verschillen bleken gerelateerd aan het aantal patiënten dat per centrum jaarlijks werd 
behandeld en geografische omstandigheden van de centra.
In hoofdstuk 3 geven we een overzicht van de zwangerschapsuitkomsten na 
laserbehandeling in 25 jaar tijd. Sinds de eerste publicaties over de laser behandeling is 
de kans op overleving voor beide kinderen significant gestegen van 35% tot 65%, met 
een constante gemiddelde zwangerschapsduur van 32 weken. Aanpassingen van de 
lasertechniek hebben deze resultaten waarschijnlijk aanzienlijk beïnvloed. Daarnaast 
spelen leercurve-effecten en verbeterde vroege neonatale zorg een rol. Dit onderzoek 
geeft een goed overzicht van de resultaten na behandeling als benchmark voor startende 
centra. 
Gecompliceerde monochoriale zwangerschappen
Sommige MC zwangerschappen zijn gecompliceerder dan andere. Het kan hierbij 
gaan om monochoriale monoamniotische (MA) zwangerschappen, zwangerschappen 
waarbij tijdens de behandeling extra complicaties optreden of drielingen waarbij TTS 
ontstaat. Het is van belang deze subgroepen te herkennen omdat de laserbehandeling in 
die gevallen technisch lastig kan zijn, of niet als eerste keus behandeling overwogen zou 
moeten worden. 
MA zwangerschappen hebben een nog hoger risico op vroeggeboorte en sterfte dan 
MC diamniotische zwangerschappen. Een groot deel van de problemen van MA 
zwangerschappen wordt veroorzaakt doordat de kinderen in één vruchtzak zitten 
waardoor verstrengeling en knopen in de navelstrengen kunnen ontstaan. Omdat MA 
zwangerschappen weinig voorkomen, zijn er maar weinig onderzoeken gepubliceerd 
over de uitkomst van deze zwangerschappen met bovendien wisselende gegevens over 
overleving, complicaties en het nut en mogelijkheid van een behandeling tijdens de 
zwangerschap. In hoofdstuk 4 bestudeerden wij de uitkomsten van MA zwangerschappen 
die in aanmerking kwamen voor een operatie voor de geboorte. Redenen voor operaties 
waren TTS, andere aandoeningen gerelateerd aan gemeenschappelijke vaatverbindingen, 
ernstige aangeboren afwijkingen bij één van de twee kinderen of het verzoek tot “selectieve 
reductie” om risico’s voor het andere kind te verminderen. In deze studie beschreven 
wij de mogelijke behandelopties en zwangerschapsuitkomst. Wij concludeerden dat 
mits de gecompliceerde procedures worden uitgevoerd in gespecialiseerde foetale 
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behandelingscentra, deze kunnen leiden tot goede zwangerschapsuitkomsten. Wanneer 
de behandeling erop gericht is om één kind te laten overleven (omdat de andere afwijkingen 
heeft die niet met het leven verenigbaar zijn) dan blijkt het helemaal doornemen van de 
navelstreng (in plaats van alleen maar afsluiten van de navelstreng van het aangedane 
kind) de beste behandeloptie. Hiermee zou verstrengeling kunnen worden voorkomen.
Laserbehandeling is een invasieve procedure die als zodanig ook de nodige risico’s 
met zich meebrengt. Eén van deze risico’s is onbedoelde perforatie van de vliezen (het 
tussenschot) tussen de twee kinderen. De kinderen, die eerst ieder in hun eigen vruchtzak 
zaten, komen als gevolg van deze complicatie in één vruchtzak te zitten. Hierbij zouden 
dezelfde problemen kunnen optreden als bij kinderen die in aanleg al in dezelfde 
vruchtzak zitten (MA tweelingen).
Als het vermoeden bestaat van een performatie van het tussenschot wordt de zwangerschap 
intensiever gecontroleerd, en wordt, wanneer de kinderen de levensvatbare grens hebben 
bereikt, de moeder soms opgenomen in het ziekenhuis om de conditie van de kinderen 
te kunnen monitoren. Vervolgens wordt een geplande keizersnede afgesproken bij een 
zwangerschapsduur van 32-34 weken om problemen ten gevolge van de verstrengeling 
te voorkomen.
In hoofdstuk 5 wordt gerapporteerd over hoe vaak perforatie van het tussenschot 
voorkomt na laserbehandeling voor TTS en vergeleken we het beleid en de 
zwangerschapsuitkomsten van de groep met deze complicatie met de tweelingen die 
een intact tussenschot hadden. In 20% van de behandelde zwangerschappen werd het 
tussenschot geperforeerd. Patienten waarbij na de operatie het vermoeden was op een 
perforatie van het tussenschot bevielen eerder dan wanneer dat niet zo was. Dit was 
geassocieerd met een laag geboortegewicht en een hogere kans op neonatale problemen, 
zoals hersenschade. Daarnaast vonden we dat perforatie van het tussenschot eerder 
optrad wanneer de ingreep technisch lastig was.
Een andere groep waarbij de laserbehandeling moeilijker kan zijn betreft de drielingen. 
Bij de meeste drielingen heeft elk kind een eigen placenta en eigen vruchtzak. Er zijn dan 
geen vaatverbindingen en de bloedsomlopen zijn niet aan elkaar verbonden. Wanneer 
er sprake is van een drielingzwangerschap waarbij twee of drie kinderen één placenta 
delen, kan TTS optreden. Vaak is het zo dat de drieling bestaat uit een tweeling, met 
een gedeelde placenta en een afzonderlijk kind met een eigen placenta en vruchtzak. 
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(“dichoriale drieling”) Hierbij zijn alleen de bloedsomlopen van de tweeling met elkaar 
verbonden. In zeldzame gevallen delen de drie kinderen samen één placenta en zijn 
de bloedsomlopen van alle drie de kinderen met elkaar verbonden (“monochoriale 
drieling”).
In hoofdstuk 6 analyseerden we de zwangerschapsuitkomsten van dichoriale en 
monochoriale drielingen met TTS in de laatste twee decennia. De kans op sterfte en 
complicaties na geboorte was significant hoger bij monochoriale drielingen vergeleken 
met dichoriale drielingen. Monochoriale drielingen werden ook veel eerder geboren. 
Wij toonden aan dat de resultaten van dichoriale drielingen niet veel verschilt van 
de tweelingen, mist de behandeling wordt uitgevoerd door ervaren operateurs. Voor 
dichoriale drielingen met TTS is laser een goede behandeling. 
Training van laser behandeling
Laserbehandeling voor TTS is een zeldzame en complexe ingreep waarvoor geen 
gestandardiseerde opleiding bestaat. Om deze reden is het laatste deel van dit proefschrift 
gewijd aan de ontwikkeling van een training curriculum voor deze procedure. Dit 
onderdeel kreeg de naam SILICONE (SImulator for Laser therapy and Identification 
of Critical steps of Operation: New Education program) en bestond uit drie delen:
Deel 1: Ontwikkeling van een evaluatie-instrument en definieren van de kritieke stappen 
van de foetoscopische laser behandeling.
Deel 2: Validatie van dit instrument met behulp van een siliconen simulator.
Deel 3: Validatie van een trainingscurriculum op basis van het instrument.
Een eerste stap op weg naar een opleidingscurriculum was het bepalen van de 
verschillende onderdelen die zouden moeten worden geleerd en beoordeeld. In hoofdstuk 
7 wordt gebruik gemaakt van de Delphi-methodiek om expert consensus te bereiken 
over de stappen die essentieel zijn bij het uitvoeren van laser behandeling voor TTS. 
Voor deze studie vroegen we de meerderheid van de foetale chirurgen wereldwijd om 
via een anonieme vragenlijst te beoordelen welke stappen naar hun mening essentieel 
zijn en deze te voorzien van commentaar. De antwoorden van de experts werden net zo 
lang aan de respondenten teruggespeeld tot iedereen het eens was. Het eindproduct was 
een lijst van de deelstappen die essentieel worden geacht voor de behandeling. Daarna 
werden deze stappen gerangschikt in volgorde van belangrijkheid. Hiermee werd een 
evaluatieinstrument opgesteld dat gebruikt kan worden om een operateur te kunnen 
beoordelen die de laserbehandeling uitvoert.
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In het tweede deel van het project (hoofdstuk 8) onderzochten we de betrouwbaarheid 
en validiteit van het instrument bij het meten van prestaties tijdens het doen van de 
laserbehandeling. Hiervoor ontwikkelden we een siliconen simulator waarin levensecht 
de laserbehandeling voor TTS kon worden nagebootst. We vroegen vrijwillers een 
laserprocedure uit te voeren op de simulator. Deze vrijwillers waren experts en 
beginners en zij kregen dezelfde opdracht. De opdracht werd beoordeeld door twee 
onafhankelijke waarnemers met behulp van het evaluatieinstrument. De scores van de 
waarnemers kwamen goed overeen zodat een goede inter-beoordelaar betrouwbaarheid 
is aangetoond. Daarnaast maakte het evaluatie-instrument effectief  onderscheid tussen 
prestaties van experts en beginners.
In het laatste onderdeel van het project (hoofdstuk 9) analyseerden we of trainen aan de 
hand van de lijst met stappen op de simulator zou leiden tot betere prestaties. Opnieuw 
maakte we gebruik van vrijwilligers die allen een opdracht uitvoerden op de simulator. 
Alle deelnemers kregen dezelfde opdracht met gelijke instructie (pre-test). Experts 
voerden de opdracht één keer uit om het expert-niveau te bepalen. Alle beginners 
voerden de opdracht twee keer uit. Voor dit onderzoek stelden we ad random twee 
groepen samen: een groep met beginners die voorafgaand aan de tweede opdracht een 
training zou krijgen en een groep dit geen training kreeg. 
De beginners die hadden geloot voor de training, kregen een training onder leiding van 
een expert gebaseerd op het instrument uit hoofdstuk 7. Zij mochten ook oefenen op de 
simulator. De andere groep kreeg geen training. Alle beginners voerden daarna nog een 
opdracht uit op de simulator (post-test). De prestaties werden door twee onafhankelijke 
waarnemers beoordeeld. De getrainde beginners presteerden significant beter dan de 
ongetrainde beginners en benaderden het niveau van de experts na het uitvoeren van de 
tweede opdracht. Deze studie toont aan dat trainen van operateurs aan de hand van een 
lijst met essentiele stappen en een simulator leidt tot een significante verbetering van de 








The past two decades have led to significant advances in the fields of prenatal diagnosis 
and fetal intervention. The rationale behind fetal interventions is to improve fetal, 
neonatal and long-term outcomes. However, advances in fetal therapy also raise ethical 
issues. These concerns involve maternal autonomy and autonomous decision-making, 
concepts of innovation versus research and organizational aspects in the development 
of fetal care centers. Priority is the safety of both pregnant women and her fetuses. 
It is impossible to treat the fetus without going through the pregnant women (either 
physically or pharmacologically); therefore any fetal intervention has implications for 
the pregnant women’s health.
Antenatal interventions have been offered for a variety of fetal diseases, many of which 
would be lethal without treatment. Nowadays, fetal surgery is standard of care for highly 
selected indications, such as TTTS, TAPS and TRAP. Availability of this technique is 
limited to approximately 100 specialized centers. Starting off  with pioneers’ “with their 
backs against the wall” attempts to prevent fetal demise, the efficacy of fetal surgery 
has now been validated for selected indications by well-designed, randomized controlled 
trials. 1, 2.
The primary problems continue to be accurately identifying which fetuses will almost 
certainly die or become severely injured without intervention, but still will have the 
capacity to recover with relatively normal function if  fetal surgery is performed, and 
to minimize the risk for preterm delivery after fetal intervention.3 The goal of fetal 
surgery is clear: to improve chances of survival and the long-term health of children by 
intervening before birth to correct or treat prenatally diagnosed abnormalities.
Volume issues
In this thesis we focused on treatment for TTTS, as it is currently one of the most 
performed fetoscopic interventions. In chapter 2 we identified that 63% of fetal 
therapists and 52% of centers perform < 20 procedures per year. Even though there is 
limited evidence concerning the ideal number of procedures that should be performed to 
maintain high quality results (chapter 1), many studies have investigated the relationship 
between hospital volume data and post-operative surgical outcomes in other fields of 
surgery. Better outcomes have been reported in high volume institutions for high-risk 
procedures.4-6 “Learning curve” and monitoring studies on fetoscopic surgery show 
that approximately 20-30 procedures per year (per operator) are needed to reach and 
maintain a requisite skill level.7 However, for intrauterine transfusion these numbers are 
higher (34-49 procedures).8 
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One of the limitations in these studies is that the effect on an individual learning curve 
by first assisting a senior operator was not measured. Also not included in the analysis 
was the extent of the operators’ experience with obstetric ultrasound, invasive fetal 
diagnostic and other therapeutic procedures, and endoscopy prior to starting laser 
therapy. 
Some other considerations have to be taken into account when assessing a learning 
curve: Case selection, or case-mix, by either treating predominantly high-risk or low-risk 
cases during the learning phase, will influence learning curve results. Moreover, when 
operating in a low volume center or center with multiple fetal surgeons, equal division 
of the number of procedures performed by each operator annually should be pursued in 
case of rare procedures such as laser surgery in TTTS. 
The learning curves in our series represented the improvement of both the operators, 
from experience and practice, and the performance of the entire team at managing 
pregnancies with TTTS. Teamwork, multidisciplinary discussion with colleagues from the 
neonatology department (including international audits)9, stimulation, controllability, 
and continuity may be beneficial factors. Another most helpful tool, in our view, was 
the systematic evaluation of each treated placenta through careful placental injection 
of colored dye.10
Quality control and monitoring
To optimize surgical outcomes and to decrease medical error, we propose the 
implementation of a continuous audit system, allowing timely feedback at each center 
(chapter 1). When a limited number of surgeries are performed annually, lower volume 
centers will be at risk of late recognition of substandard care or the incidence of 
complications. Aside from medical-legal aspects arising from the public’s interest and 
willingness to invest in healthcare, we found that doctors themselves are increasingly 
interested in development and maintenance of expertise. The objective measurement 
and understanding of surgical expertise acquisition is, not surprisingly, at the forefront 
of surgical education programs.
To fully assess the perinatal outcomes related to the expanding number of centers 
performing fetoscopic laser therapy reporting and monitoring is necessary. Each center 
should at least report short- and long-term maternal and pediatric outcomes and the 
results of placental injection. Furthermore, centers performing fetal therapy should 
have multidisciplinary teams that evaluate the care being offered and discuss difficult 
cases. Regular structural reflection on ones’ own practice is essential to prevent late 
detection of suboptimal performance. If  less favorable outcomes are noticed, a quality 
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cycle including further education, supervision of practice and improvement of learning 
environment should be initiated. As stated in chapter 3, we encourage starting up centers, 
as well as established centers to share their performance for peer review and publish their 
series. 
A suggestion for monitoring of performance could be implementation of a central registry. 
Expert centers should establish criteria for certification and periodic rectification, and 
review the certification process. This should include criteria to be considered competent 
to perform laser surgery as well as the optimal volume of cases. We believe patients and 
referring colleagues are entitled to obtain knowledge of at least center performance for 
any operative procedure, including fetoscopic surgery. Practically, in case of a period of 
deviating or disappointing outcomes, real-time assessment using for example CUSUM 
methodology should be standard practice. Awareness of underperformance alone may 
already improve outcomes.
Access and centralization 
Balancing offering geographical access while maintaining sufficient quantity of cases is 
challenging. (Chapter 2). Concentration of care for this highly specialized procedure has 
been advocated.11, 12 On the other hand, geographical circumstances may justify the need 
for low volume centers, since timely referral and treatment is associated with improved 
dual twin survival and decreased neurodevelopmental delay.13
Centers offering fetal therapy should be geographically distributed throughout a country 
(or province, or continent) to improve access. Patients should be allowed to receive care 
at the institution of their choice even when this institution is located abroad, provided 
that care is given without unnecessary loss of time, or unrealistic burden on health 
care expenses when provided by public money. Close links and ongoing education to 
community providers and referral centers is essential to ensure timely referral. 
 
New fetal therapy centers
The expertise and services required to be considered a fetal center appropriately 
equipped to perform prenatal surgical interventions (such as fetoscopic laser therapy), 
involves a tremendous institutional commitment.14 This should include: an experienced 
fetal care team, (with fetal surgeons, dedicated sonographers and specialized nurses), 
available for urgent referrals every day of the year, a level III neonatal intensive care 
unit, a labor and delivery unit capable of caring for perioperative complications and 
obstetric emergencies with around the clock availability of MFM specialist/obstetricians. 
Logically, neonatologists should be involved, because they will typically be the primary 
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physicians managing the care of the neonate and dealing with the medical consequences 
of the antenatal intervention. Moreover, it should be an institutional commitment to 
track long-term pediatric neurodevelopmental outcomes. Follow-up into childhood 
is indispensable to determine outcome in terms of motor, cognitive and behavioral 
development.15 Additionally, a center should have the capability, manpower and 
laboratory to perform placental injection studies to evaluate treatment.
Postoperative and delivery care may be provided at an outside perinatal center or referring 
secondary or tertiary care center acting in close liaison to the fetal therapy center that 
performed the intervention. The resources should be similar to the resources provided 
at the fetal therapy center in order to maintain uniform care for ongoing outcome 
evaluation. This includes regular of weekly contact with the fetal team coordinator with 
(bi) weekly review by the MFM obstetrician. The fetal therapy team must provide the 
opportunity of around the clock immediate contact and advice for caregivers outside 
the perinatal center.
It is essential to have an established functional cohesive multidisciplinary team with 
the individual members of the team exhibiting and maintaining a level of expertise 
in their respective fields. To ensure quality and safety, it is paramount that this fetal 
surgery team operates together with some regularity. Centers developing new fetal 
therapy programs must receive guidance and training from experienced centers. This 
should include mentoring on the process of evaluation, performing the actual procedure 
and perioperative and post-operative care. The optimal definition for a fetal therapy 
center has yet to be established. Preferably however, national professional bodies such 
as Boards of Obstetricians & Gynecologists should have guidelines describing optimal 
care for pregnancies complicated by fetal anomalies potentially treatable before birth.
 
Challenges for fetal surgeons 
Despite the increasing number of studies that have been published the last decade 
increasing our knowledge, MC pregnancies complicated by TTTS still pose challenging 
problems. Some pregnancies are even more complicated than others.
We studied antenatal surgical interventions in spontaneous MA in chapter 4. When 
anomalies affect only one twin, selective feticide is frequently offered as an intervention. 
In case of a single intended survivor, our results suggest improved pregnancy outcomes 
in cases treated with cord transection. Although often performed with technical success, 
surgical procedures in MA pregnancies can be technically challenging. Especially, cord 
entanglement can be hazardous during fetoscopic interventions. Multiple loops of 
entanglement make identification of the correct cord difficult. Although rare, accidental 
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coagulation of the wrong cord does occur, as presented in our series and previously 
reported.16
In summary, all surgical interventions in MA twins, despite being minimally invasive 
techniques, carry a high risk of complications and require highly skilled operators. To 
improve outcomes in these rare, high-risk pregnancies, international collaboration, 
sharing data on techniques and protocols, benchmarking, and setting standards for 
indications and interventions are achievable and still very valuable goals.
Perforation of the intertwin membrane during the laser procedure, creating an iMAT 
pregnancy, is a common complication, which is associated with preterm birth (chapter 
5). Possible explanations for this increased risk are the intensive fetal surveillance and 
preterm elective Cesarean sections that are carried out in this group in order to prevent 
cord accidents.
Recent evidence suggests that cord entanglement and monoamnionicity in themselves 
(after excluding congenital abnormalities) are not associated with increased perinatal 
mortality or morbidity17, 18. Moreover, iMAT differs from spontaneous amnionicity in 
many respects: in our series, cord entanglement was observed in only 12% of iMAT cases 
after birth, while it is observed almost universally in spontaneous MA pregnancies. The 
placental angioarchitecture of these two groups is also quite different.19, 20 It is likely that 
not only cord entanglement or monoamnionicity itself, but also technical difficulties of 
the laser procedure and aggressive perinatal management influence perinatal outcome in 
iMAT pregnancies. 
Another challenging group includes the triplet pregnancies complicated by TTTS 
(chapter 6).
In MC triplet pregnancies the outcome was poor. Most likely, this is due to the technical 
difficulties of the fetoscopic treatment because of the identification and coagulation of 
vascular anastomoses between all 3 fetuses. Care should be taken when interpreting these 
results due to the limited data on perinatal outcome in triplets with TTTS, particularly 
MC triplets. Only 27 cases of MC triplet pregnancies with TTTS have been reported in 
the literature. The actual number of MC and DC triplets with TTTS may be higher due 
to underreporting/publication bias. Several cases in which the pregnancy was terminated 
or fetal demise occurred spontaneously have probably not been reported. Irrespective of 
zygosity, triplets are high-risk pregnancies due to the high incidence of preterm delivery, 
intrauterine growth restriction and congenital anomalies.21
However, the rarity of these conditions, the required operator and prenatal diagnostic 
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skills, the variety of management options and the requirement of in-depth counseling 
of patients currently limit the availability of such interventions to referral centers for 
fetal medicine.
Training fetal therapy
There is a need to train and educate the next generation of fetal surgeons. Expert fetal 
centers need a solid program in order to prepare their trainees to take over practice. 
Moreover, it is expected that new centers that start to perform fetal therapy will exhibit a 
learning curve and require guidance in learning the procedure. To ensure that the level of 
expertise is maintained, an evidence-based training curriculum and continuous process 
of reporting and monitoring of outcomes would be highly valuable.
In the absence of standardized protocols for fetal therapy, the content of the training 
curriculum developed in this thesis was created with international (authority based) 
consensus (chapter 7). It is important to note that the existence of a consensus does 
not mean that the correct answer, opinion or judgement has been found.22 However, 
according to our expert panel, an acceptable accuracy is created. A potential limitation 
of the methodology is that no significance to each step in terms of outcome could be 
addressed. Although consensus was reached on specific substeps of the procedure, this 
study does not provide information whether this correctly executing a certain substep is 
associated with better or worse outcomes in those that perform it.
Besides evidence on how to perform the procedure, experience with performing the 
procedure itself  is essential. The rapid pace of innovation in surgical procedures, 
combined with new technologies, the need to enhance patient safety and limited 
operating room resources illustrate the need for simulator training.
Simulator training
Simulators provide a useful tool for the attainment and maintenance of trainees’ surgical 
skills and for immediate or late assessment of their proficiency in those skills (Chapter 
8). The process of skills acquisition may demonstrate individual differences between 
trainees depending on cognitive capacity, perceptual speed, and psychomotor abilities.23 
Setting a certain number of procedures performed on a simulator or actual patients 
to form an option for fetoscopic proficiency may cause bias. Furthermore, initial 
improvement in performance cannot be retained without regular repetition.24 
Perhaps more important than the simulation equipment itself, is the creation of the 
simulation program or curriculum. As with any curriculum development, the educator 
must determine several factors to create a simulation program that will be useful. 
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Simulation is simply one aspect of the larger educational program, not the focus of the 
program.25 
Implementation of training
Despite all positive effects of simulation in fetoscopic surgical training, there are 
various practical limitations to implementing simulation training programs. The most 
obvious obstacle is the need for instructors with available time to teach those learning 
on simulators (internationally). The expenses currently incurred in obtaining a simulator 
model adequate for fetoscopic surgical training may also be challenging for individuals 
of MFM centers, especially in developing countries. 
In addition, validation of simulator-based fetoscopy training is required by correlating 
the actual surgical experience with the performance on the simulator. A significant 
amount of important work has been done to validate simulators as viable systems 
for teaching technical skills outside the operating room. The next step is to integrate 
simulation  training  into a comprehensive curriculum (Chapter 9). Randomized 
controlled trials from the general surgery literature have proven that simulation-based 
training leads to detectable benefits for learners in clinical settings.26, 27 
International collaboration
Fetal therapy centers have developed through a variety of multi-disciplinary collaborative 
relationships among pediatric surgery, maternal-fetal medicine and radiology (sub)
specialists. They exist within established obstetric departments of (academic) centers or 
freestanding centers. Cooperation between fetal therapy centers should be encouraged 
to establish collaborative research networks (such as www.tapsregistry.org) and training 
curricula. 
Since fetal therapy concerns rare diseases and procedures, the establishment of centers 
of excellence for those procedures that are both rare and technically challenging may 





Supervised training is essential for safe and effective development of surgical skills. 
Fetoscopic procedures are performed on an infrequent basis, therefore there is a need 
for prolonged and expensive stay in distant fetal therapy centers to accumulate hands-on 
experience.
We believe that a potential new strategy, involving telementoring, could enhance the rate 
of trainees’ supervision, making training safer. Moreover, telementoring could be used 
to support real “competency based” training, guiding trainees from competence under 
supervision to competence for unsupervised procedures in a controlled environment.
Telementoring could also be used for intraoperative consultations between colleagues 
and to deliver new skills to remote units without the need for the mentor to be physically 
present or for the surgeons to travel and attend courses in distant locations. Similarly, 
telementoring could be an inexpensive and efficient system to accredit specialists for 
advanced techniques.
Finally, versatile telementoring systems could be used as a teaching aid for groups of 
trainees and students gathered outside the OR (e.g. in a lecture room), thus reducing 
the number of observers in the room, often competing for a narrow surgical field like 
fetal therapy. If  this technique is combined with the use of a simulator, this would allow 
future fetal surgeons to train new techniques at a desired moment, with guidance of a 
fetal expert without jeopardizing patients safety. 
Technical innovations
Since relatively new, often described as ‘experimental’, some fetal interventions 
are performed within research protocols. It is important to distinguish which fetal 
interventions are standard or evidence based therapy and which are innovative or 
experimental. Especially in this field, surgeons encounter blurring boundaries between 
scientific research and therapeutic medicine. Although innovative practice is associated 
with the rapidly developing technologies used in fetal intervention, this raises concerns 
about the protection of pregnant women and their fetuses from the risks of unproven 
therapies.14 On the other hand without these innovations fetal therapy would not even 
exist. Once feasibility and potential benefit have been identified; innovations should be 
subjected to systematic formal research as soon as feasible.
Fetoscopic surgery, as all endoscopic surgeries, has shown rapid development in recent 
decades, including advances in quality of imaging instruments and surgical techniques. 
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The fetoscope is used as a diagnostic tool to expand vision by magnifying objects inside 
the uterus, displaying the images on a 2D monitor. Diagnostic accuracy depends on 
optical resolution of the scope and the physiological ability of the operators’ brain for 
perception. During surgery the fetoscope is moved to cover the wide area inside the 
uterine cavity creating a flowing image. All information produced by the endoscope, 
i.e. motion, color and shape, is integrated to create a spatial color map in the brain of 
the operator that cannot be produced in a still picture. In other words, an entire three-
dimensional image is created in the mind of the surgeon that cannot be shared objectively; 
this may result in imprecise identification of location and size of the placental vessels 
after fetoscopic observation. Also, each endoscope generally has a blind spot.
In fetoscopic surgery, magnified vision enables visualization of the fine architecture of 
the placenta and fetuses. At the same time, the surgeon encounters several challenges due 
to the limitations of this technique; including incorrect accommodation of the surgeons 
hand and vision, loss of 3D information, and narrow field of view. These associated 
problems could be reduced by the use of a high dynamic range camera, computer and 
new software to enhance imaging. In other words, showing the operator an augmented 
overview of the placental surface and the vascular equator to enhance efficient en 
complete coagulation of the anastomoses. Optimizing the operation conditions by 
improving imaging will undoubtedly benefit the outcomes. Computer-based image 
processing of fetoscopic video images adds new functionality to conventional fetoscopy, 
following the development of new surgical devices, laser techniques and approaches and 
biological knowledge. 
As a surgeon, on has a unique and best view on the operating field. No trainee will 
experience that same look and feel before being in charge on his own. Imagine the 
benefits of seeing through the surgeon’s eyes at that moment. Today, the implementation 
of a small camera, a screen and audio capability in a spectacles’ frame (Google Glass, 
Google Inc, Mountain View, CA) is able to do that and more. The concept of using 
Google glass consultation while performing an operation has recently been proven.29 
In addition to communication with others, interaction with live information adds 
value to technical devices such as these glasses. Imagine the possibilities: patient charts, 
monitoring data, pre-operative diagnostic information, equipment warning signs or 
augmented reality overlays, can be presented without having to turn away from the 
patient. Operating under the watchful eye of a world’s expert, either walking you through 
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CLD Chronic Lung Disease 
COLFAP Combined Laparoscopy and Fetoscopy in cases with completely 
Anterior Placenta
cPVL Cystic Periventricular Leukomalacia 
CUSUM Cumulative Sum analysis
DC Dichorionic
DVP  Deepest Vertical Pocket
FLS Fetoscopic Laser Surgery
GA Gestational Age
iMAT Iatrogenic Monoamniotic Twins 
IUFD Intrauterine Fetal Demise
IUT Intra Uterine Transfusion
LC-CUSUM Learning Curve Cumulative Sum analysis
LUMC Leiden University Medical Center
MA Monoamniotic
MC Monochorionic
MFM Maternal Fetal Medicine 
NEC Necrotizing enterocolitis 
NND  Neonatal Death
PDA  Patent ductus arteriosus
PPROM Preterm Premature Rupture Of Membranes
RA Residual Anastomosis 
RDS Respiratory Distress Syndrome
RFA Radiofrequency Ablation
ROP Retinopathy of prematurity
RVOTO Right Ventricular Outflow Tract Obstruction
SILICONE SImulator for  Laser therapy and  Identification of  Critical steps 
of Operation: New Education program
sIUGR selective Intrauterine Growth restriction
TAPS  Twin Anemia Polycythemia Sequence
TRAP Twin Reversed Arterial Perfusion
TTTS Twin-Twin Transfusion Syndrome
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